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The complement control protein (CP) module (also known as SCR or sushi 
domain) is prevalent amongst proteins that regulate complement activation. 
Functional and mutagenesis studies have shown that in most cases two or more 
neighbouring CP modules comprise specific interaction sites for other molecules. 
Hence the orientation in space of a CP module with respect to its neighbours and the 
flexibility of the intermodular junction are likely to be critical for function. The 
Vaccinia virus complement control protein (VCP) is a complement regulator 
composed in its entirety of four tandemly arranged CP modules. The central two 
modules of this protein have been successfully expressed in Pichia pastoris and the 
structure of the modules, numbers 2 and 3 (VCP2,3), solved using NMR 
spectrometry. Each module has a typical CP module structure and the two modules 
do not share an extensive interface. Inspection of fifty structures calculated 
independently on the basis of the NMR-derived data revealed that the inter-modular 
orientation does not vary much implying that the 40 linker-to-module NOEs limit the 
possible movement of the two modules relative to one another during the structure 
calculation. Module 2 contains a five residue insertion and has a more elongated 
appearance than module 3. Module 3 appears bulkier due to the laterally protruding 
hypervariable loop. Module 3 of VCP-2,3 differs a little in structure from module 3 
from the VCP-3,4 module pair. The structure of VCP-2,3, allowed reconstruction of 
VCP2,3,4 and provides a means of gaining structural information about VCP as a 
whole using a dissect and rebuild strategy. A recent crystal structure of intact VCP 
exhibits a somewhat different orientation of the two central modules. 
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YNB - Yeast nitrogen base 
YPD - Yeast extract peptone dextrose medium 
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Chapter 1 - CP modules and the Vaccinia virus 
complement control protein 
1.1 Modular proteins 
1.1.1 Introduction 
Many proteins are assembled from modules (Baron et al., 1991, Campbell & 
Downing, 1994, Bork et al., 1996). Such modular or "mosaic" proteins may be large 
since many modules can be joined together to form the intact protein. This has posed 
a considerable problem for the study of such proteins by NMR spectroscopy due to 
the size limitations of the technique. 
Modular proteins have been shown to occur in a diverse range of 
environments, appearing in proteins with a range of functions (Bork et al., 1996). The 
term 'module' refers to a unit of protein structure, usually less than 200 amino acids in 
length. Modules are generally encoded by a single exon, have a conserved or 
recognisable tertiary structure, and tend to occur within proteins that have a diverse 
range of functions, frequently alongside other modules (Doolittle, 1995, Bork et al., 
1996). The overall fold of the module is a result of invariant, or semi-conserved, 
residues in the protein sequence and it is this "consensus" sequence that determines 
the module-type (Hegyi & Bork, 1997). Although there are now several instances 
where intact 3D structures of multi-modular proteins have been solved by X-ray 
crystallography (e.g. Naismith et al., 1996, Bouma et al., 1999, Schwarzenbacher et 
al., 1999), crystallisation of modular proteins, which are frequently extended and 
flexible, has often proved an intractable problem. In most cases, however, it is 
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possible to identify modules and to produce in isolation, single modules or pairs of 
contiguous modules (Campbell & Downing, 1998), thanks to the rapid advances in 
genomics and recombinant DNA technology. Several expanding databases that store 
genomic sequences have been instrumental in allowing the identification of open 
reading frames that may encode modular proteins. Pattern-searching can indicate the 
number of repeated, or individual module types that may be present (Ponting et al., 
1999). Techniques such as the polymerase chain reaction (Saiki et al., 1985, 1988), 
which can allow the propagation of a specific piece of DNA conferring a whole, or 
part of, a gene is now routine. This technique, when combined with the many 
available expression systems that can utilise plasmid vectors for expression of a 
protein in a controlled way, has led to the recombinant expression of many different 
module-types in quantities suitable for structure determination. Recombinant DNA 
technology has also allowed pairs of contiguous repeats and longer fragments to be 
structurally analysed. The resulting information can be used in a "dissect and rebuild 
strategy" to gain an insight into the structure of the intact multiple modular protein. 
1.2 The role of modules 
Modular proteins may be composed of multiple examples of a single module 
type, or may contain different module types (mosaic proteins) (Doolittle & Bork, 
1993, Herissat & Bork, 1996). The combination of a limited but diverse range of 
module-types allows a wide-range of possible binding-surfaces. Futhermore, the 
orientation of one module with respect to its neighbours, whether modules of the same 
type or not, can vary, thus conferring extra diversity to the shapes and surface features 
of the parent proteins. Binding sites frequently extend over more than one module. 
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In this way, a relatively small number of building blocks may be assembled in 
different ways to provide a wide range of binding activities. An understanding of how 
the different combinations of modules are arranged, by studying the structures of pairs 
of modules, could help pave the way for modelling the structures of large, intact 
proteins. 
Some examples of tandemly arranged modules that have been studied include 
the structure of two immunoglobin-like domains from CD4 (Wang et al., 1992, Brady 
et al., 1993), fibronectin type 1 domains (Williams et al., 1994), fibronectin type III 
domains involved in cell adhesion (Leahy et al., 1996), and the fibronectin type 
1/epidermal growth factor-like domains of tissue type plasminogen activator (Smith et 
al., 1995). In these examples, the module pairs were determined to have a rigid 
intermodular orientation. Other examples of module pairs exhibit a significant degree 
of flexibility between the modules and examples include immunoglobins in the CD2 
receptor (Jones et al., 1992), the tandem phosphatase SH-PTP2 phospholipid 
recognition domains (Eck et al., 1996), adjacent zinc finger motifs (Bruschweiler et 
al., 1995, Ominchinski et al., 1992) and modules within the cell recognition region of 
fibronectin (Leahy et al., 1996). Other module pairs studied have shown no apparent 
interactions at the modular interface (Hansen et al., 1994, Nakaseko et al., 1992). 
The orientation of one module with respect to the next, which could be one of 
the most important considerations with respect to linking structure to function, is 
defined by the intermodular interface and the extent of the contact between the 
modules (Barlow et al., 1993, Wiles et al., 1997, Casasnovas et al., 1999, 
Scwarzenbacher et al., 1999, Spitzfaden et al., 1997). This seems to be dependent on 
the number of amino acids that link the repeats and the proximity of loops and turns 
within the neighbouring modules. The extent of the intermodular interface in module- 
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module interactions studied to date is attributed to the predominantly non-bonding 
(ionic, hydrophobic, van der Waals) and H-bonding interactions that are present at the 
interface. In certain cases, however, metal ions (Huber et al., 1994) or disulphide 
bonds (Eck et al., 1996) have been shown to participate. 
1.3 CPModules 
1.3.1 Introduction to CP modules 
When considering the contribution of module-module junctions to the overall 
structure and function of proteins, a well-studied example is the family of modular 
proteins that contain complement protein (CP) modules. These modules are so called 
because of their presence in many of the proteins that are part of the complement 
regulatory system (Reid et al., 1986), a major component of the body's innate 
immune system (Figure 1 i). Although the CP module has been most commonly 
associated with proteins from the complement system (Morgan & Harris, 1999), it has 
been identified in many other animal proteins. These include proteins in many 
mammalian tissues and some examples are the blood clotting factor XIII beta chain 
(Day et al., 1989), the GABAb receptor subtype 1 a (Kaupman et al., 1997, I-Iawrot et 
al., 1998), the alpha chain of the interleukin 2 receptor, haptoglobin, endothelial 
leukocyte adhesion molecule 1 and thyroid peroxidase (Day et al., 1989). Prior to the 
completion of the work described in this thesis, 31) structures have been determined 
for two individual CP modules (Norman et al., 1991, Barlow et al., 1991, 1992), for 
three pairs of CP modules 
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Figure 1 i - Proteins in the complement system that contain CP modules. Many of the proteins contain 
more than one module type, but have at least two contiguous CP modules. 
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(Barlow et al., 1993, Wiles et al., 1997, Casasnovas et al., 1999), for a CP-module 
serine-protease domain pair from Cl r (Gaboriaud et al., 2000), and for four CP 
modules plus one atypical CP-like module from 132 glycoprotein 1 (Bouma et al., 
1999, Schwarzenbacher etal., 1999). 
The CP module is characterised by a unique consensus sequence that includes 
glycines, prolines and hydrophobic and aromatic residues (Reid & Day 1989). Most 
characteristically, each CP module also contains four highly conserved cysteine 
residues that form two disulphide bonds close in space to the N- and C- termini of the 
CP module. These disulphide bonds are formed in a I-Ill, TI-TV manner and underpin 
a structural scaffold that is likely common to all CP modules. This consists of several 
(normally between five and eight) 13-strands that surround a hydrophobic core. The 13-
strands are linked by H-bonds to form anti-parallel 13-sheets. A virtually invariant 
tryptophan residue lies in the N-terminal half of the module, next to the (I-Ill) 
disulphide bond. The CP modules are joined to each other in a C - N (head-to-tail) 
fashion. 
1.3.2 Occurrence of CP modules and structural studies 
The 3D structure of a CP module is shown in figure 1 ii. The structures of 
those CP modules studied to date reveal a high degree of similarity although sequence 
homology may be low (20% in some cases). The proteins in which CP modules 
occur, however, have different binding properties. This suggests that non-conserved 
residues at the intermodular interface or linker, and variations in the distribution of 
charged residues around the protein, are likely responsible for functional diversity 
Two CP modules have been identified in each of Cl r and Cis, proteins 
involved in the initiation of the classical complement activation pathway. 
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Figure lii - Structure of a typical CP module 
a) 	N 
b) T 
Figure 1 ii - (a) Fold of a typical CP module. (b) arrangement of 13-strands that form anti-parallel 13-
sheets that contribute to maintaining the overall fold. 
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Pairs of CP modules are also found in other complement proteins such as C7 and C6, 
which are involved in formation of the membrane attack complex (MAC), the 
terminal complex in the complement cascade. C2 and factor B, proteins involved in 
formation of key convertases in the complement cascade contain three contiguous CP 
modules, as does the n-chain of C4b binding protein, which regulates complement 
following classical activation of the cascade. Other complement regulators such as 
decay accelerating factor (DAF) and membrane co-factor protein (MCP) contain four 
consecutive modules, whereas C4b binding protein's a-chain has eight consecutive 
modules. Two complement receptors, complement receptor type 1 (CR1) and 
complement receptor type 2 (CR2) have 30 and 15 (or 16) modules respectively. 
Factor H, another complement regulator, contains 20 tandemly arranged CP modules. 
The diversity in binding of these proteins may be attributed to the variations in 
the sequence of each module due to local insertions, deletions and substitution of 
residues in loops and turns. The first example of a CP module to be structurally 
characterised was the 16th  module of human factor H (Barlow et al., 1991), a protein 
involved in the inhibition of the complement cascade, using solution state NMR 
techniques. This structure determination was closely followed by the solving of the 
structure of another module from the same protein (module 5) (Barlow et al., 1992), 
before the structure of the first CP module pair was published, namely factor H 
modules 15 and 16 (fl-F15,16) (Barlow et al., 1993). These two modules were found 
not to have an extensive interface between them, since there was a lack of contacts 
between amino acids in different modules whose close proximity would have been 
readily detectable as nuclear overhauser effects (NOEs) by NMR. The next module 
pair to be structurally characterised was that containing modules 3 and 4, i.e. the C-
terminal half, of the four CP-module vaccinia virus complement control protein 
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(VCP) (Wiles et al., 1997). In VCP, which is another complement inhibitor, module 3 
has 19% sequence identity compared to ff{-15, and module 4 has 17% sequence 
homology to fH16. In the case of VCP modules 3 and 4, a well-defined 
intermodular interface was observed. The intermodular orientations were described 
mathematically by creating x, y and z axes for each module based on its inertia tensor, 
and calculating the angles through which one module would have to rotate to be 
aligned with the other. The z axis in each case was the long axis of the module, and 
the (mutually orthogonal) x and y axes were defined on the position of the a-carbon 
of the conserved tryptophan that was judged to occupy an equivalent position in each 
module. The angles were then described as the 'tilt' (0), the angles through which one 
module has to move with respect to the other to align the z-axes, (figure 1 iii) 'twist' 
(co) and 'skew' (ö), the angles through which the long axis would have to rotate to 
align the x and y axes. Angles were calculated for each member of the NMR-derived 
ensembles and averaged (± standard deviation). In the case of the pair from factor H, 
ffi-'15,16, the angles were 0, 50 ± 13 0; , 155 ± 23 0;  co, 230 ± 17 0;  these may be 
compared with the angles for VCP3,4 - 0, 59±4 0; , 324 ± 5 0;  co, 22 ± 60. Thus as 
well as being more flexible fH-15,16 appears to have different intermodular angles 
to VCP-3,4. These findings gave the first clear indication that modelling pairs of CP 
modules by homology with known structures would not be straightforward and would 
require more examples to establish patterns that could potentially correlate the 
residues close to an intermodular interface to a particular orientation. 
The structure of the first two CP modules of membrane cofactor protein 
(MCP, CD46) have been solved by X-ray crystallography (Casasnovas et al., 1999). 
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Figure liii - Angles used to describe different orientations of 







Figure 1 iii - The angles used to describe intermodular orientation are shown. The z-axis of each 
module is defined as the principal inertia tensor. The x and y axes are defined by the position of the 
conserved tryptophan residue. The relationship of the second module to the first module is described 
by; Tilt - the angles through which the second module has to move to align with the z axis of the 
reference module; Twist - the angle through which the second module would have to turn to align its x 
and y axes with the x and y axes of the reference module; Skew - the angle at which the original tilt 
was made with respect to the x-axis. The x axis is defined as the CHcx bond of the conserved 
tryptophan, with the y axis 900  to x and perpindicular to the z axis. 
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Each of the two modules at the N-terminus of MCP, which collectively comprise the 
Epstein Barr virus-binding portion of MCP, showed characteristics typical of the other 
CP modules that had been characterised, with 13-sheets surrounding a predominantly 
hydrophobic core. The crystal form of MCP modules 1 and 2 (MCP-1,2) was 
based on six independent module pairs which form a hexamer in the unit cell, 
although no biological relevance has been attached to the formation of the oligomeric 
unit. The two modules, MCP-4 and MCP-2 are joined by a four residue linker 
sequence. A calcium ion was present at the interface in the crystal structure and has 
been implicated as a potential stabilising factor at the interdomain interface in this 
particular case. The calcium ion, however, is not thought to be of any physiological 
importance. Very few interdomain contacts were apparent in the module pairs as they 
appeared in the crystal structure. Inspection of the interface of each MCP1 ,2 pair 
revealed that there was a certain degree of flexibility, since tilt angles varied by '-15 0 
Further movement might have been restricted by contacts associated with the 
hexameric oligomer formed within the crystal. These results implied that 
intermodular movement is a real phenomenon, as opposed to a result of a lack of 
distance restraints in NMR derived structures. 
One of the most interesting CP module-containing structures to emerge 
recently was the crystal structure of Beta 2-Glycoprotein I, which contains four CP 
modules together with a fifth atypical example (Bouma et al., 1999, Schwarzenbacher 
et al., 1999). The protein is present in human plasma and is involved in phospholipid 
binding. This crystal structure again shows that the CP module interfaces can differ 
drastically although in this case there was no evidence of flexibility. The CP 1 -CP2 
interface shows -SO 0  tilt angle, but has a twist angle of 115 
0  The interface is defined 
by four H-bonds and several hydrophobic interactions. The CP2-CP3 pair have a tilt 
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angle of -30 0, a twist angle of -110 
0  and a rather low buried interface surface area 
(270 A2). Three H-bonds stabilise the interface and eleven residues are involved in 
van der Waals interactions, which contribute to the solvent inaccessible nature of the 
interface. CP3-CP4 have a tilt angle of 55 0  a twist of -40 ° and a higher buried 
surface area of 318 A2 , which is defined by hydrophobic interactions between eleven 
side chains - there are no H-bonds at this interface. 
Another recent CP module to be crystallised is in the CP module-serine protease 
domain pair from Cis, a protein involved in the events following the classical 
pathway of complement activation (Gaboriaud et al., 2000). The structures of several 
CP modules are shown in figure 1 iv. It can be seen that the modules are similar in 
structure, making it very interesting when considering the relationship between 
sequence and function. By looking at some of the proteins in the complement system, 
this can be better illustrated. 
1.4 Complement and the Vaccinia virus complement control 
protein 
1.4.1 The complement system 
The complement system is part of the mammalian innate immune system and 
serves as one of the first lines of defence against pathogenic attack and entry of 
foreign material (Law & Reid (eds), 1998). The complement cascade is summarised 
in Figure 1 v. It is divided into two main pathways, the classical and alternative 
routes of activation and it serves to target any foreign material for destruction (an 









Figure 1 iv - Examples of CP module structures 
Figure 1 iv - Examples of known CP module structures for2-g1ycoprotein I. factor H modules 15 and 
16. factor H module 5, Vaccinia virus complement control protein modules 2 and 3 and membrane 
cofactor protein modules I and 2. The individual modules have a similar overall fold, attributed to the 
homology between the protein sequences that characterise the CP module family. 32-glycoprotein I has 
4 CP modules and I CP-like module at the C terminus. 
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Figure 1 v - Shown are the major reactions in the activation pathways of complement. The MAC 
(membrane attack complex) is the terminal component of the complement cascade. Anaphylatoxins 




The activation mechanisms for the two pathways differ in the initial stages, but 
involve complement protein 3 (0) at a later, pivotal point in the cascade. Activation 
of C3 triggers a positive feedback loop resulting in more activated C3 being produced 
(Dodds & Sim, 1997). The positive feedback loop allows the complement system to 
carry out an immune response that may be described as explosive. At several points 
in the cascade, anaphylatoxins are released that are powerful mediators of the 
inflammatory response. The entire system is a series of enzymatic interactions which 
create active fragments that go on to trigger the next stage until the membrane attack 
complex (MAC) is formed. The MAC is a multiple protein complex that integrates 
into target cell membranes and causes cell lysis by 'punching' holes in the membranes. 
C3 is considered activated when it is cleaved to form C3a and Ob. This exposes an 
internal thiolester bond that can bind to hydroxyl or acceptor groups on cell surfaces 
and target them for destruction via the MAC (Dodds et al., 1996), immune clearance 
or for an immune response via antibodies. C4 is also a key protein in the cascade, 
which possesses a similar thiolester bond. Activation can be antibody-mediated 
(classical) or non-antibody-mediated (alternative). Neutral sugars on bacterial cell 
surfaces can also trigger a third pathway, known as the lectin pathway, which operates 
in much the same way as the classical pathway, but does not require antibody (see 
Figure 1 v). 
The potential for damage to tissue is high with such an explosive 
inflammatory response, so it is important that the main convertases are tightly 
regulated in order to prevent host tissue being attacked. To limit the amount of 
destruction to self-tissue, a series of proteins, the regulators of complement activation 
(RCA) are involved. These proteins include DAF (CD55), which increases the rate of 
dissociation of the important convertases in the pathway (Fujita et al., 1987), MCP 
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(CD46), which acts as a cofactor for proteolytic cleavage of C3b and C4b by factor I 
(Seya et al., 1986), CR1 (CD35), a large complement inhibitor with decay 
accelerating and co-factor activities for both the classical and alternative pathways 
(Fearon, 1979, lada & Nussenzweig, 1981, Medof et al., 1982), C4b binding protein 
(C4bBP) which has decay accelerating and co-factor activities for the classical 
pathway (Ogata et al., 1993) and factor H which confers decay accelerating and co-
factor activities in the alternative pathway (Reid & Day, 1989). As mentioned 
previously these RCA proteins all consist in part, or completely, of tandemly repeated 
CP modules (figure 1 i). Binding studies of the complement regulators have shown 
that two, and more commonly three or four, contiguous CP modules are required to 
confer functional activity (Klickstein et al., 1988, Martin et al., 1991, Kalli et al., 
1991, Krych et al., 1991, 1998, Clarkson et al., 1995, Gordon et al., 1995, Iwata et 
al., 1995, Manchester etal., 1995, Brodbeck et al., 1996, Sharma & Pangburn, 1996, 
Kuhn & Zipfel, 1996, Smith et al., 2000, Rosengard et al., 1999). CR1 has a broad 
range of complement regulatory activity, with different binding properties and 
specificities being associated with different triplets within the 30 CP modules, which 
make up its entire extracellular portion. 
Many viruses have evolved proteins able to bind to, or inhibit, key 
components of the complement system as a way to sustain pathogenicity (Rosengard 
& Ahearn, 1999). One of the most interesting examples of such a virus, is the 
Vaccinia virus, which secretes a protein that mimics the human complement 
regulators, thus defending the protein from the complement cascade. 
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1.4.2 The Vaccinia Virus 
Vaccinia virus is a member of the orthopoxviridae and, like other poxviruses 
such as the Variola virus and Cowpox virus, replicates in the cell cytoplasm. The 
virus exists in two forms, the intracellular mature virus (IMV), which is the most 
abundant of the infectious progeny, and the extracellular enveloped form (EEV), 
which is formed when the IMV becomes wrapped in membranes to produce an 
intracellular enveloped virus (1EV) that subsequently fuses with the plasma membrane 
to form the EEV. The different forms of the virus have different cell surface proteins 
and this helps to give the virus biological and immunological diversity and contributes 
to virulence. Different strategies arise from these different forms with regard to 
immune system evasion although all poxviruses release cytokines, chemokines and 
interferons from the infected cells to prevent neutralisation (Kotwal, 2000). The EEV 
is resistant to neutralisation by antibody and is probably the key to dissemination of 
the virus throughout the host. Historically, the immune-evasive nature of Vaccinia 
was fundamental to the eradication of smallpox. Smallpox is caused by the Variola 
virus, which is antigenically related to the Vaccinia virus. Although the Vaccinia 
virus can escape neutralisation by antibodies, the immune response persists after 
vaccination and will attack any antigenically related virus. 
It was mentioned previously that one of the earliest lines of immune defence 
the body has is the complement system, which will target all pathogenic and foreign 
material for destruction. The EEV has been shown to incorporate some of the host's 
complement regulatory proteins into its viral coat as a way of protecting itself. The 
IMV also possesses its own complement regulatory activity, through production of a 
protein that is secreted from cells infected with the virus, which inhibits complement 
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activity by mimicking host RCA proteins (Smith et al., 1997,1999). This protein is the 
Vaccinia virus complement control protein. 
1.4.3 Vaccinia virus complement control protein (sp35) 
Vaccinia virus complement control protein, or VCP, was initially discovered 
after polypeptides were identified in the medium surrounding cells infected with the 
virus (Kotwal & Moss, 1988). When an attenuated form of the virus, designated the 
6/2 mutant, was spontaneously formed these polypeptides were no longer present in 
the surrounding medium. This mutant had a segment of DNA near the left-hand-side 
of the genome missing. One of the proteins, of apparent molecular mass of 35 kDa on 
an SDS polyacrylamide gel, was purified and N-terminal sequence determined. This 
sequence was then compared to the 17 open reading frames within the deleted 
segment of the attenuated virus. One of the open reading frames, corresponding to the 
gene C21L, matched the protein sequence exactly and would encode an open reading 
frame of 263 amino acids. Comparison with other proteins showed that this protein 
could be predicted to form four repeating units, which each shared a consensus 
structure with a module-type (the CP module) known to be common in proteins 
involved with the regulation of complement activation. The viral protein showed 
highest sequence homology with the N-terminal half of C4bBP a—chain. This 
implied that the viral protein may also be involved in complement regulatory activity. 
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1.5 VCP as a complement regulator 
1.5.1 Inhibition of the classical complement pathway 
Several experiments were used to test the complement regulatory activity of 
VCP (Kotwal et al., 1990). The medium from cells infected with the 6/2 attenuated 
mutant, which lacked the open reading frame for VCP, did not inhibit hemolysis of 
IgM-sensitised sheep red blood cells. Hemolysis, an effect of the terminal 
components of complement, was inhibited when the wild type virus was used to infect 
the cells. Other mutant strains, which were engineered to encode selectable markers 
instead of VCP were also created (vSIGK1 and vSIGK3). When medium from cells 
infected with the two mutant strains was used along with human serum and 1gM-
sensitised sheep red blood cells, hemolysis occurred. This effect was not observed 
when the wild type virus was used to infect the cells. To prove that VCP was 
responsible, all the proteins in the medium surrounding the cells infected with the 
virus were purified using a DEAE "Biogel" column, but only the fraction that eluted 
as VCP was shown to have complement inhibiting activity. Further analysis 
subsequently revealed that the protein could bind to C4b, or could promote decay of 
the C4b2a convertase, two effects that would inhibit the complement cascade 
(McKenzie etal., 1992). 
1.5.2 Inhibition of the alternative pathway 
Two pathways exist in the complement system, so it was important to test 
whether the virus could neutralise both pathways, and if the effect could be attributed 
to VCP. The serum from guinea pigs, deficient in C4, an essential protein in the 
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classical pathway, was shown to neutralise the attenuated form of the virus, but not 
the wild type (Isaacs et al., 1992). This suggested that VCP could be affecting the 
alternative pathway of complement. C3b- and C4b-Sepharose columns were prepared 
and the contents of the medium surrounding cells infected with the virus were passed 
down these columns. VCP was shown to stick to both of the columns, and protein 
subsequently eluted from the C4b-sepharose column was passed down the C3b-
sepharose column and retained 75% of the original binding efficiency. Binding to 
either component of the complement system could explain the complement regulatory 
activity of VCP (McKenzie et al., 1992). 
1.5.3 VCP and other complement regulators 
VCP was compared with the other known complement regulators to examine 
its efficiency at inhibition. When examining the IC 50 values of lysis of rabbit and 
sheep erythrocytes, recombinantly generated VCP was shown to be less potent than 
CR1 and Factor H at inhibiting the alternative pathway, and was less effective at 
inhibiting the classical pathway than CR1. It was, however, four-times more potent at 
inhibiting the classical cascade than factor H. VCP also possesses co-factor activity, 
although its mechanism is slightly different from that of factor H and CR1. Both of 
these proteins act as co-factors for the cleavage of C3b by factor I at three different 
sites, termed site 1 (Arg' 281 -Ser' 282), site 2 (Arg' 298-Ser 1299) and site 3 (Arg 932-G1u933). 
VCP, however, only assists cleavage at site 1 (Sahu et al., 1998). 
VCP, therefore, seems to represent a very compact and effective complement 
inhibitor that can inhibit both the classical and alternative pathways, displaying decay-
accelerating, C3b- and C4b-binding, and co-factor activity. CR1 and factor H, have 
respectively 30 and 20 CP modules in their structures but the viral genome would 
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have no need to be burdened with long stretches of DNA since an efficient and more 
compact protein has been evolved. The sequence of VCP, which is not glycosylated, 
is shown (figure 1 vi) and compared with C4b-binding protein, the closest human 
homologue, and the variola virus smallpox inhibitor of complement enzymes 
(SPICE), which is four times more potent than VCP at inhibiting complement, yet has 
95% sequence similarity in its four CP modules (Rosengard & Ahearn, 1998). Other 
viral complement regulators, which also contain four tandemly arranged CP modules 
and are likely similar in structure are the cowpox virus inflammatory modulatory 
protein (IMP) (Miller et al., 1997) and the herpesvirus saimiri complement control 
protein homologue (CCPH) (Albrecht & Fleckenstein, 1992). 
1.5.4 Therapeutic potential of VCP 
Because of its potent functional and compact structural properties, VCP is an 
excellent candidate to study as an anti-inflammatory therapeutic. The complement 
system has been implicated in many diseases, and is thought to be the principal cause 
of the debilitating symptoms of arthritis. The complement system is also responsible 
for the tissue rejection associated with transplants. It can trigger hyperacute rejection 
(HAR), an acute immune response that can cause the very rapid (minutes) rejection of 
transplanted tissue in for example xenotransplantation. The potential to engineer 
porcine organs to express VCP on their surface is an interesting potential use of this 
protein and might, in combination with other drugs, allow xenotransplantation to take 
place effectively, masking the foreign organ from the host's complement system (Al-
Mohanna et al., 2001). However, because of the potential risks posed by dormant 
retroviruses which may exist in the porcine organs, xenotransplantation in this way is 
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Figure 1 vi - Sequence of VCP and homologues C4b binding 













LSCCTIPSRPINMKFKNSVTEDANANYNIGDTIEYLCLPGVRKQKMGPI YAKCTG 	IC WTLFN QCIK 
NCGPP P T LS F AAP MDIT LTE TRF KTCTTLKYTCLPGYVRSHS TQTLTCNSD VGEW VYN TFCI 
LSCCTIPSRPINMKFKNSVTEDANANYNIGDTIEVLCLPGYRKQKMGPI YAKCTG 	TG WTLFN QCIK 
RRCPS PRDIDNGQLDI 	GG VD FGSSITYSCNSGYHLIG E SKSYCELGSTGSMVWNPEAP ICES 
YKRCRH PGELRNCQVEI KTD LS FCSQIEFSCSEGFFLIGS 	TTSRCEVQDRGIG WSHPLP QCE 
RRCP S PRDI DN C L DI 	GG VD FGSSI TYSCNSCYILI C E YKSYC LGSTGSMVWNP AP ICES 
	
VKCQSPP SISNGRHNG Y ED FYTD GSVVTYSCNSCYSLIGN 	SGVLCSG 	GEWNDP P TCQI 
IVKCKPPP DIRNGRHSG E EN FYA YGFSVTYSCDPRFSLLGH ASISCTVENET GVWRPSPP TCEV 
VKCQLPP SISNCRHNG Y ED FYTD GSVVTYSCNSGVSLICN 	SGVLCSG 	GEWNP P TCQI 
VKCP HP TILNGYLSS FGKR S Y S YNDNVDFICKYCYVLSCS SSSTCSPG NTWPELP KCVR 
KITCR KP DVSHGEMVS FGGP IYN YKDTIVFKCQKGFKLRCS 	SVIHCDAD 	SKWNPSPP ACE 
VKCP HP TISNGYLS S FGKR S Y S YNDNVDF KCKYGY V L S G S SSSTCSPG NTWKPELP KCVR 
Figure 1 vi - Sequence of VCP modules 1 (VI) to 4 (V4). The sequence of two homologues of VCP 
are also shown; CO binding protein (C1-C4); Smallpox inhibitor of complement enzymes (SPICE, Si-
S4). The consensus residues are highlighted in bold. SPICE is 95% homologous to VCP. The residues 
in SPICE that differ from VCP are underlined in bold. 
strongly opposed. Other potential therapeutic effects would be in Alzheimers Disease 
(Daly & Kotwal, 1998). The structure of VCP will provide an excellent basis for 
elucidating details of how the CP modules act to inhibit the complement system, 
providing information about exposed surface residues and charge distribution. While 
the individual CP modules could be modelled by homology, module-module 
interactions and angles are difficult to model at present. Nonetheless modelling 
studies have been used to generate structures of VCP (Smith et al., 2000), MCP 
(Listewski et al., 2000) and several other RCAs. The NMR structure of the C-terminal 
half of VCP has been solved previously and it was shown to be composed of two 
typical CP modules, with (as mentioned earlier) an extensive interface between the 
modules such that they have a well defined orientation to one another. Both of these 
modules are (as observed in other CCP modules, see above) composed of eight 3- 
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strands, which form H-bonded n—sheets and they are well-defined in general, with 
little deviation between the structures. The area of highest deviation was the 
"hypervariable loop", a region that shows little sequence conservation when 
compared to other CP motifs and did not adopt a set structure in module 3 (Wiles et 
al., 1997). After the work described in this thesis had been completed, a crystal 
structure of intact VCP was solved (Murthy et al., 2001). This is discussed, and 
compared with the NMR results, in Chapter 6. 
Solving the structure of the intact protein by NMR would be difficult due to 
the heavy overlap of cross-peaks and the line-broadening associated with large 
proteins. Even if the protein were C 13 labelled, it would still be badly overlapped in 
most regions due to the high degree of conservation in chemical shifts for equivalent 
residues in the respective CP modules. To make progress with understanding the 
structure and function relationships of CP module groups, this thesis presents the 
structure of VCP module 2 and 3 (VCP-'2,3), the central two modules of the protein. 
The intention was to provide another CP module structure and another example of a 
CP module pair with its associated intermodular orientation. The fact that module 3 is 
common to both VCP2,3 and VCP3,4, allowed, for the first time, a reconstruction of 
what the intact VCP2,3,4 may look like. This work will aid our understanding of this 
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Chapter 2 - Protein production and purification 
2.1 Pichia pastoris as an expression system 
Choosing an effective protein expression system is an important consideration 
in a project of this nature due to the requirement for milligram quantities of pure, 
isotopically labelled material. In this respect, biological expression systems are more 
suitable than chemical synthesis since isotopic labels can be easily incorporated into 
the expressed protein provided the recombinant organisms are able to survive on 
minimal media. 
Although bacterial expression systems have been used widely (Smith & 
Johnson, 1988, Matthews et al., 1994, Itakura et al., 1977), a eukaryotic expression 
system is a logical choice for proteins that contain disulphide bonds. Using a 
eukaryotic expression system has several advantages; it can properly process the 
protein, fold it and secrete it. Escherichia coli expression, on the other hand, often 
requires additional refolding steps and more extensive purification protocols. 
The Pichia pastoris expression system is similar to that of Saccharomyces 
cerevisiae, and is capable of producing large quantities of protein in a cost-effective 
manner. P. pastoris has many advantages over the S. cerevisiae system. It has been 
shown, in general, to produce better yields of protein, with one copy of the gene in P. 
pastoris expressing comparable amounts of protein to multi-copy insertions in S. 
cerevisiae. P. pastoris plasmids are also more stable than those from S. cerevisiae 
and the expressed protein will more often undergo hyperglycosylation in S. 
cerevisiae, which can lead to problems with purification and activity of the expressed 
protein (Cereghino & Cregg, 2000). Very high levels of protein production are 
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possible with the P. pastoris expression system - 1 - 10% of all successful 
transformants result in a multiple gene-insertion event, where the gene of interest is 
spontaneously inserted several times at a specific locus through genetic recombination 
between the yeast genome and several successfully transformed plasmids. 
2.2 AOX genes involved in protein transcription 
The expression system based on P. pastoris utilises the methylotropic nature 
of the yeast, which allows it to utilise methanol as its sole carbon-source. In order to 
do this effectively, without accumulation of toxic by-products such as hydrogen 
peroxide, P. pastoris contains two genes involved in controlling the transcription of 
alcohol oxidase (AOX). AOX activity is expressed when methanol is the sole carbon 
source available. The enzyme acts as a catalyst in the oxidation of methanol to 
formaldehyde and hydrogen peroxide (Buckholx & Gleeson, 1991, Egli et al., 1980). 
The AOX activity is controlled by two genes that encode alcohol oxidases, AOXJ and 
AOX2. These genes are 97% homologous but have different activities. The presence 
of only one gene instead of two alters the phenotype of the yeast. If AOXJ alone is 
transcribed, the resulting phenotype is known as mut
+  (wild type methanol 
utilisation). This is the phenotype of GS 115 P. pastoris strains, which can utilise 
methanol very efficiently due to the high levels of alcohol oxidase that AOXJ 
encodes. The AOXJ gene is responsible for most of the alcohol oxidase activity in the 
cell (Veehhuis etal., 1983, Ellis et al., 1985, Cregg etal., 1989). Substitution of the 
AOXJ gene with ARG4 from S. cerevisiae results in the expression of the AOX2 gene, 
which can also be used to metabolise methanol, but results in a muts  phenotype (for 
methanol utilisation slow; strain KM71 is an example). This has a much slower rate of 
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utilisation of methanol due to the decrease in alcohol oxidase levels in the absence of 
the AOXJ gene. Both AOXJ and AOX2 genes are under the control of the single AOX 
promoter (Tschopp et al., 1987, Chiruvolu et al., 1997, Cregg & Madden, 1987). The 
gene encoding the protein of interest is inserted into a plasmid that will confer one of 
the phenotypes, mutS  or mut, depending on the strain selected. The gene encoding the 
target protein is subsequently incorporated into the yeast genome due to a single 
crossover event that can occur at any one of three different loci in the genome. In 
successful transformants, the gene of interest will lie downstream of the AOX 
promoter, which will promote transcription of the protein when methanol is the only 
carbon source available. Protein production can therefore be induced by supplying 
minimal media with methanol as the sole carbon source (Cereghino & Cregg, 2000). 
The P. pastoris system can be engineered to incorporate a gene that encodes the S. 
cerevisiae a-factor pre-propeptide which acts as a signal sequence for secretion of the 
protein (Kurjan & Herkowitz, 1982). The resulting protein contains 19 extra amino 
acids (the signal-sequence). These amino acids are normally cleaved from the 
expressed protein in two stages. Initially, the product of the KEX2 gene cleaves at a 
dibasic (Lys-Arg) site, whilst the STE13 cleavage product acts at one of two possible 
cleavage sites consisting of Glu-Ala repeats (discussed later). 
2.3 Plasmids in Pichia Pastoris 
Two plasmids were employed in VCP-2,3 expression. The first plasmid used 
was pPICZaA (Figure 2 i), which confers a phenotype of P. pastoris that requires 
histidine to be supplied to the growth media. pPICZaA has a zeocin-resistance gene 
that can be used as a selection marker for positive transformants carrying the plasmid. 
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The plasmid pPIC9K was also used; it carries ampicillin and kanamycin-resistance 
and contains the HIS4 gene, allowing the cells to metabolise histidine intracellularly. 
Both plasmids were manufactured by Invitrogen (San Diego, CA, U.S.A). The 
plasmids are inserted into the yeast by transformation and the plasmid DNA is then 
incorporated into the yeast genome by genetic recombination (figure 2 ii). 
32 
Chapter 2 








Figure 2 I - Maps of plasmids A) pPICZxA and B) pPIC9K. Each plasmid contains genes that confer 
antibiotic resistance. The plasmids also contain AOX I promoter regions and restriction sites. pPIC9K 
also carries the HIS4 gene. This allows cells to metabolise histidine intracellularly. The gene of interest 




Figure 2 ii - Genetic recombination event involving P. pastoris 




Figure 2 ii - A) The pPICZaA plasmid undergoes a genetic recombination event, as shown, resulting 




2.4 Engineering Pichia pastoris to synthesise VCP-2,3 
2.4.1 Preparation of the VCP-2,3/pPICZctA 
The Vaccinia virus (VV) DNA was a kind gift from Dr. Geoffrey Smith, 
Department of Pathology, Oxford University, Oxford, UK. The VV DNA was used 
to amplify the DNA encoding VCP-2,3 using primers that incorporated EcoRI and 
Nod restriction sites at the 5' and 3' ends of the VCP-2,3 coding sequence 
respectively. 
EcoRI primer 5'-3": 
CCGGAATTCATTAAACGGAGATCGCCATCG 
Nod primer 5'-3': 
ATAGTTTAGCGGCCGCCTATTAAACAATCTGACACGTGGGTGGATCGGA 
The primers were used to amplify the coding sequence forVCP-2,3 (Kowtal & 
Moss, 1988) using the polymerase chain reaction (PCR) (Saiki et al., 1985, 1988). 
The resulting PCR products were then loaded onto an agarose gel and fragments of 
-'400 bp were cut out and purified using a QIAGEN gel extraction kit (Qiagen, 
Hilden, Germany). The fragments were then incubated at 37 °C overnight in the 
presence of EcoRI and Nod restriction enzymes and purified using a QIAGEN mini-
prep kit. The plasmid pPICZaA was also incubated overnight in the presence of the 
same restriction enzymes, EcoRI and NotI, and the linearised product was purified 
using the QIAGEN system. The VCP--'2,3 DNA was ligated into the plasmid at room 
temperature in the presence of T4 DNA ligase and left overnight (Weiss et al., 1968, 
Cohen et al., 1973). The resulting mixtures were purified using the QIAGEN method, 
as before. The reaction solutions and conditions are outlined in protocol 2 i. 
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2.4.2 Transformation into E.CoIi 
Escherischia coli was used to propagate the pPICZaA/VCP--2,3 construct. 
Competent E. coli Top 10 F' cells were prepared to enable uptake of the plasmid. 
Transformation of the construct into the cells was via the calcium chloride (Cohen et 
al., 1972) method (protocol 2 ii) and the resulting cells were plated on Luria-Bertani 
(LB) plates containing 50 tg/ml zeocin to select for positive transformants. Control 
plates with competent cells (untransformed) were also prepared and incubated 
overnight at 37 °C to allow growth. Growth was observed on the plate containing the 
cells transformed with the plasmid and eight colonies from the pPICZaAIVCP2,3 
cells were used to inoculate 10 ml of low-salt LB containing 25 tg/ml of zeocin and 
grown overnight at 37 °C in a shaking incubator. The resulting cells were harvested 
by centrifugation (7 mins at 4000 g; supernatant discarded) and the plasmid DNA was 
extracted using a QIAGEN mini-prep kit. A sample containing 17 p1 of the extracted 
plasmid DNA from each of the eight initial colonies was then left overnight in the 
presence of EcoRI and NotI restriction enzymes. Analysis on an agarose gel showed 
that transformantion had been successful, as indicated by the presence of two bands 
representing the linearised plasmid pPICZaA and the 400bp VCP-2,3 fragment 
(Figure 2 iii). Three of the colonies that contained the successful constructs were, 
again, grown in 10 ml low-salt LB containing 25 p.g/ml zeocin, the plasmid DNA 
extracted as before and sequenced using the dye termination method (Amersham 
Pharmacia, Uppsala, Sweden). The DNA sequencing showed that one colony 
harboured a plasmid that contained the correct DNA sequence for VCP2,3. This 
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Protocol 2 i - PCR, restriction digest and ligation conditions 
PCR Conditions 
Reactant Volume (..tl) 
Thermopol buffer 10 
dNTP's 10 
5' primer 1 
3' primer 1 
VV genome 1 
Taq DNA polymerase (deep vent) 1 
F120 1 
Cycle Number Time (s) Temp (°C) 
1 300 95 (melting) 
2-36 30 95 (annealing) 
30 55 (annealing) 
60 72 (annealing) 
37 300 72 (complete elongation) 
Restriction digest mixture 
Contents for PCR digest Vol. used (p1) 
QIAGEN purified PCR product 5 
1 O EcoRI buffer 2 
EcoRI 0.5 
Nod (kept on ice until used) 0.5 
H20 13 
Contents 	for 	pPICZaA 
digest  
Vol. used (p1) 
QIAGEN purified pPICZaA 5 
1 O EcoR! buffer 2 
EcoRI 0.5 
Not! (kept on ice until used) 0.5 
H20 13 
Ligation reaction mixture 
Contents for ligation reaction Vol (p1) 
pPICZaA cut EcoRI - Nod 1 
PCR amplified fragment cut EcoRI - Not! 7 
T4 DNA ligase 1 
1 Ox ligation buffer 1 
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Protocol 2 I cont'd 
d) PCR conditions for dye terminations sequencing 
Reactant Volume (.tl) 
PCR rection mix 4 
QIAGEN purified DNA 3.5 
5' primer 0.5 
1120 2 
Cycle Number Time (s) Temp (°C) 
1 300 95 (melting) 
2-36 30 96 (annealing) 
15 50 (annealing) 
240 60 (annealing) 
37 300 72 (complete elongation) 
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colony was grown overnight in low-salt LB zeocin to generate more plasmid DNA, 
and plated on low-salt LB plates containing 25 p.g/ml of zeocin to create stocks. The 
plasmid DNA was purified using the Qiagen mini-prep system, as before. Details of 
the transformation methods are outlined in protocol 2 ii. 
2.4.3 Transformation of VCP-2,3/pPICZaA into Pichia pastoris 
To linearise the VCP2,3/pPICZaA construct, the plasmid was left to 
incubate overnight in the presence of the Sacl restriction enzyme, since the pPICZaA 
contains this restriction site. The linearised DNA was separated from the mixture by 
phenol/chloroform-extraction and applied to an agarose gel to confirm the presence of 
the linearised product. Although the linearised plasmid is the same molecular weight 
as the circular plasmid, the intact plasmid will supercoil, which provides a simple 
means of assessing whether the linearisation has been successful or not. Analysis of 
the agarose gel showed that the plasmid had been linearised successfully (figure 2 iv). 
Electroporation was used to transform the linearised plasmid DNA into the yeast 
cells. Application of a 1500 V pulse on a Bio-Rad pulser (resistance 200 Q, 
capacitance 25 tF) causes the yeast cell wall to rupture temporarily, at which time 
surrounding DNA may be taken in. Both strains of the yeast, GS 115 (Cregg et al., 
1985) and KM7 1 (Cregg & Madden, 1987), were prepared for electroporation as 
described in the Invitrogen manual. 
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Figure 2 iii - Agarose gel of linearisation products 
(a)—~ 
Figure 2 iii- Agarose gel showing restriction digest products a fter incubation of plasmid from 
transformed cells with EcoRI and NotI restriction enzymes. (a) shows the linearised plasniid pPICZxA. 
(b) shows the 400bp fragment of VCP2,3. 
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Protocol 2 ii - Reaction conditions for creating pPICZ(xANCP-2,3 
construct 
Preparation of competent cells and insertion of plasmid DNA 
A single colony of E. coil top 1 OF' cells was added to 100 ml LB (Luria-Bertani 
(LB) broth containing 1% Tryptone, 0.5% yeast extract (YE), 1% NaCl, pH 7.0) in 
a 1 litre flask and incubated in a shaking incubator at 37 °C for 3 hours at 300 
r.p.m. The cells were then transferred to sterile 50 ml Falcon tubes using aseptic 
techniques and stored on ice for 10 mins. Cells were harvested by centrifugation 
(10 mins at 4000 rpm, 40  C) and the tubes inverted to drain traces of the media. 
Each pellet was resuspended in 10 ml ice cold CaC12 (0.1 M) and stored on ice. 
The cells were then centrifuged and the media drained, as before. The pellet was 
then resuspended in 2 ml ice cold CaC12 and 200 p.1 of each suspension was 
transferred to a sterile microfuge tube, and 5 p.1 of pPICZaA/VCP2,3 DNA was 
added to each. The contents were mixed and left on ice for 30 mins. The tubes 
were then placed in a water bath which had been pre-heated to 42 °C and left to 
incubate for 90 s before tranferring the tubes to an ice bath and leaving to chill for 
2 mins. LB media (1.5 ml) containing 50 p.1/mi zeocin was added and left to 
incubate for 45 mins at 37 °C. Top agar (1 ml) was then added to the solution and 
left to set. The plates were inverted and left to incubate overnight at 37 T. 
Restriction digest reaction mixture 
Contents of mixture Volume (p1) 
QIAGEN purified DNA 17 
EcoRI 0.5 
Not! 0.5 
EcoRI buffer 2 
41 
Chapter 2 
Both strains were plated on yeast peptone dextrose (YPD) plates containing 1 M 
sorbitol and 1 % histidine, which helps the yeast recover after electroporation) and left 
to incubate overnight. Several colonies were then re-plated on YPD plates containing 
25 [tg/ml zeocin and 1% histidine to select for the positively transformed cells that 
contained the construct. A total of nine KM7 1 colonies and four GS 115 colonies grew 
successfully when zeocin was present. The details of the methods are outlined in 
protocols 2 iii. 
2.5 Protein production and purification 
2.5.1 Screening Pichia pastoris for VCP-2,3 production 
Initially, BMGY (buffered minimal medium with glucose and yeast extract) 
solutions had been used to screen for protein, but this method proved ineffective due 
to infection by E. coli. E. coli do not grow as efficiently in the absence of yeast 
extract, hence BMG (buffered minimal medium containing glucose) was used 
subsequently. 
Protocol 2 iv lists the ingredients for BMG and BMM (buffered minimal 
media + methanol). Each of the nine KM71 and four GS 115 colonies were used to 
inoculate 15 ml of BMG solution, containing 1% histidine. The cells were allowed to 
grow in a glucose-rich medium until an optical density at 600 nm of between 2 and 6 
had been attained. At this point the cells are in the log-phase of growth and will 
produce most protein when methanol replaces glucose as the sole carbon-source. 
Chapter 2 
Figure 2 iv - Agarose gel showing linearised plasmid 
Figure 2 iv - Restriction digest using Sacl revealed two bands on agarose gel. a) Linearised plasrnid 
DNA, as expected. b) Feint band corresponding to supercoiled plasmid DNA. 
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Protocol 2 iii 
a) Linearising Plasmid DNA 
Contents of mixture for Linearisation Volume (p1) 
BSA (bovine serum albumin) 2 
QIAGEN purified pPICZaAIVCP--2,3 plasmid DNA 176 
NEB (New England Biolabs) buffer 20 
Sacl restriction enzyme 4 
Phenol/Chloroform extraction 
Phenyichioroform (200 il of 1:1) was added to the reaction mixture containing the 
linearised plasmid DNA. The resulting solution was mixed, centrifuged at 12000 g 
for 30 s in a microcentrifuge and the top layer (-100 p1) removed. The DNA was 
recovered by ethanol precipitation. This involved adding 10 p1 of 3 M sodium 
acetate (pH 5.2) to the extracted layer to give a concentration of 0.3 M. Ethanol 
(250 p.1 of 70% v/v in water) was then added, the mixture centrifuged for 20 mins at 
13000 g and the supernatant carefully discarded. The DNA pellet was the washed 
using 1 ml 70% ethanol, centrifuged for 1 min at 13000 g and the supernatant 
discarded. The DNA pellet was then vacuum-dried and resuspended in 10 p.1 water. 
Electroporation and Transformation 
Pichia pastoris was grown overnight at 30 °C in a 50 ml conical flask containing 5 
ml YPD (yeast extract peptone dextrose medium, 1% yeast extract, 2% peptone, 
2% dextrose). The overnight growth (0.5 ml) was added to 500 ml of fresh YPD in 
a 2 L flask and grown until an 0D 600 of 1.5 had been attained (- 16 hours). The 
resulting cells were harvested (5 mins at 1500 g, 4 °C) and the pellet was re-
suspended in ice-cold sterile water. The cells were the harvested, as before, and re-
suspended in 250 ml ice-cold sterile water. The cells were harvested again and re-
suspended in 20 ml ice-cold sorbitol (1 M). Finally, the cells were harvested and re-
suspended in 1 ml ice-cold sorbitol (1 M). This created the cells that were 
competent for electroporation. For transformation, 80 p.1 of the cells were mixed 
with 2 p.1 of the ethanol-precipitated plasmid DNA and transferred to an ice-cold 
0.2 cm  cuvette. The cells were left to incubate for 5 min before applying the 1500 
V pulse (25 p.F, 200 Q) for 10 ms. Ice cold sorbitol (1 ml of 1 M) was immediately 
added to the cuvette and the contents transferred to an ice-cold, 15 ml sterile Falcon 
tube. The cells were then left to incubate at 30 °C for 2 hours. Cells (--100 p1) were 
spread on separate YPDS plates plates (as with YPD with addition of 1 M sorbitol). 
The plates were incubated at 30 °C. 
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The P. pastoris cultures were grown overnight in a shaking incubator at 30 °C 
and the 0D 600nm  was checked frequently to detect for log-phase growth. Once the 
desired cell density had been attained, the cells were harvested by centrifugation (5 
mins at 1500 g) and resuspended in 15 ml BMM /1% histidine solution (which is 
equivalent to BMG with methanol replacing the glucose as the carbon source). This 
turns on the AOX promoter and induces protein production. Methanol induction 
levels were maintained by adding 1% methanol and 1% histidine to each inoculated 
vial every 24 hours. After two days of induction, samples of 1.0 ml were removed 
daily and analysed by SDS polyacrylamide gel electrophoresis (PAGE). 
Several of the colonies tested, both KM7 1 and GS 115 strains, showed the 
presence of an SDS-PAGE band (-'20 kDa) that could indicate expression of 
VCP-'2,3. This was -6 kDa higher than the theoretical molecular weight of VCP-2,3, 
although this may be expected due to the anomalous running on an SDS-PAGE gel of 
intact VCP observed by Kotwal (Kotwal et al., 1988). The band was particularly 
prominent in one of the KM7 1 colonies, so a scale-up procedure was carried out. This 
involved growing an initial 10 ml culture of transformed KM7 1 in BMG overnight, 
and using this to inoculate 100 ml of BMG solution. This was grown until an OD600nm 
Protocol 2 iv 
a) Preparation of BMG and BMM media 
One litre of BMG medium contains 100 ml of 1 M potassium phosphate buffer, 
pH 6.0, 100 ml of lOx YNB (134 g yeast nitrogen base dissolved in 1000 ml 
water), 2 ml 500 x biotin (20 mg biotin dissolved in 100 ml water), 100 ml lOx 
GY (1 OOml glycerol added to 900 ml water), made up to 1 litre with water. Each 
solution was filter-sterilised through a 0.4 .tm membrane, or autoclaved before 
use. Preparation of BMM used the same recipe with 10 x M (5 ml methanol 
mixed with 95 ml water) replacing the 10 x GY. 
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of 2.5 had been reached and the cells were then harvested and re-suspended in 20 ml 
BMM (because of KM71's slow rate of utilisation of methanol, the BMM volume 
was 20% of the BMG volume; GS 115 strains are resuspended in an equivalent 
amount of BMM to BMG because of the faster rate of utilisation of the methanol). 
The culture of KM7 1 cells in BMM was grown overnight in a baffled flask in a 
shaking incubator (-P250 rpm at 30 °C); the baffles were important for effective 
oxygenation of the cell culture during expression. Methanol and histidine were again 
added to a final concentration of 1% daily to maintain induction levels, and the level 
of protein secretion was assessed by SDS-PAGE using 1 ml samples removed from 
day 2 onwards (figure 2 v). The induction was stopped after five days, as 
recommended by the Invitrogen manual. 
Inspection of the SDS-PAGE gels revealed high levels of protein production 
for the KM71 strain that had been subjected to the scale-up procedure. This indicated 
that a "jackpot" clone had been created due to a multiple-copy insertion event. To test 
that the protein being secreted was indeed VCP2,3, a 1.0 ml sample of the 
supernatant from five days post-induction was subjected to SDS-PAGE and 
subsequently blotted onto nitrocellulose for N-terminal amino acid sequencing. The 
sequencing confirmed the presence of EAEFIKRRCP and EFIKRRCPSP 
corresponding to the N-terminus of VCP-2,3, preceded by an additional six residues 
(EAEFIK) for one species, or four residues (EFIK) for the second species. The two 
species were present in an apparent ratio of 85:15 in the sequenced protein sample. 
The additional residues were artefacts of incomplete cleavage of the signal sequence 
(EA) and of the cloning procedure (EFIK) (figure 2 vi). 
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Figure 2 v - SDS gel analysis of I ml samples to monitor 
protein expression 















	 Day  
Day  
Figure 2 v - SDS gels of 0.5 ml samples from days 2 - 5 of protein induction. Each of the four lanes A-
D represents the protein from one of the four growth flasks. 
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Figure 2 vi - cloning artefacts 
MRFPSIFTAVLFA ASS ALAAP 





Figure 2 vi - Residues within the dotted box are part of a-factor signal sequence. Initially, the Kex2 
gene product cleaves at the site indicated by the black triangle. The Ste 13 gene product then cleaves at 
one of two positions indicated by the other two black triangles. Residues in bold are part of expressed 
VCP-2,3 + cloning artifacts. Residues surrounded by the thin box are due to incorporation of EcoRl 
restriction site. The thick black box shows part of the expression system not included in VCP-2,3 due 
to cloning of a stop codon after the Not! restriction site. 
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2.5.2 Large scale growth and protein purification 
For large-scale preparation of VCP-2,3, undertaken in order to produce the NMR 
samples, a 10 ml culture of the "jackpot" clone in BMG was prepared and allowed to 
grow overnight in a shaking incubator at 30 T. This 'starter' culture was then used to 
inoculate 2 1 of BMG, and cultured in a shaking incubator until an 0D600 of 2.5 had 
been attained. The pellet was then harvested by centrifugation (5000 g for 10 mins) 
and re-suspended in 400 ml of BMM, to induce expression of VCP-2,3. Aliquots of 
1.0 ml of the suspension were removed and analysed by SD S-PAGE, which revealed 
the presence of protein at the expected molecular weight. Methanol and histidine were 
both added to a final concentration of 1% every 24 hours. After five days of 
induction, the supernatant was collected (10000 g for one hour) and concentrated to 
-50 ml using an Amicon pressure cell with 3 kDa molecular weight cut off 
membrane. The retained concentrate was then centrifuged at 20000 g for 1 hour and 
the pellet discarded. The protein was then applied to a PD-10 (Amersham Pharmacia, 
Uppsala, Sweden) gel filtration column, which removed 95% of the salt in the 
concentrate. The concentrate was eluted from the column in a volume of 3.5 ml and 
applied to a separate PD- 10 column that had been previously equilibrated with 5 mM 
sodium acetate, pH 4.0, and was eluted in a volume of 3.5 ml. This provided an 
effective means of exchanging the concentrate into the desired buffer for cation-
exchange chromatography. The eluate was filtered through a 0.2 p.m membrane and 
applied to a mono-S cation-exchange column, also equilibrated with 5 mM sodium 
acetate pH 4.0. A linear gradient of 0 - 1 M NaCl (1 ml/min over 20 mins) was 
applied to the column and the protein was eluted at 0.6 M NaCl. The cation-exchange 
purification technique was chosen since pure protein was eluted from the column over 
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a short time period (confirmed by SDS-PAGE analysis of the eluent (figure 2 vii)). 
This proved to be a better purification system than a previously tested anion-exchange 
protocol that used a mono-Q column, equilibrated with 15 mM Tris buffer, pH 9.0 
and a 0 - 1 M NaCl gradient over 20 mins to elute any bound protein. Using mono-Q, 
the protein was eluted immediately (figure 2 viii); inspection by SDS-PAGE indicated 
that the protein was pure, but it was subsequently shown to co-elute with a non-
covalently bound carbohydrate that gave strong peaks in 1D NMR analysis. In all ion-
exchange protocols, the absorbance was monitored at 280 nm throughout the elution 
profile to check for those fractions that contained protein. All fractions corresponding 
to absorbance peaks at 280 nm were analysed by SDS-PAGE for the presence of 
VCP-2,3. For mass spectrometric analysis, the fractions that contained VCP2,3 
were desalted using a C4 reverse phase column, (eluting with an acetonitrile gradient, 
figure 2 ix ), freeze-dried, dissolved in 50% acetonitrile in aqueous solution 
containing 0.1% formic acid and analysed by electrospray-ionisation mass 
spectrometry (figure 2 x). The mass obtained was 13582 Da, which was within one 
mass unit of the expected molecular weight of VCP2,3 plus the cloning artefacts 
(EAEFK) at the N-terminus. Two separate peaks were also present, one at 13381 Da, 
corresponding to the alternative form of the protein without the E and A residues at 
the N-terminus (resulting from the Ste 13 cleavage at a different position to the site of 
cleavage in the 'major' species), and the other at 13620 Da (the + K adduct). 
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Figure 2 vii - i (a) Elution profile from mono-S cation exchange column; 5 mM sodium acetate buffer 
was used (pH 4.0) with a linear salt gradient of 0 - I M NaCl applied after 10 mins. Gradient was 
applied over 20 min period. Fractions were collected at 1.0 ml/min. (b) SDS analysis of fractions which 
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Figure 2 viii - a) Elution profile from mono-Q cation exchange column; 50 mM Iris phosphate buffer 
was used (pH 9.0) with a linear salt gradient of 0 - I M NaCl applied after 10 mins. Gradient was 
applied over a 20 min period b) & c) Corresponding SIDS gels from fractions corresponding to 
absorbance peaks on elution profile. 
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Figure 2 ix - elution profile from reverse phase column 
AU 
Minutes 
Figure 2 ix - Elution profile from C4 reverse phase column, used to desalt VCP-2,3 before mass 
spectrometric analysis. An acetonitrile gradient of 80% H 20 (0.1% TFA)/20% AcN (0.1% TFA) to 
10% H20/90% AcN was applied over a 30 minute period. 
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Figure 2 x - Electrospray ionisation mass spectrometry of the 
HPLC-purified protein fraction 
VCP HPLC Fraction 
VAC 1(2.864) Tr (1000:3000,0.13,Mid); Sm (Mn, 2x2.00); Sb (3,20.00) 	Scan ES+ 
8.17e7 
A 
I fltOl fl 
Mass (Da) 
Figure 2 x - Mass spectrometric analysis of protein fragment shows three main bands. Peak A - 




2.6 Preparation of VCP-2,3 for NMR analysis 
2.6.1 ID and 2D homonuclear experiments 
For preparation of VCP2,3 for NMR analysis, the freeze-dried protein was 
dissolved in 1.00 ml H20. The absorbance of the protein at wavelengths 280 nm 
(13.95), 320nm (0. 1), and 350nm  (0.05) were recorded and applied to equation 1, as an 
estimate of the protein concentration (Mach et al., 1992). The concentration of the 
protein from the absorbance measurements indicated that the final sample was 
mM, which was suitable for 2D NMR experiments. The protein was dissolved in 550 
p.1 of 10 mM sodium phosphate, pH 6.0, and 50 p.1 of 2H20 for the 1D and 2D NMR 
experiments. 
Equation 1 
A280 - 10 (2.5 log A320 - 1.5 log A350) 
C= 
5540nW + 1480,Y + 134nC 
C: Concentration in moles/litre 
nw: Number of tryptophan residues in VCP2,3 (2) 
y: Number of tyrosine residues in VCP-2,3 (4) 
nc: Number of cysteine residues in VCP2,3 (8) 
A280 : Absorbance at 280nm 
A320: Absorbance at 320 nm 
A350 : Absorbance at 350 nm 
2.6.2 Preparation of 15N - labelled VCP-2,3 for 3D NMR analysis 
To prepare the 15N-labelled sample, the nitrogen source for both BMG and BMM 
media, normal yeast nitrogen base (YNB), was replaced with YNB that contains no 
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amino acids or ammonium sulphate. Normally, ammonium sulphate is present at a 
concentration of 1% in the YNB but a series of test cultures were prepared in YNB 
with ammonium sulphate present as the sole nitrogen source at concentrations of 
0.2%, 0.4%, 0.6%, 0.8% and 1% (w/v). These test cultures revealed no decrease in 
protein production (estimated from SDS-PAGE) when 0.2% 15N-labelled ammonium 
sulphate was used, so all subsequent ' 5N-labelled growths were carried out using this 
concentration. However, the KM7 1 strain used for protein production required a 
histidine supplement in the growth medium due to the MUtS/Hj5 phenotype of the 
strain. To ensure that all amino acids, including histidines, had been 15N-labelled, the 
plasmid pPIC9K was transformed into the 'jackpot' cell line, using identical methods 
to the initial transformation of pPICZaAIVCP-2,3 into P. pastoris (protocol 2.4.2.i). 
This produced a KM7 1 strain with phenotype MutVHis (as pPIC9K contains the 
HIS4 gene), allowing the cells to metabolise histidine intracellularly. 
The protein concentration was estimated using Equation 1. The absorption 
values were A280, 13.35, A320, 0.1, A35 0, 0.05 which gave a sample concentration of 
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Chapter 3 - NMR 
3.1 Basic principles of NMR 
Nuclear magnetic resonance, or NMR, is an effective tool for gaining 
information about the chemical composition or structure of large and small molecules. 
It is used in classifying compounds, determining the chirality of small molecules, 
solving protein 3D structures and measuring the dynamics of substances in solution. 
NMR relies on the fact that some atoms have a spin quantum number that is a 
multiple of V2  . These nuclei possess a magnetic moment and behave like tiny bar 
magnets when exposed to a high-strength magnetic field. The orientation of the 
nuclei is restricted to 21+1 orientations in space, where I is the magnetic moment of 
the nuclei in question. The different orientations have different associated energy 
levels and slightly more nuclei will exist in the lower state than the higher state, 
according to the Boltzman distribution. Transitions between these states can be 
induced by applying electromagnetic radiation at an appropriate frequency, which 
disrupts the population states of the nuclei. When an external magnetic field, B 0 is 
applied, the nuclei do not align exactly with or against the field, but precess around it 
at the Larmor frequency (v 0). The Boltzman distribution ensures that when this initial 
magnetic field is applied, the bulk magnetisation is in the lower energy state. 
Application of an intense radio-frequency pulse at the Larmor frequency can induce 
inversion or reduction of the bulk magnetisation. The nuclei then precess around the 
new direction of the bulk magnetisation. As they precess, the magnetisation varies 
and can be detected by placing a wire coil near the oscillating nuclei. When the pulse 
is cut off, the magnetisation decays back to the equilibrium state. During this period, 
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the nuclei, which have different local chemical environments, will resonate at 
individual frequencies. The oscillating frequency decay, which varies sinusoidally as 
the nuclei precess, is known as the free induction decay (FID) and can be readily 
measured. 
In essence, the FID encodes the frequency of each nucleus in the sample, 
shifted upfield or downfield from the reference (Larmor) frequency depending on the 
magnetic environment of the nucleus. Thus the 'chemical shift' of nuclei in similar 
environments tend to approximate to characteristic values. The NMR spectrum is 
created by performing a Fourier transformation (FT) on the FID. This allows the 
intensity of each chemical shift to be plotted on a continuous frequency scale. 
The quality of a NMR spectrum depends on the strength of the magnetic field 
used. For small molecules, a magnet of 6.4 Tesla (270 MHz) is sufficient, whereas 
large proteins, which will have nuclei with many overlapping chemical shifts, require 
a magnet of 14.2 Tesla (600 MHz) or above. As the magnetic field is increased, the 
ratio of signal:noise improves (due to increases in the population differences between 
the two energy states), but just as importantly the lines are narrower on the parts per 
million (ppm) scale that is used to quantify the chemical shift. This gives an 
increased resolution in the resulting spectrum (Cavanah et al. (Eds), 1996, Rattle (Ed), 
1994). 
For a protein such as VCP-2,3, which has a MW of -13 500 Da, 1D NMR is 
useful as an indicator of sample strength and of whether the protein is folded and 
mono-disperse. For structural analysis of a protein, however, 2D and 3D spectra are 
necessary to resolve the large number of resonances that are present. The most 
important nuclei in biomolecular NMR are 'H, ' 3C, ' 5N, along with 19F (incorporated 
artificially) and 31 P (in e.g. DNA or phospoproteins). For the study of VCP-2,3, 
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experiments using 1 fl and ' 5N nuclei were sufficient for interpretation of the nuclear 
spins - but for a bigger protein, additional labelling with 13C would have been 
necessary. The various NMR spectra that were acquired for the structural analysis of 
VCP-2,3 are described briefly below along with their merits (the pulse sequences 
shown to illustrate the individual experiments were the ones used to acquire the 
spectra of VCP-2,3). 
3.2 ID and 2D NMR experiments 
3.2.1 ID NMR; pulse and acquire 
A fully Fourier transformed and processed 1D hII  NMR spectrum will contain 
a peak for every proton frequency in the sample although in most cases the peaks will 
be overlapped. A 1D spectrum is obtained by transmitting a radio-frequency (rf) 
pulse at the Larmor frequency, which rotates the bulk magnetisation into a different 
direction. After the pulse of rf, the receiver is switched on, which will detect the 
oscillating frequencies of the nuclei as they relax back to their initial (ground) state. 
If Cartesian co-ordinates are considered, the pulse is normally applied along the x-
axis, causing the bulk magnetisation (aligned along z) to 'flip' into the xy plane. This 
would be a 90 ° pulse. In fact, the duration and direction of the pulse can be altered to 
tilt the bulk magnetisation through any angle. The 'pulse sequence' used to obtain a 
1D spectrum is shown in figure 3 i. 
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Figure 3 1 - The basic pulse and acquire sequence for obtaining a ID NMR spectrum. The resonances 
from the precessing nuclei are detected during the acquire stage as they decay back to the ground state. 
Figure 3 ii - Four stages in 2D NMR experiment 
900 Pulse 
Spins given 	 Spins precessing at 
time to 	 frequency v 1 for 
relax time t1 
preparation 	 evolution 
90° Pulse 
Detection - data collected 
as spins precess at 
frequency v 2 for time t2 
mixing 	 acquisition 
Figure 3 ii - Basic scheme for a 2D NMR pulse sequences. The first pulse excites the nuclei and they 
are given time to evolve during t1. Magnetisation transfer between protons occurs during the mixing 




3.2.2 2D NMR 
All two-dimensional (2D) NMR experiments have the same basic theory and 
can be broken down into four stages outlined in figure 3 ii. The pulse sequences in 
2D NMR are designed to allow detection of magnetisation transfer (coupling) 
between nuclei. The coupling can be through covalent bonds (scalar coupling) or 
through space (dipolar coupling). Two pulses can be applied to the bulk 
magnetisation and the size of the resulting signal will depend on the Larmor 
frequency of the nuclei and the time (t1) between applying the first and second pulse. 
The FID can be collected over another set period of time 42). Therefore, alteration of 
(ti) will result in different Larmor frequencies (vi) having different intensities. 
Acquiring many FIDs at different ti will generate a series of FIDs that can be Fourier 
transformed with respect to both ti and t2 to give a 2D matrix showing intensity 
against frequency (v i ,v2). The chemical shifts of the nuclei that are observed in the 
1D NMR spectrum remain the same and appear as the diagonal of the 2D spectrum. 
Signals that arise from coupling are a product of two nuclei, and will therefore have 
two chemical shifts - the signal is a product of magnetisation transfer between proton 
I and proton J and will have co-ordinates of Ippm,Jppm  in the 2D frequency matrix. In a 
2D experiment, the various frequencies of the nuclei are 'labelled' by their chemical 
shifts during ti and magnetisation transfer from the frequency-labelled protons occurs 
during the mixing period. The initial pulse ensures that the nuclei precess coherently, 
and it is this 'phase coherence' of a group of similarly precessing spins that can be 
transferred to a different group of protons. 
The 2D spectra have more "frequency space" than 1D experiments and 
therefore there is less overlap between peaks. A combination of different, specifically 
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designed, pulse sequences allows identification of signals that are caused by scalar 
coupling through no more than three bonds (correlated spectroscopy, COSY) or 
through up to five or six bonds (total correlation spectroscopy, TOCSY), or by dipolar 
coupling through space (nuclear Overhauser spectroscopy, NOESY). In combination, 
these experiments allow one to distinguish between the sets of nuclei in the different 
side-chains of amino acids and identify pairs of nuclei, perhaps in different amino 
acid residues, that are close enough to participate in through-space interactions. This 
provides the information necessary to determine the structure of a protein. 
3.2.3 2D correlated spectroscopy (COSY) 
A 2D COSY experiment (Jeener, 1971, Aue et al., 1976) is useful for 
identifying atoms that are no more than three covalent bonds apart. The spin 
couplings in a COSY experiment are not transmitted through the peptide bond. The 
experiment produces a spectrum which is particularly useful for amino acid-type 
assignment, since each 'H nucleus in a side chain will have its own predictable system 
of coupled spins. 
The scalar coupling between two nuclei results in four possible energy levels, 
due to the different energy states available to each spin (figure 3 iii). The four energy 
states for the two-spin system are very similar, but have slightly different frequencies, 
so that transition between the states is possible. In practice, a COSY experiment 
typically uses the pulse sequence shown in figure 3 iv. The most simple COSY 
experiment involves a hard 90 ° pulse (prior to ti) that excites all four transitions at the 
same time and a subsequent 90 ° pulse causes sharing of the coherence between the 
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A 1 A2 	X I X2 
 doublet X doublet 
10 
V 
Figure 3 iii: a) Energy level diagram for a two spin (A and X) coupled system. Each of the spins of 
each nucleus can be aligned with or against M. resulting in a doublet for A and X respectively (c). 
Frequency labelling at v for A 1 would result in a two-dimensional spectrum shown in (b). 
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Figure 3 iv - COSY pulse sequence 
RAW SCUBA 	DQF WATERGATE 
IT 
180 90 9090 	180 
90H20 	 M 	 M 	M , 9u'.'I.1r._ C OH n 
G0 	 G 1 
G 
Figure 3 iv - The pulse sequence for a COSY experiment. Techniques such as RAW (randomisation 
approach to water suppression), SCUBA (stimulated crosspeaks under bleached alphas) and DQF 
(double quantum filtering) allow protons close to the water resonance or diagonal to be observed. 
WATERGATE is used to suppress the water signal by applying selective pulses to the water resonance 
(the gradients serve to dephase and re-phase non-water signals) 
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Figure 3 v - 2D spectrum of two spin system when all 





A, A2 	XI X2 
Figure 3 v - A hard 900 pulse excites all four transitions at the same time to produce the sixteen-peak 
contour map for the two spin system. 
transitions. This gives sixteen cross-peaks for the two-spin system, as shown in figure 
3 v. This represents an idealised view of the COSY experiment - advances in NMR 
techniques have resulted in more complex pulse sequences (as shown above) that help 
isolate the useful signals (Altieri et al., 1995). Artefacts are in fact normally present 
that have to be eradicated using methods beyond the scope of this thesis, but 
involving cycling through a number of different pulse and receiver settings for each 
FID 
3.2.4 Total correlation spectroscopy (TOCSY) 
A 2D TOCSY experiment (Braunschweiler & Ernst; 1983), like the COSY 
experiment, makes use of the fact that spin coupling is not transferred through a 
peptide bond and thus the spin systems contained within each amino acid residue of a 
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protein are isolated. In a TOCSY experiment, rf is applied throughout the mixing 
time after a second 90 ° pulse. This provides continuous irradiation and acts as a spin-
lock, as the precessing magnetisation vectors are forced to rotate at the frequency of 
the continuous rf (the Hartmann-Hahn condition) (Hartmann & Hahn, 1962). This 
makes magnetisation transfer very efficient and the extent of the transfer depends on 
the length of the mixing time. In a TOCSY pulse sequence (figure 3 vi) (Shaka, etal., 
1988, Hwang & Shaka, 1995, Callighan et al., 1996) a sequence of quickly repeated, 
180 ° pulses, causes phase coherence to be transferred throughout the coupled spins 
(DIPSI-2 stage). The result is a series of signals representing the transfer of 
magnetisation between all the spins in an amino acid for a chosen mixing time (short 
mixing times result in less propagation of the coherence throughout the side chain of 
an amino acid, longer mixing times improve the transfer efficiency). 
Examples of the resonance patterns expected for amino acids in a TOCSY 
experiment are shown in figure 3 vii. It is obvious that the resonances that appear in a 
COSY spectrum will also appear in a TOCSY spectrum since the latter detects all of 
the possible transitions within the side chains' spin systems. The sixteen peaks that 
may result from a two-spin system in a COSY spectrum are not resolved in a TOCSY 
spectrum due to increased line-width. COSY pulse sequences usually use anti-phase 




Figure 3 vi - TOCSY pulse sequence 
TOCSY 	 DPFGSE 
90 90 	 90 	180 	180 
180., -' - iFTI 
G 0 	G0 G 1 	G 1 G2 	G 2 
G 	 flfl flfl 
Figure 3 vi - TOCSY pulse sequence. The gradients (G) destroy the xy magnetisation whilst the 
DIPSI-2 spin-lock period causes polarisation transfer. Water suppression is via the DPFGSE method 
(double pulsed field gradient spin echo). DPFGSE works with similar principles to WATERGATE, but 






















Figure 3 vii - 2D contour maps of amino acid patterns from 
TOCSY experiment 
Figure 3 vii— contour maps of TOCSY resonances from side-chains of Alanine, Cysteine and 
Methionine 
3.2.5 Nuclear Overhauser spectroscopy (NOESY) 
The NOESY experiment (Jeener et al., 1979) provides information about 
through-space connectivities between nuclei and can, therefore, be used to map the 
position of amino acids with respect to one another. A nuclear Overhauser effect 
(NOE) represents the change in intensity of one resonance when another nearby 
resonance is perturbed. The affected peak gains or loses intensity due to cross-
relaxation, the transfer of magnetisation through space, rather than through scalar 
coupling. The size of the NOE is dependent on the distance between the two nuclei 
and decreases as the sixth power of the inter-nuclear distance. Thus, detection of 
NOEs and measurement of their intensities provide distance restraints and information 
useful in assignment. 
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90 90 	90 	180 
	
180 
I t1  I NOEmix 180i 180H 0 ! 
G 1 	G, G 2 G 2 
G 
Figure 3 viii - NOESY pulse sequence. NOE m ix  is the period during which cross-relaxation between 
protons occurs, resulting in the NOE (detected by applying a third 90 ° pulse). The water suppression, 
as with the TOCSY experiment, uses DPFGSE. 
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Callighan et al., 1996). The third pulse in the sequence allows the dipolar coupling 
between two spins to be observed when a group of spins, precessing coherently during 
t1, undergo cross-relaxation during the mixing period and have a different frequency 
during t2 due to the effects of nearby spins. This involves applying a 90 ° "saturation 
pulse" that will perturb the energy state of one group of precessing spins and result in 
an NOE if cross-relaxation (dipolar coupling) takes place. In practice, this effect can 
only occur if the two nuclei are <-5.5 A apart. 
Although the 2D NOESY spectrum gives enhanced resolution compared to the 
1D version, the spectrum still contains many signals and overlap is inevitable. For 
larger proteins then, resolution is still a problem, even in 2D experiments. For this 
reason, use is made of other NMR observable nuclei (13C,15  N) and, in the case of 
VCP2,3, isotopically labelling with ' 5N was necessary since this allowed 
acquisition of 3D experiments. 
3.3 3D NMR 
3.3.1 Principles 
Three dimensional (3D) NMR operates in much the same way as 2D NMR, 
although the FIDs are now acquired during a third time period, t3, instead of during t2. 
The time periods t1 and t2 are still systematically varied and inclusion of a third time 
period results in a 3D matrix rather than a 2D matrix. The pulse sequences for 3D 
'H 15N HSQC-NOESY and 3D 'H' 5N HSQC-TOCSY experiments are shown in 
figures 3 ix and 3 x (Skienar etal., 1993, Mori et al., 1995). During a 3D experiment, 
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Figure 3 ix -H-',5N HSQC-NOESY pulse sequence. 
	
3D NOESY 	HSQC 
© 	1©1© 
N NOE 	NH 	NH H-e-H" 	N 
NOESY 	 HSQC 
WATERGATE 
1FI 	t1 	 to 	 I tI 	/ILrIi 
15 
N 	
'I 0 I l l 
I 	\I[ 2 	 BB decouPIIj 
H 	HR 	HR 	H 
90 deg pulse 	 180 deg pulse 	 PT 
Figure 3 ix - 'H-'N HSQC NOESY pulse sequence. The pulse sequence for the HSQC NOESY is 
similar to that of the 2D NOESY initially. The magnetisation is transferred to the nitrogen nucleus and 
is then transferred back to the protons before acquisition. This allows connectivities involving protons 
bound to 'N atoms to be observed. 
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Figure 3 x - 1 H-15N HSQC TOCSY pulse-sequence 
	
3D TOCSY 	HSQC 
00ii 
spin-lock N NH 	NH 
H--H 	N - HN 
HSQC 
WATERGATE 
1 H 	t1 	rn-lock  
15N 	 I 	\I 2 	I' BB decoupling 
H 	HH 	HR 	HR 	H 
90 deg pulse 	 180 deg pulse 	 L 	PT 
Figure 3 x -  1H-15N HSQC TOCSY pulse sequence. The pulse sequence is similar to the 2D TOCSY 
experiment. The magnetisation is transferred to the ' 5N atoms and then back to protons again, as in the 
'H-' 5N HSQC NOESY experiment. 
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the phase coherence of a group of spins is transferred to the isotopically labelled ' 5N 
during t2, allowed to evolve and then transferred back to the 'H nuclei. This requires 
two different types of rf pulses, in order to manipulate the different nuclei. The result 
is a third frequency label, v 3 , which is dependent on the Larmor frequency of the ' 5N 
atoms. Thus, the 3D matrix can be used to separate amide protons on the basis of the 
chemical shift of the amide proton and the chemical shift of their attached nitrogen 
atoms. The amide protons are labelled with the frequencies of other protons close 
enough in space to allow exchange to occur and the resolution is improved 
dramatically. The 3D cube can be split into slices in any of the two 'H-proton 
dimensions or in the 15N dimension. A 2D version of the spectrum can also be 
collected which displays each 1 11 15N chemical shift with co-ordinates F' Hppm, F2Nppm . 
Such 2D heteronuclear single quantum coherence spectra (HSQCs) are valuable 
reference spectra, as one peak should appear for each amide proton in the protein. 
Changes in protein structure or conformation can be monitored by acquiring a series 
of HSQC's under different experimental conditions and mapping the changes in 
position of the cross-peaks. 
3.3.2 HNHA experiments 
The HNHA experiment can be used to measure the 3JHNHa scalar coupling. 
The pulse sequence for a HNHA experiment is shown in figure 3 xi (Kuboniwa et al., 
1993, Vuister & Bax, 1993). The HNHA experiment provides valuable information 
since the ratio of the intensity (or integral) of the diagonal (HN) peak to the Ha peak 
is dependant on the angle between the two bonds and can be calculated, in Hz, to give 
structural information. The Karplus curve (figure 3 xi) can be used to correlate the 
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Figure 3 xi - Karplus curve and HNHA pulse sequence 
I 	
I 	I I 	I 	I 	I 
3 JHNHU (Hz) 6 
2- 




60 	120 	180 
b) 
90 	180 	90 90 	180 	90 90 90 
ç 	 I1I I 
I 90 	180 	180 	180 	90 	I 
15 A I T+ t2 /4 I T- t2 14 I T+t,/4 I T- t2 14 	A 	 Decouple] 
G 	
C 1 G 	 C3 	 C3 	 G 2 C 1 G 
fin fin' 
Li 
Figure 3 xi - a) The Karplus curve used to calculate 4i from the 3JHNHa  coupling data. b) Pulse sequence 
for 1-INHA experiment. 
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coupling to the dihedral () angle in the backbone of the protein. In protein structures, 
a 4 angle -120 ° is inferred from a coupling constant of >7.5 Hz and an angle of -60 
is inferred from a coupling constant of <5.5 Hz. 
3.4 Water suppression 
The concentration of protons in water is 1 10 M, which is high compared with 
the -2.5mM proton concentrations in a NMR sample. The result is a huge signal 
originating from the water signal, that would mask an important region (4.4-4.9 ppm) 
of the spectrum corresponding to peaks from Ha protons. One way of eliminating the 
water signal is to acquire spectra using 2H20 as solvent. This provides a means of 
assigning those resonances hidden by the water signal, but does not display 
resonances originating from amides that normally exchange with water but which are 
visible in 1 1­120, such as backbone amides that are not participating in H-bonds and 
side chain asparagine HN protons. 
To combat the water signal problem, a technique called presaturation can be 
applied, which uses a weak radio-frequency at the Larmor frequency of the water 
resonance. So many transitions then take place that there is no bulk magnetisation in 
the M direction corresponding to the water protons when the initial 90 ° pulse is 
applied and so no magnetisation in the M xy plane is observable. In recent years, 
however, more advanced methods of suppressing the water have emerged. Double 
pulsed field gradient spin echo water suppression (DPFGSE) (Grzesiek & Bax, 1993) 
and water suppression techniques such as WATERGATE (Piotto et al., 1992) can be 
employed in multidimensional experiments, as noted in the description of pulse 
sequences of previous sections. Both involve de-phasing the solvent magnetisation by 
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applying pulse gradients to the water signal, causing the bulk magnetisation to tend 
towards zero. 
3.5 Processing NMR spectra 
Before any NMR spectrum can be inspected, the FID has to be properly 
processed. Each FID (intensity versus time) is Fourier transformed to give a spectrum 
that is a plot of intensity versus frequency. The FID can be "zero- filled" before the 
FT to give a better quality spectrum. This effectively adds more data points to each 
FID; normally the FFT (fast Fourier transformation) yields real and imaginary results 
for each FID, which results in two NMR spectra. They contain equivalent 
information, but only half the data points of the original FID are used. Zero filling, 
adds zeros to the data to give more data points and more efficient use of the real or 
imaginary data from the FID. It is also normal to apply a mathematical function to the 
FID, which can reduce the amount of noise and help eliminate distorted peaks that 
often arise at the beginning or towards the end of a FID. Examples are gaussian or 
sinebell functions, which change the shape of the FID to place emphasis on the good' 
parts of the FID. 
After FT, each spectrum must be phased. Bloch equations tell us that the 
product of a FT of a FID varies between absorption and dispersion. Phase-correction 
is necessary to allow a phase error to be carried throughout the spectrum, resulting 
(ideally) in a constant baseline, instead of the fluctuating positive and negative peaks 
normally seen before phasing. Different spectra, however, are phased in different 
ways, although most spectra for VCP-2,3 were phased to produce evenly shaped, 
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Chapter 4 - Assignment of VCP-'2,3 
4.1 Introduction 
Despite constant technical advances, solving the 31) structure of a protein by 
NMR spectroscopy is still not a straightforward process. It involves the successful 
completion of a series of steps. 
Expression and purification the protein may prove to be a time-consuming 
task that provides the first hurdle. Fortunately, the creation of more efficient systems 
to aid protein expression and purification has been the goal of many academic 
research groups and biotechnology companies. The result is an increase in the 
chances of successfully expressing and isolating suitable quantities of the protein of 
interest in a reasonable timescale. For VCP2,3, the Pichia pastoris expression 
system proved to be an extremely efficient system for expressing large quantities of 
the protein in a convenient period of time (see Chapter 2). Purificaton also proved to 
be routine once suitable protocols had been established. 
When studying a protein by NMR, its concentration in solution within the 
NMR tube is an important factor as this will affect the length of time for which a 
spectrum needs to be acquired in order to achieve a suitable signal-to-noise ratio. The 
protein must also be stable during the course of the experiment and this could be 
influenced by microbial contamination of the sample, air oxidation and other chemical 
modifications of the protein, temperature, pH and hydrolytic breakdown by proteases. 
Once the protein has been obtained in milligram quantities, a 1D NMR 
spectrum may be acquired that provides information about the behaviour and 
characteristics of the protein sample in solution. A ID NMR spectrum indicates, for 
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example, if there are likely to be any complications such as dimerisation (or formation 
of higher order aggregates), unfolding or precipitation. A suitable sample will usually 
result in a spectrum that has a good signal-to-noise ratio and well-dispersed, sharp 
resonances; these indicate the protein to be in a folded state. Providing the sample is 
stable and does not oligomerise, further, complex spectra can be acquired that contain 
information necessary to assign each amino acid in the protein, a pre-requisite for any 
structure calculation. 
4.2 The NMR spectra of VCP-2,3 
4.2.1 	ID NMR spectrum of VCP-2,3 
A typical 1D NMR spectrum of —2.5 mM VCP--2,3 dissolved in 550 jtl of 10 
mM sodium phosphate buffer, pH 6.0, with 50 p1 2H20, is shown in figure 4 i. It can 
be observed that the peaks are relatively sharp and appear in all regions of the 
spectrum in which signals would be expected from a folded protein. This indicates 
that the conditions used for the data collection were consistent with the structural 
integrity of the protein. The small peaks at the left hand-side of the spectrum represent 
the tryptophan side-chain NH resonances, one of which is present in each of the two 
modules of VCP-2,3. Those peaks that have negative chemical shifts are particularly 
strong indicators of a folded protein, since they are shifted away from any of the so-
called 'random coil' shifts expected from an unfolded protein. The narrow line-widths 
of peaks in thelD spectrum of VCP-2,3, and the persistence of signals over many 
hours in the spectrometer indicated that the protein was not oligomerising and 
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Figure 4 i - 1D NMR spectrum of VCP-2,3 
-- t 	 - 
6 (PPM) 
Figure 4 i - ID NMR spectrum of VCP-2,3. The spectrum, collected over 128 scans, shows a good 
signal-to-noise ratio. The two peaks around 10 ppm represent tryptophan side chain resonances. The 
—vely shifted peaks are strongly indicative of a compactly folded protein. 
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remained stable over time. The signal-to-noise ratio was consistent with the estimated 
concentration (Chapter 2, Equation 1) of the protein. 
4.2.2 	2D 1 H NOESY and TOCSY 
A set of 2D NMR experiments were acquired using --2.5 mM VCP2,3 and 
these yielded spectra that were deemed to be of sufficient quality for assignment and 
structural analysis, without changing any of the experimental conditions (pH 6.0, 10 
mM sodium pho spate, 310 K). The spectra were considered to be adequate for 
assignment because the cross peaks were abundant and well-dispersed in each of the 
spectra. NOESY and TOCSY spectra were collected with different mixing times. It 
was found that the longer mixing time for the NOESY of 150 ms compared with 100 
ms, and shorter mixing time for the TOCSY of 39 ms compared with 63 ms, gave 
spectra that were more suitable for assignment purposes. These longer mixing times 
resulted in spectra that had stronger, and an increased number of resonances. Portions 
of the 2D NOESY and TOCSY spectra, along with the experimental details, are 
shown in figure 4 ii. A 2D COSY spectrum was also acquired. 
The water signal was suppressed using a DPFGSE (see Chapter 3). Despite 
this, water gave such a strong signal that it was impossible to suppress completely. 
This is a problem when Ha resonances lie close to or under the water signal. Such 
proved to be the case for the 2D spectra of VCP-2,3 acquired in 'H 20, where many 
signals were lost due to such difficulties. 
A 1 D analysis of the VCP-2,3 sample after it had been used to collect the 2D 
data, revealed that no new or unusual signals were present. This showed that the 
protein had not undergone degradation or unfolding during the acquisition, and 
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Figure 4 ii —20 NOESY and 20 TOCSY NMR spectra 
(i) 
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Figure 4 ii - (i) 2D 'H NOESY of VCP-2,3 in 550 il 10 mM sodium phosphate, pH 6.0 + 50 i.il 2H 20. 
(ii) 2D TOCSY (conditions the same as in (i)). Spectral widths were 12001.2 Hz in F, and 8000 Hz in 
F2 . 128 transients were accumulated in each of the 512 increments. The acquired matrix was 2048 x 
512 complex data points. 
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confirmed that there was no need to adjust any of the acquisition conditions such as 
buffer, pH or temperature. 
4.2.3 	2D NOESY, TOCSY and COSY experiments, using 2 1­120 as 
solvent 
Acquiring spectra with 2H20 as the solvent is useful since 2H20 gives no 
NMR-detectable signal in a T I-I spectrum. In the case of VCP-2,3, many signals that 
had not been visible in the Ha-Ha region of the 2D 1 1­120 NOESY spectra (e.g those 
close to the water resonance), appeared in the 2H20 spectra. The 2H20 NOESY 
spectrum is also useful as a way of determining those cross-peaks originating from 
exchangable protons such as backbone or sidechain NHs. These only appear in the 
2D NOESY where 1 1­120 is the solvent. The 2H20 NOESY, TOCSY and COSY 
spectra and acquisition parameters are shown in figures 4 iii. The 2H20 spectrum was 
also used to assign the cross-peaks originating from resonances from aromatic ring 
protons, as the aromatic region of the spectrum was less crowded (due to fewer NH 
signals in the 6-8 ppm region). This is evident in figures 4 iv, which displays a 
comparison of these regions from the 1 1­120 and 2H20 spectra. 
4.2.4 	3D spectra of VCP-2,3 
The 2D NMR spectra of VCP-'2,3 confirmed that the protein behaves well in 
solution, and would therefore be suitable for 3D NMR spectra acquisition. This was a 
necessity since there were many similar backbone NH chemical shifts, which could 
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Figure 4.iii - NOESY, TOCSY and COSY spectra recorded with 
2 H 20 as solvent 
dim 2 6 (ppm) 
C) 





dim 2 ö (ppm) 
Figure 4 iii - a), b) and c) : 2D NOESY, TOCSY and COSY spectra respectively acquired with 99.99% 
2 H20 as solvent. All three spectra were recorded in 600 1.11 10 mM sodium phosphate buffer. pH 6.0 in 
2 H 20. Spectral widths for NOESY, TOCSY and COSY spectra were 10000 Hz in F, and 6600 Hz in 
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Figure 4.iv - Aromatic regions of NOESY spectra in H 20 and 





1 5 	3 	45 	6 
	
dim 2 8 (ppm) dim 2 8 (ppm) 
Figure 4 iv - a) and b) show the aromatic regions of 'H 20 NOESY and 2 H 20 NOESY spectra. Because 
of the decrease in the number of signals in this area in the 2 H20 NOESY, the cross-peaks arising from 
the aromatic resonances are easier to see and assign. 
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normally obtained, but this was unnecessary in the case of VCP2,3 as ' 5N-edited 
data were deemed to be sufficient to complete resonance assignment. Thus an 
isotopically labelled ' 5N-'H VCP-2,3 was produced after the 2D spectra had been 
obtained, processed and assessed for quality. This allowed an assessment of suitable 
conditions using the unlabelled protein that was not expensive to produce. 
The 3D 'H-' 5N HSQC-NOESY and 31) 'H-' 5N HSQC-TOCSY spectra were 
used to initiate the backbone assignment of VCP-2,3. In these spectra, any NH 
proton that does not exchange with water on an immediate time-scale should give a 
set of cross-peaks, corresponding to the 15N and 'H chemical shifts of the amide. In 
this way, the information that is contained within the fingerprint region of the 2D 'H 
NOESY and TOCSY spectra is resolved on the basis of the chemical shift of the 
attached ' 5N (figure 4 v). The two 'H, 'H projections of the HSQC-NOESY and 
HSQC-TOCSY spectra are shown in figure 4 vi. Also shown is the 21) 'H-' 5N HSQC 
of VCP2,3. 
4.2.5 	Other acquired spectra 
In addition to the spectra used for the backbone and side-chain assignments, 
described above, other useful spectra were acquired. Several 2D 'H-' 5N HSQC 
experiments were performed, each at a different temperature, to obtain an indication 
of those residues whose chemical shifts are most susceptible to peturbation upon 
temperature-induced denaturation of the protein (figure 4 vii). This gave an insight 
into the relative thermal stability of the two protein modules. HSQC were also 
collected at increasing concentration of guanidium chloride. These data were used in 
combination with other biophysical studies (performed by Dr. Marina Kirkitadze in 
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this laboratory) to characterise the intermodular interface in VCP2,3, as discussed in 
Chapter 6. Finally, a series of HSQC experiments were also acquired with 2H20 as the 
solvent; the freeze-dried protein was dissolved in 
99.99%2  H20 and HSQC spectra 
acquired after 5, 13, 30, 60 and 120 mins (figure 4 viii). Only those NH protons that 
were in the most stable chemical environments remained detectable as time 
progressed, since the remainder exchanged with the 2H20. This provided a basis for 
inferring H-bonded NH protons, which is very useful information in calculating the 
secondary structure within the protein. The fully assigned 'H-' 5N HSQC spectrum of 
VCP-'2,3 is shown in figure 4 ix. The last spectrum collected was an HNHA 
spectrum, which was used to determine values of 3Jhnha, i.e. the three bond scalar 
coupling constants between the HN and the HA protons. Jhnha  is related to the 4' angle 
by the Karplus equation and hence may be used to infer secondary structure. The 




Figure 4 v - Extracting slices from a 1 H-15 N HSQC TOCSY or 
NOESY NMR spectrum based on 15N chemical shift 
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Figure 4 v - (a) The 'N dimension (Fl) gives each amide resonance a third co-ordinate in a 3D matrix 
(Fl, ' 5N; F2, H dim2, F3 1 H dim 1). (b) and (c) illustrate how slices can be extracted from this matrix 
based on ' 5N chemical shift. (d) shows how the resolution is lost if the resonance patterns in (b) and (c) 
cannot be separated by N shift (e.g as would occur in a 'H-H 2D NOESY spectrum) 
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Figure 4 vi - 15N-edited NMR spectra 
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Figure 4 vi - (1) and (ii) show the 'H, 'H projections of the 3D 'H, 'N HSQC - TOCSY and NOESY 
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Figure 4 vii - 1 H-15N HSQC spectra of VCP-2,3 acquired at 
different temperatures or in presence of GdmCI 
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Figure 4 vii - HSQC spectra of VCP-2,3 obtained at different temperatures. or in the presence of 1 or 
2 M guanidium chloride. Those HSQC peaks that could be reliably monitored at the different 
temperatures are shown with assignments at 37 °C (red, VCP-2. black. VCP-3, green, not assigned). 
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Figure 4 viii - 2 H20 HSQC spectra of VCP-2,3 
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Figure 4 viii -HSQC spectra of VCP-2,3 recorded after incubating in 99.8% 2 H20 for the time periods 
indicated. The amide resonances that prevail are in more stable environments since they do not 
exhange rapidly with the 2H 20. This can be used to infer locations of H-bonds. 
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Figure 4 ix - Assignments for module 2 (pink) and module 3 (black) are shown for the 1 H-' 5N HSQC 









4.3 Full proton assignment of VCN2,3 
4.3.1 	Using ANSIG for backbone assignment 
To facilitate resonance assignment and subsequent progress, the NMR spectra 
were loaded into a software package called 'ANSIG' (Kraulis, 1989, Kraulis et a!, 
1994). ANSIG incorporates a range of associated macros that were used to automate 
some of the more laborious peak-picking tasks associated with NMR assignment. 
Initially, a macro that allows automatic peak-picking was used. After defining a 
maximum line-width for each dimension (0.03, 0.03 and 0.3 ppm for the directly 
acquired 'H, indirectly acquired 'H and 15N dimensions, respectively), a separate 
macro was used to integrate each NOESY or TOCSY peak, and a cross was displayed 
on the screen representing the centre and most intense region of the NOE or TOCSY 
connectivity. The program was then utilised in a user-interactive manner to allow 
decisions to be made about each peak, i.e. whether a peak is legitimate and should be 
accepted and allowed to keep its associated cross, or should be "deleted". In this way 
it was possible to very quickly place a cross in the centre of each legitimate peak, 
resulting in a series of "cross-peaks". After each cross-peak had been picked and 
vetted, a series of macros were utilised to aid sequential assignment, as discussed 
below. These proved to be an invaluable tool. 
4.3.2 	Starting the assignment 
The 'H-' 5N HSQC TOCSY and 'H-' 5N HSQC NOESY spectra, with their 
enhanced dispersion, were a good starting point for assigning residues in VCP-2,3. 
As originally noted by Wuthrich (1986) for a hypothetical fragment of protein, shown 
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in figure 4 x, there are certain pairs of protons that should be near enough to each 
other for an NOE to occur between them. Examples of these connectivities in 
VCP-2,3 are shown in figure 4 xi. The Ha at residue i, should always be close 
enough in space to the amide proton of i+1 to produce a detectable NOE . Glycines 
normally have two Ha proton resonances in the range of -3-5 ppm and (unless they 
are degenerate) these yield a pair of Ha-NH cross-peaks that are similar in shape and 
appearance in the HSQC-TOCSY spectrum, making the glycine residues a good 
starting point for assignment. In practice, the HSQC-NOESY peak corresponding to a 
Ha—NH(Gly) connectivity was selected and an ANSIG macro called 'Close in 'H' 
macro was used to find other HSQC-NOESY cross-peaks that matched the 'H 
chemical shift of one of the two Ha(Gly) protons. Amino acids coming after 
glycines in the sequence were relatively easy to identify since the second Ha cross-
peak should also have a corresponding peak in the 'H-' 5N 'strip' of the following 
residue ('strip' refers to all the resonances from any given HN proton). The normal 
procedure involved establishing a few potential candidates for the sequential 
assignment, and then trying to verify one of these by further investigation of 
sequential residues. Additionally, it was possible to use other sequential NOEs, e.g. 
NH1 - NH (i+1).  The main problems arose from sequential amino acids whose Ha or 
HN protons had the same chemical shift. When amino acids had similar HN chemical 
shifts, differences in ' 5N chemical shifts were used to discriminate between 
resonances from the overlapping UN protons. Also, several good candidates often 
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Figure 4 x - Resonance connectivities normally visible in a NOESY spectrum. Strong arrow, Ha 1-
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Another problem with the backbone assignment occurred when the Ha chemical shift 
lay directly beneath, or very close to, the water signal. This problem was overcome 
by reference to the 2H20 spectra and their use in combination with the 3D spectra. 
The key information that could be extracted from each spectrum (three-bond 
connectivity in COSY, intra-residue connectivities in TOCSY, inter- and intra-residue 
connectivities in NOESY) was utilised fully to collect enough evidence to deduce the 
assignment of backbone protons that were overlapped. Assignments were made based 
on two key criteria: 1) the 'H-' 5N strip of the residue must contain resonance patterns 
consistent with the side-chain of that particular amino acid; 2) the residue must have 
good sequential connections to other amino acids that are consistent with the protein 
sequence. The exceptions to this assignment strategy were the proline residues, which 
contain no HN protons and therefore do not have a 1 14- 15N strip. The assignment of 
the proline residues is discussed later. While this mainchain-directed approach 
furnished the majority of the assignments, knowledge of other CCP module structures 
and the developing picture of the VCP-2,3 secondary structure also proved invaluable 
- this is discussed below. 
4.3.3 	Side-chain assignment 
Once nearly all of the backbone Ha and I-IN protons had been assigned, the 
goal was to assign the rest of the protons in each amino acid side-chain and hence 
identify a distinct chemical shift for each proton in the protein. The assignment of the 
y and 6 protons of amino acid residues required further utilisation of the 2D 
COSY, TOCSY and NOESY spectra. A good example of how these techniques were 
employed to fully assign a side-chain was the case of tryptophan assignment. The full 
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assignment of tryptophan 118 is shown in figure 4 xii. It was found that it was 
important when making side-chain assignments to be intuitive, looking at peak 
shape/size and at other connectivities to verify previous inferences. 
In proteins, strong NOEs between NH1 - NH1+1 or NH1+2 indicate potential 
turns. Strong Hai - Ha1+>4, Hai - HN 1+>4 or RN1 - HN11>4 NOEs are indicative of 
residues involved in n-strands, since these NOEs originate from 'cross-sheet' 
connectivities. As assignment of VCP-2,3 progressed, a picture of the secondary 
structure begun to emerge and this provided further confidence in the procedure as 
described below. 
4.3.4 Assignment of the proline residues 
Prolines proved to be the most difficult residues to assign in VCP-2,3, as they 
possess no backbone amide proton. Because of this, the prolines do not have HSQC 
peaks or associated strips. To make matters more complicated, VCP-2,3 contains 
three sequential pairs of prolines and two further prolines. Assigning prolines 
therefore required different tactics, as the Ha-NH connections and NH-NH 
connectivities normally used, do not apply. Figure 4 xiii shows the different 
connectivities which should be detectable for a proline in cis or trans arrangement. 
Identification of the Ha proton of some of the pro lines was not too difficult providing 
the proline preceeded a non-proline residue. This is because a strong Ha(p ro)NH(pro+I) 
NOE was normally visible in the HSQC-NOESY strip of the Pro+1 residue. 
Identification of the proline H8 protons was possible by looking for reasonably strong 
Ha(pro i) - H8(pro) peaks in the aliphatic region of the 2D NOESY spectrum. This was 
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Figure 4 xii - Tryptophan assignment 
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Figure 4 xii - (i) connectivities through three bonds for Trp 118 in 2H2 0 COSY. (ii) 2 H20 TOCSY has 
the same connectivities as COSY plus additional peaks for connectivities> 3 bonds. (iii & iv) - 21i.O 
NOESY and 1 H-,O NOESY. Resonances from the HcI side chain amide are not visible in the 2 H2O 




particularly difficult for CP modules of VCP-'2,3, as the conserved prolines in the 
respective modules are in very similar chemical environments and overlap is present. 
Assignment of the prolines was aided using an indirect approach that utilised 
the inferred secondary structure of the two modules. Many cross-sheet NOEs 
between assigned residues had been identified by this point, and NOEs that implied 
turns or loops between them had also been identified. In this way, an approximate 
picture of the secondary structure was deduced. Furthermore, examples of CP 
modules studied previously were examined, the consensus residues identified and 
their position within the crude secondary structure of VCP-2,3 was noted. In this 
way knowledge of residues that were likely to be in close proximity to the prolines 
was employed in an attempt to identify NOEs originating from the proline protons of 
VCP-2,3. An example is the second proline in VCP-2. In all CP module structures 
examined previously, the Hy protons of this proline are in close enough proximity to 
the HN of the first consensus cysteine to produce an NOE. Furthermore, the H 
protons of the conserved tryptophan are also likely to be close to the Hy protons of the 
Pro. Inspection of NOEs originating from these Trp peaks revealed four cross-peaks 
which could correspond to the Hyl/I-fy2(Pro) - H(Trp) and H'yl/Hy2(Pro) - HN(Cys) 
connectivities. Inspection of the 2D TOCSY and 2H20 COSY spectra revealed that 
the two potential H1' peaks were connected through-bonds and could be linked to 
other resonances that fell in the pattern of a proline side-chain. Using the conserved 




Figure xiii - characteristic resonances indicative of cis or 
trans arrangement of proline residues 
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Figure 4 xiii - A) shows the resonance visible when proline is in the trans conformation (HapRo-
HNPRO+l, H(xpRoI -HpRo). When proline is in cis conformation (B), a medium strength HcLPROI-HXPRO 
NOE is observed. 
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4.3.5 Assignment techniques particular to CP modules 
Using the consensus structure of the CP modules proved to be a critical tool for 
assigning the prolines. The complete assignment of the remainder of the VCP2,3 
protons was also aided by the information available from other CP module structures. 
Because the CP module has a large number of well conserved, or invariant, residues 
their chemical environments are similar and correct prediction of the presence of 
NOEs is possible in many cases. Because of their easily recognisable side-chain NH 
resonance, the tryptophan residue of each module was easily assigned. On top of 
this, one of the invariant, disulphide bonded cysteines had an Ha proton directly 
across the n-sheet from the Ha proton of the conserved tryptophan in all CP modules 
structures examined. On that basis, using the 2D NOESY spectrum, it was possible to 
look for any Ha-Ha NOEs from the tryptophan 118 Ha proton. One very strong 
possibility was found and could be connected, using the 2D COSY to two 3-protons, 
as would be expected for a cysteine. The amino acid was then confirmed as the 
cysteine (C 113) by sequential assignment, or by considering other hypothetical cross-
sheet NOEs, since the cysteine is always found in a n-strand. This proved to be an 
additional and valuable method for assigning the backbone and side-chain protons. It 
was very important, however, when applying this method to keep an open mind and 
verify the residues by the classical main-chain directed route described earlier. 
4.4 Special features of the VCP-2,3 resonance assignment 
Ultimately, most of the backbone and side-chain protons and 15N were assigned 
for VCP-'2,3 although many of the protons were determined to be of a degenerate 
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nature (see Appendix 1 for the chemical shift table). Certain unusual features, besides 
the atypical chemical shift of the proline HP protons, were noted. These included the 
first disulphide-bonded cysteine (C9, C71) in both modules having unusual H3 shifts, 
probably a result of the close proximity of the tryptophan side chain. This was also 
the case for one of the H3 protons of the first proline of module 3. It was also 
impossible to resolve all the side-chain arginine protons using the available spectra. 
Tryptophan 118, was shown to have two distinct ring HN shifts in the 2D spectrum 
consistent with two very slowly-exchanging conformers. The cross-peaks arising 
from these different amides were to protons from the same residues, but showed 
different intensities. One of the side-chain amides, though, had a stronger set of 
cross-peaks, indicating that this was probably the major form. 
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Chapter 5 - Structure calculation using X-PLOR 
and ARIA 
5.1 Data required for structure calculation 
A combination of NMR spectra are used to manually assign chemical shifts to 
each of the 'H atoms in the protein (see Chapter 4). Each cross-peak in the NOESY 
spectra can then be assigned as an NOE between two protons, or two sets of protons 
with identical chemical shifts. The various assignment possibilities for each of the 
NOE cross-peaks are used as data input for the structure calculation itself. The 
intensity of the NOE is related to the distance between the protons involved, and 
NOE's are normally categorised as weak (reflecting an interproton distance of < 5 A), 
medium (<3.3 A) or strong (<2.7 A). Other useful empirical information, such as the 
location of disulphide and hydrogen bonds or dihedral angle restraints, may also be 
used. In addition knowledge of the covalent chemistry of the molecule is 
incorporated into the calculation. 
Taken collectively, the data provides a network of restraints which describe 
the structure of the protein. 
5.2 Finalising the chemical shift 
In calculating the structure of VCP--2,3, the program ARIA (Nilges et al, 
1997) (a set of scripts written within the program X-PLOR (Brunger, 1992)) was used 
as there were many ambiguous cross-peaks - i.e. cross-peaks that could not be 
assigned to a unique pair of protons due to overlapping chemical shifts. In these 
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cases, ARIA invokes procedures that result in some possibilities being eliminated on 
the basis of the emerging three-dimensional structure. In the event that two or more 
equally feasible NOEs exist for a given cross-peak, ARIA creates an ambiguous 
distance restraint. 
Three NOESY-based experiments, the ' 5N-'H HSQC-NOESY, the 2D 'H-'H 
NOESY and the 2D 'H-'H 2H20 NOESY, were used as a source of NOEs in the 
structure calculation of VCP 2,3, and a separate chemical shift table was generated 
for each of them. This was performed by exporting a selected set of assigned (see 
Chapter 4) cross-peaks (integrated according to peak volume) from each spectrum. 
Macros within a program called AZARA (Boucher, http//:www.bio.cam.ac.uk/azara) 
(a separate program that can also be used for viewing NMR spectra and has useful 
macros that are not available in ANSIG) were then used to generate the three 
chemical shift lists in the following way. 
The first script to be used was the "make —shift—list script" (Appendix A), 
which reads all the cross-peaks from each spectrum and makes a table of all the 
chemical shifts associated with the manually assigned peaks. This table then served 
as input for the "make—shift—summary" macro. This reads the table, groups together 
all the chemical shifts for each assigned atom, and lists them in ascending order of 
chemical shift; although the chemical shift of a proton would be expected to be the 
same each time it was allocated to a particular NOE, errors in establishing the peak 
centres mean that there may be small differences in the chemical shifts associated 
with the same atom if it participates in more than one NOE within the same spectrum. 
A user-defined threshold (0.03 ppm for ('H) dimensions 1, 2 and 0.3 ppm for (' 5N) 
dimension 3) was set, and all chemical shifts associated with an atom had to be within 
this threshold to be included in the main output file from "make —shift—summary". If 
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the chemical shifts from any one atom were above the defined threshold, all 
assignments that included the "offending" atom were exported to a separate file for 
examination. Examination of the output file normally highlighted one chemical shift 
that was significantly different from the others, and this proved an effective way of 
screening for assignment mistakes that could subsequently be amended. 
Ultimately, the sorted list of chemical shifts was used as input for the 
"make—connected—shifts" macro. This took all the chemical shifts from 
"make—shift—summary" and combined them to give an average chemical shift for 
each proton or nitrogen atom. Thus, the output from "make —connected—shifts" was 
taken as the final chemical shift assignment table (Appendix B). Because of the 
discrepancy in cross-peak positions, each chemical shift was given an associated 
error, which was the same error margin or tolerance as those described for 
"make—shift—summary". 
Once a chemical shift table had been finalised for each spectrum, restraint 
tables were generated for use as input into the structure calculation program. This 
involved a series of scripts called 'connect'. These scripts read in all the cross-peaks 
picked in any one spectrum and used the chemical shift table for that particular 
spectrum to infer restraint possibilities. Those cross-peaks that had earlier been 
assigned manually remained "unambiguously" assigned, whilst the remainder were 
connected to unambiguous or ambiguous assignments depending on the number of 
possibilities available to them. An example of the output from the connect scripts is 
shown in figure 5 i. Each of the restraint tables generated for the three NOESY 
spectra were treated independently by the subsequent steps of the ARIA protocol. 
Restraint tables that listed the inferred hydrogen bonds (chapter 4) were also created 
as input for the ARIA protocol (figure 5 ii). The disulphide bonds (Chapter 1) were 
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also entered as distance restraints for the structure calculation of VCP2,3, as shown 
in figure 5 .iii. The dihedral angles were calculated from the coupling constants taken 
from the HNHct data (Chapter 4). The coupling between the two protons (in Hz) was 
fitted to the Karplus curve, which was used to obtain the dihedral angle restraints as 
additional data for the structure calculation. The coupling constants are listed in figure 
5 iii. 
5.3 ARIA - An automated method for assigning ambiguous 
restraints 
5.3.1 Distance calibration - relating NOE intensity to distance 
Any structure calculated by NMR spectroscopy relies on the fact that cross-
peak (NOE) intensity is proportional (f 6 dependancy) to the distance between two 
protons this is the essence of all structure calculations using NOB information. One 
of the most important considerations therefore is the distance calibration, which 
relates cross-peak intensity to inter-proton distance. ARIA uses the formulae shown in 
equations 1 and 2 to represent the upper and lower distance-bounds for an NOE 
related to the integrated volume of the cross-peak. As mentioned briefly in section 
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Figure 5.i - Example of output from "connect" script 
assign ( resid 74 and name HB2 
resid 75 and name HD2 
or resid 88 and name HB1 
or resid 89 and name HB1 
or resid 108 and name HB1 
or resid 118 and name HB2 
5.0 5.0 0.0 volume=0.463 peak=3074 ppml=-0.202 pprn2=2.888 
assign ( resid 74 and name HB2 
resid 7 and name HH1# 
or resid 7 and name HH2# 
or resid 33 and name HE1 
or resid 33 and name HE2 
or resid 97 and name HE1 
or resid 97 and name HE2 
5.0 5.0 0.0 volume=0.314 peak=4225 ppml=-0.204 ppm2=6.490 
assign ( resid 74 and name HB2 
resid 118 and name HE1 
6.0 6.0 0.0 volume=0.231 peak=4204 ppml=-0.204 ppm2=9.514 
assign ( resid 31 and name HD11 
or resid 31 and name HD12 
or resid 31 and name HD13 
resid 3 and name HA 
or resid 12 and name HA 
or resid 119 and name HB2 
6.0 6.0 0.0 volume=0.191 peak=5557 ppml=-0.517 ppm2=4.110 
Figure 5 1 - Example of output from connect script. Each cross-peak from the NMR spectra is assigned 
unique identifying number and chemical shifts in dim(ension)I and dim 2. Each peak also has a 
volume, corresponding to intensity of the NOE between the contributing protons. The numbers on the 
bottom row (e.g. 5.0 5.0 0.0) refer to maximum internuclear distance for the two protons contributing 
to the NOE. All possible contributing protons with chemical shift, ppm 1 and ppm 2, are listed. 
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Figure 5 ii - Some distance-restraints used as ARIA input to 
represent H-Bonds 
assign (resid 19 and name 0 ) (resid 34 and name HN 	) 1.88 	0.3 	0.42 
assign (resid 19 and name 0 ) (resid 34 and name 	N ) 1.88 	0.3 	1.32 
assign (resid 34 and name 0 ) (resid 19 and name RN 	) 1.88 	0.3 	0.42 
assign (resid 34 and name 0 ) (resid 19 and name 	N ) 1.88 	0.3 	1.32 
assign (resid 48 and name 0 ) (resid 60 and name HN 	) 1.88 	0.3 	0.42 
assign (resid 48 and name 0 ) (resid 60 and name 	N ) 1.88 	0.3 	1.32 
assign (resid 60 and name 0 ) (resid 48 and name RN 	) 1.88 	0.3 	0.42 
assign (resid 60 and name 0 ) (resid 48 and name 	N ) 1.88 	0.3 	1.32 
assign (resid 21 and name 0 ) (resid 32 and name RN 	) 1.88 	0.3 	0.42 
assign (resid 21 and name 0 ) (resid 32 and name 	N ) 1.88 	0.3 	1.32 
assign (resid 32 and name 0 ) (resid 21 and name RN 	) 1.88 	0.3 	0.42 
assign (resid 32 and name 0 ) (resid 21 and name 	N ) 1.88 	0.3 	1.32 
assign (resid 65 and name 0 ) (resid 42 and name RN 	) 1.88 	0.3 	0.42 
assign (resid 65 and name 0 ) (resid 42 and name 	N ) 1.88 	0.3 	1.32 
assign (resid 42 and name 0 ) (resid 65 and name RN 	) 1.88 	0.3 	0.42 
assign (resid 42 and name 0 ) (resid 65 and name 	N ) 1.88 	0.3 	1.32 
assign (resid 125 and name 0 ) (resid 104 and name RN ) 	 1.88 	0.3 	0.42 
assign (resid 125 and name 0 ) (resid 104 and name 	N ) 	 1.88 	0.3 	1.32 
assign (resid 104 and name 0 ) (resid 125 and name RN ) 	 1.88 	0.3 	0.42 
assign (resid 104 and name 0 ) (resid 125 and name 	N ) 	 1.88 	0.3 	1.32 
assign (resid 119 and name 0 ) (resid 112 and name RN ) 	 1.88 	0.3 	0.42 
assign (resid 119 and name 0 ) (resid 112 and name 	N ) 	 1.88 	0.3 	1.32 
assign (resid 112 and name 0 ) (resid 119 and name RN ) 	 1.88 	0.3 	0.42 
assign (resid 112 and name 0 ) (resid 119 and name 	N ) 	 1.88 	0.3 	1.32 
assign (resid 106 and name 0 ) (resid 123 and name RN ) 	 1.88 	0.3 	0.42 
assign (resid 106 and name 0 ) (resid 123 and name 	N ) 	 1.88 	0.3 	1.32 
assign (resid 123 and name 0 ) (resid 106 and name RN ) 	 1.88 	0.3 	0.42 
assign (resid 123 and name 0 ) (resid 106 and name 	N ) 	 1.88 	0.3 	1.32 
assign (resid 113 and name 0 ) (resid 93 and name RN ) 	 1.88 	0.3 	0.42 
assign (resid 113 and name 0 1 (resid 93 and name 	N ) 	 1.88 	0.3 	1.32 
assign (resid 93 and name 0 ) (resid 113 and name RN ) 	 1.88 	0.3 	0.42 
assign (resid 93 and name 0 ) (resid 113 and name 	N ) 	 1.88 	0.3 	1.32 
assign (resid 111 and name 0 ) (resid 95 and name RN ) 	 1.88 	0.3 	0.42 
assign (resid 111 and name 0 ) (resid 95 and name 	N ) 	 1.88 	0.3 	1.32 
assign (resid 95 and name 0 ) (resid 111 and name RN ) 	 1.88 	0.3 	0.42 
assign (resid 95 and name 0 ) (resid 111 and name 	N ) 	 1.88 	0.3 	1.32 
assign (resid 81 and name 0 ) (resid 98 and name HN ) 	 1.88 	0.3 	0.42 
assign (resid 81 and name 0 ) (resid 98 and name 	N ) 	 1.88 	0.3 	1.32 
assign (resid 98 and name 0 ) (resid 81 and name RN ) 	 1.88 	0.3 	0.42 
assign (resid 98 and name 0 ) (resid 81 and name 	N ) 	 1.88 	0.3 	1.32 
Figure 5 ii - Data from slowly exchanging amide experiments were used to create restraints for 
inferred hydrogen bonds between the amide and carbonyl groups of two different residues. The three 
columns to the right are distances in A, and these three distances, x, y, z, are interpreted as representing 
a distance> (x-y) and <(x-z) by X-PLOR. 
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Equation 	 L= 	v) 
6 — 
Yref 
U = Upper bound for interproton distance 
L = Lower bound for interproton distance 
dref = reference distance between contributing protons (in this case, an average of all unambiguous 
distance restraints) 
Vref = reference peak volume (in this case, an average of all peak volumes from unambiguous 
restraints) 
= error for upper bound (in this case 0.125D 2 where D is the calibrated distance) 
= error for lower bound (in this case 0.125D 2 where D is the calibrated distance) 
5. 1, a typical approach is to classify an NOE as being medium, weak, or strong, and 
the distance between two protons is correlated to these distance boundaries. The 
ARIA method, instead, uses the distances and cross-peak volumes of a series of 
"known" distance restraints (from unambiguous assignment data) and calibrates every 
other cross-peak accordingly. These reference restraints that are used to relate cross-
peak volume to distance, are recalculated on an iterative basis as the automated 
assignment proceeds. The distances estimated from the NOEs have set errors (A and 
iV (see equations 1 and 2)), that were defined in this case as 0.125D 2  where D is the 
estimated distance according to the peak volume. ARIA proceeds in an iterative 
manner, using information from each previous iteration to generate more accurate and 
lower energy structures each time; the closest structure to the actual structure will 
have the lowest energy, so ARIA uses the lowest energy structures from one iteration 
to help guide the subsequent calculations. 
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Figure 5 iii - SS bond restraints and dihedral angles 
assign (resid 9 and name sg) (not resid 9 and name sg) 2.08 0.1 0.1 
assign (resid 49 and name sg) (not resid 49 and name sg) 2.08 0.1 0.1 
assign (resid 35 and name sg) (not resid 35 and name sg) 2.08 0.1 0.1 
assign (resid 66 and name sg) (not resid 66 and name sg) 2.08 0.1 0.1 
assign (resid 71 and name sg) (not resid 71 and name sg) 2.08 0.1 0.1 
assign (resid 113 and name sg) (not resid 113 and name sg) 2.08 0.1 0.1 
assign (resid 99 and name sg) (not resjd 99 and name sg) 2.08 0.1 0.1 




























































8 and name C ) (residue 
9 and name CA) (residue 
18 and name C ) (residue 
19 and name CA) (residue 
20 and name C ) (residue 
21 and name CA) (residue 
21 and name C ) (residue 
22 and name CA) (residue 
24 and name C ) (residue 
25 and name CA) (residue 
25 and name C ) (residue 
26 and name CA) (residue 
29 and name C ) (residue 
30 and name CA) (residue 
30 and name C ) (residue 
31 and name CA) (residue 
32 and name C ) (residue 
33 and name CA) (residue 
33 and name C ) (residue 
34 and name CA) (residue 
34 and name C ) (residue 
35 and name CA) (residue 
38 and name C ) (residue 
39 and name CA) (residue 
40 and name C ) (residue 
41 and name CA) (residue 
41 and name C ) (residue 
42 and name CA) (residue 
45 and name C ) (residue 
46 and name CA) (residue 
46 and name C ) (residue 
47 and name CA) (residue 
47 and name C ) (residue 
48 and name CA) (residue 
57 and name C ) (residue 
58 and name CA) (residue 
58 and name C ) (residue 
59 and name CA) (residue 
59 and name C ) (residue 
60 and name CA) (residue 
61 and name C ) (residue 
62 and name CA) (residue 
62 and name C ) (residue 
63 and name CA) (residue 
64 and name C ) (residue 
65 and name CA) (residue 
65 and name C ) (residue 
66 and name CA) (residue 
66 and name C ) (residue 
67 and name CA) (residue 
71 and name C ) (residue 
72 and name CA) (residue 
72 and name C ) (residue 
73 and name CA) (residue 
76 and name C ) (residue 
77 and name CA) (residue 
80 and name C ) (residue 
81 and name CA) (residue 
9 and name N) 
9 and name C) 1 -120 50 2 
19 and name N) 
19 and name C) 1 -120 50 2 
21 and name N) 
21 and name C) 1 -120 50 2 
22 and name N) 
22 and name C) 1 -120 50 2 
25 and name N) 
25 and name C) 1 -120 50 2 
26 and name N) 
26 and name C) 1 -120 50 2 
30 and name N) 
30 and name C) 1 -120 50 2 
31 and name N) 
31 and name C) 1 -120 50 2 
33 and name N) 
33 and name C) 1 -120 50 2 
34 and name N) 
34 and name C) 1 -120 50 2 
35 and name N) 
35 and name C) 1 -120 50 2 
39 and name N) 
39 and name C) 1 -120 50 2 I 
41 and name N) 
41 and name C) 1 -60 50 2 
42 and name N) 
42 and name C) 1 -120 50 2 
46 and name N) 
46 and name C) 1 -120 50 2 
47 and name N) 
47 and name C) 1 -120 50 2 
48 and name N) 
48 and name C) 1 -120 50 2 
58 and name N) 
58 and name C) 1 -120 50 2 
59 and name N) 
59 and name C) 1 -120 50 2 
60 and name N) 
60 and name C) 1 -120 50 2 
62 and name N) 
62 and name C) 1 -60 50 2 
63 and name N) 
63 and name C) 1 -120 50 2 
65 and name N) 
65 and name C) 1 -120 50 2 
66 and name N) 
66 and name C) 1 -120 50 2 
67 and name N) 
67 and name C) 1 -120 50 2 
72 and name N) 
72 and name C) 1 -120 50 2 
73 and name N) 
73 and name C) 1 -60 50 2 I 
77 and name N) 
77 and name C) 1 -120 50 2 
81 and name N) 
81 and name C) 1 -120 50 2 
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Figure 5.iii cont'd 
ASSIgn (residue 85 and name C ) (residue 86 and name N) 
(residue 86 and name CA) (residue 86 and name C) 1 -120 50 2 
ASSIgn (residue 86 and name C ) (residue 87 and name N) 
(residue 87 and name CA) (residue 87 and name C) 1 -120 50 2 
ASSIgn (residue 87 and name C ) (residue 88 and name N) 
(residue 88 and name CA) (residue 88 and name C) 1 -120 50 2 I 
ASSIgn (residue 88 and name C ) (residue 89 and name N) 
(residue 89 and name CA) (residue 89 and name C) 1 -120 50 2 
ASSIgn (residue 89 and name C ) (residue 90 and name N) 
(residue 90 and name CA) (residue 90 and name C) 1 -120 50 2 
ASSIgn (residue 92 and name C ) (residue 93 and name N) 
(residue 93 and name CA) (residue 93 and name C) 1 -60 50 2 
ASSIgn (residue 93 and name C ) (residue 94 and name N) 
(residue 94 and name CA) (residue 94 and name C) 1 -120 50 2 
ASSIgn (residue 94 and name C ) (residue 95 and name N) 
(residue 95 and name CA) (residue 95 and name C) 1 -120 50 2 
ASSIgn (residue 96 and name C ) (residue 97 and name N) 
(residue 97 and name CA) (residue 97 and name C) 1 -120 50 2 
ASSIgn (residue 97 and name C ) (residue 98 and name N) 
(residue 98 and name CA) (residue 98 and name C) 1 -120 50 2 
ASSIgn (residue 98 and name C ) (residue 99 and name N) 
(residue 99 and name CA) (residue 99 and name C) 1 -120 50 2 I 
ASSIgn (residue 99 and name C ) (residue 100 and name N) 
(residue 100 and name CA) (residue 100 and name C) 1 -60 50 2 
ASSIgn (residue 102 and name C ) (residue 103 and name N) 
(residue 103 and name CA) (residue 103 and name C) 1 -120 50 2 
ASSIgn (residue 103 and name C ) (residue 104 and name N) 
(residue 104 and name CA) (residue 104 and name C) 1 -120 50 2 
ASSIgn (residue 105 and name C ) (residue 106 and name N) 
(residue 106 and name CA) (residue 106 and name C) 1 -120 50 2 
ASSIgn (residue 108 and name C ) (residue 109 and name N) 
(residue 109 and name CA) (residue 109 and name C) 1 -60 50 2 I 
ASSIgn (residue 110 and name C ) (residue 111 and name N) 
(residue 111 and name CA) (residue 111 and name C) 1 -120 50 2 
ASSIgn (residue 111 and name C ) (residue 112 and name N) 
(residue 112 and name CA) (residue 112 and name C) 1 -120 50 2 
ASSIgn (residue 112 and name C ) (residue 113 and name N) 
(residue 113 and name CA) (residue 113 and name C) 1 -120 50 2 
ASSIgn (residue 113 and name C ) (residue 114 and name N) 
(residue 114 and name CA) (residue 114 and name C) 1 -120 50 2 
ASSIgn (residue 116 and name C ) (residue 117 and name N) 
(residue 117 and name CA) (residue 117 and name C) 1 -120 50 2 
ASSIgn (residue 117 and name C ) (residue 118 and name N) 
(residue 118 and name CA) (residue 118 and name C) 1 -120 50 2 
ASSIgn (residue 122 and name C ) (residue 123 and name N) 
(residue 123 and name CA) (residue 123 and name C) 1 -120 50 2 
ASSIgn (residue 123 and name C ) (residue 124 and name N) 
(residue 124 and name CA) (residue 124 and name C) 1 -120 50 2 
ASSIgn (residue 124 and name C ) (residue 125 and name N) 
(residue 125 and name CA) (residue 125 and name C) 1 -120 50 2 
Figure 5 iii - a) Restraint input table for residues involved in disulphide bonds. b) Restraint input table 
for dihedral angle restraints. The two columns on the right (between I and 2) e.g. -120 50 are 
interpreted as e.g. -120 ± 50 ° by X-PLOR. 
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5.3.2 Automatic assignment of ambiguous NOE's 
At the start of the structure calculation in ARIA, the NOEs that have been 
unambiguously assigned during an initial manual stage, define the initial fold. As the 
calculation proceeds, ARIA creates additional assignments on the basis of the 
chemical shift tables and by reference to inter-proton distances in the emerging 
structure. ARIA works on an iterative basis and generates a new assignment table in 
each iteration, based on the calculated structures from the previous round. ARIA also 
eliminates duplicate restraints that are present in the same, or in different spectra, 
pooling the data from the different spectra into one final restraints table. Each 
spectrum is considered individually during the structure calculation, but the resulting 
NOE tables are a combination of them all. 
In ARIA, a user-specified number of the structures from the previous iteration 
are used to generate the assignment tables for subsequent iterations; the lowest energy 
structures will have the most correct restraints, so only the lowest energy structures 
are used to create the subsequent assignment tables (the actual number used can be 
changed from iteration to iteration). ARIA compares all the possible assignments for 
an NOE with the measured distances in the structures available and considers the 
contribution that each restraint is making to the cross-peak. In the restraints tables 
generated from the connect scripts, many of the possible restraints will be unfeasible, 
as two protons may lie at opposite ends of the structure, yet would still be listed as a 
possible restraint. ARIA filters out these assignment possibilities since their 
contribution to the overall cross-peak intensity will be insignificant. Those restraints 
that appear likely to contribute to cross-peak intensity are assigned an appropriate 
contribution value (C). A cut-off value (p) can be applied to specify the percentage a 
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NOE must contribute to the cross-peak intensity to be included as apossibility within 
the distance restraint. 
In initial iterations, all possible restraints are considered. In later iterations, the 
value of p is lowered - typically, from 1 (100%) to 0.9 (90%). All assignment 
possibilities are ordered such that the highest contributing restraint possibility is given 
priority, followed by all other contributing restraints in order. The contributions are 
defined as outlined in equation 3. The fewest number of contributions are chosen such 
that the condition shown in equation 4 is satisfied. The effect is to keep the shortest 
restraints that cumulatively acount for 90% (0.9) of total cross-peak intensity and 
discard the remaining restraints. If the automatically assigned restraints are accurate, 
the energy of the system is lowered and the structures will improve - the ambiguous 
-6 
Equation 3 	
C = ________________ 
C, 	- Contribution to cross-peak from assignment n 
-6 - minimum or average distance for the restraint(s) 
NA 
d -6 - NOE intensity (a runs through N6 contributions; d a is distance 
a1 a between two protons corresponding to a 1 contribution) 
N 
Equation 4 	 C a > P 
a1 
restraints are re-considered in each iteration. Occasionally, assignment possibilities 
are chosen which do not tie in with other restraints. In these circumstances, the energy 
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of the system will go up and the structures will not be used for subsequent iterations. 
These errors are not carried forward to the next iteration, as only those structures 
which have the lowest Etotai are used for the calibration of restraints in the next round. 
In the structure calculation of VCP-2,3, four different parameters in ARIA 
were altered at each iteration. These parameters were: 
. The number of structures generated in each iteration (N) 
. The number of lowest energy structures from the previous iteration 
kept as starting structures (S) 
. The number of lowest energy structures from iteration (i) used to 
create the restraint tables for i+1 (Equation 4) (A) 
. The value of p (Equation 4) 
Eleven iterations were performed in total with the respective values of N, S, A and p 
set according to table 1 (these values were arrived at after significant amounts of trial 
and error). In the first iteration, p is set at 0.999 so that almost all contributing 
assignments are used to generate the assignment table for iteration 2. This value is 
progressively lowered so that those assignments contributing very little to the overall 
NOE intensity are filtered out. A, the number of lowest energy structures used for 
creating the restraint tables for iteration (i+ 1) is also systematically altered. In the 
final iteration, no starting structures are used. Thus, all 100 final structures are 
generated from random starting structures using restraint tables generated from the 25 
lowest energy structures from iteration 10. 
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Table i - Values of N, S, A and p are altered at each iteration to assist the structure calculation and 
reduce computational cost. 
ITERATION N S A p 
1 20 0 0 0.999 
2 20 15 10 0.999 
3 20 15 10 0.99 
4 20 15 5 0.98 
5 20 15 5 0.97 
6 20 15 10 0.96 
7 20 15 10 0.95 
8 30 15 5 0.94 
9 50 20 5 0.93 
10 100 25 5 0.90 
11 100 0 25 0.90 
5.3.3 Simulated annealing 
The basis for solving a structure by simulated annealing involves optimising a 
target function Etotai  that represents the overall energy of a protein structure. This total 
energy will take into account the covalent bond energy, energy associated with bond 
angles, planarity, and van der Waals' interactions in addition to energies associated 
with the experimentally derived restraints used as input such as the NOEs, H-bonds, 
dihedral angles and the disulphide bonds. The structure calculation aims to find a 
global minimum for all atoms, representing the lowest energy conformation of the 
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protein. It uses molecular dynamics to solve Newton's equations of motion for each 
atom in the protein to get E01. One problem is that atoms can find themselves in local 
minima and require kinetic energy to escape. To avoid this, the simulated annealing 
protocol incorporates provision of a constant temperature water bath that provides 
kinetic energy to the system, allowing atoms to escape from the local minima. In 
order to do this effectively, certain energy parameters such as the van der Waals' 
repulsion terms are initially switched off, allowing the atoms to pass through each 
other in the early stages. This decreases the computational time required for the initial 
minimisation. When the global minimum has been attained, the system is cooled and 
the van der Waals' potential is re-introduced. X-PLOR is a widely utilised software 
tool that runs the complex algorithms to calculate the energy of the system and to 
perform the simulated annealing process. 
5.4 Structure calculation and troubleshooting 
5.4.1 Distance re-calibration 
During a structure calculation, many restraints are violated, i.e the calibrated 
distance is larger than the measured inter-proton distance. Within ARIA, when this 
occurs in more than a user-defined proportion of the ensemble of calculated 
structures, the restraint is subjected to a re-calibration procedure, whereby the 
distance is set to a pre-defined value plus a defined error margin. The re-calibrated 
distance represents the upper bound for the longest distance for which an NOE should 
be visible. This allows effects such as spin-diffusion, whereby an NOE may appear 
stronger than it would normally be due to effects of other atomic spins in the vicinity, 
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to be taken into account. These re-calibrated peaks are incorporated into the structure, 
if possible. If the algorithm cannot restrain it to the appropriate distance, then the 
cross-peak is considered to be a genuine violation and will be excluded from the final 
set of structures and the output restraints file. 
In the case of VCP-2,3, many NOE-derived distance restraints that were 
consistently violated in different structure calculations were thoroughly examined 
and, in some cases, excluded from the input tables in subsequent calculations on the 
grounds of being artefactual peaks or too overlapped to allow reliable assignment or 
integration. Dealing with violated NOEs turned out to be one of the most important 
and time-consuming parts of the structure calculation. Extra peaks may arise due to 
artefacts of the spectral processing, bad water suppression, sample impurities, peak 
splitting due to strong coupling, or from the presence of different conformations of. 
During successive iterations of the structure calculation of VCP2,3, and as 
the structures improved (in terms of total energy and the number of violations), the 
ARIA parameter for violation tolerance was modified. In early iterations and structure 
calculations, the violation tolerance was defined such that NOE's causing violations in 
50% of the,calculated structures and violated by more than 0.5 A were listed in a 
violation output file for subsequent analysis. In the final stages of structure 
calculation, stricter violation tolerances were applied so that restraints violated by 
more than 0.1 A in any structure were listed. These output files highlighted some of 
the problems with the different NMR spectra, peak-picking or assignment, as 
discussed below. 
With VCP-2,3, peak splitting (due to very strong scalar coupling between the 
geminal a protons) was a problem in the case of glycine residues, resulting in two 
separate cross-peaks emanating from one resonance. Once identified, this problem 
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was overcome by manually determining the centre of the two peaks. Sequential 
assignments were used as an extra checking mechanism to ensure the cross-peak 
centre was correct. 
The analysis of violated peaks often led to identification of previously 
unassigned atoms, which were thought to be degenerate. In several cases, the 
unassigned atom was missed in the initial assignment stages because the chemical 
shift was unusual; an approximate reference of chemical shift exists for each atom in 
an amino acid (Wuthrich, 1986) and those atoms with chemical shifts outside of the 
"expected" range were much less easy to assign. 
When dealing with violations, it was important to consider how bad the 
violation was in terms of distance, how realistic the different restraint possibilities 
were, and whether the violated peak could in fact be coming from an unassigned 
proton. It was possible to make decisions about violated restraints by looking at the 
spectrum and finding all the cross-peaks that could emanate from a resonance at that 
particular chemical shift. In some cases, several different violated cross-peaks would 
have the same chemical shift in one dimension. Examination of the spectrum then 
revealed that these peaks had strong connections to one particular amino acid so the 
full assignment of that residue was then checked to see if all atoms had been assigned 
or if there were degenerate atoms. In other cases, incorrect unambiguous manual 
assignments were removed to resolve the problem. 
Cross-peaks with very strong spin-systems in the COSY and TOCSY spectra, 
but very little NOESY information were signs of an artefact. Peak shape and size was 
also a good indication of an artefact, which underlined the importance of effective 
peak-picking at the start of the spectral analysis. The "normal" cross-peaks were 
almost circular in shape and showed a degree of consistancy throughout the spectrum. 
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NOEs arising from artefacts had a tendancy to be noticeably different from the others 
in shape (often elongated and pointed) or intensity. 
5.4.2 Dealing with pro-chiral groups 
Another obstacle that must be overcome during the structure calculation is the 
assignment of the pro-chiral atoms. If a pair of pro-chiral atoms can be resolved, then 
to use a pseudo atom (an imaginary atom placed midway between the pro-chiral 
protons) results in a loss of information. The system that is used in the ARIA protocol 
is to 'float' the pro-chiral centres. Using this method, the atoms can be given an 
arbitrary assignment initially and the algorithm subsequently allows them to be 
swapped over during the structure calculation so that both possibilities are considered. 
This means that unambiguous manual assignment of protons with regard to chirality 
was not necessary in the structure calculation of VCP-2,3. 
5.4.3 Tolerance levels 
An additonal problem that had to be overcome in the structure calculation of 
VCP2,3 arose from the tolerance level of 0.03 ppm (i.e. the tolerance allowed during 
automated assignment on the basis of the chemical shift table) in the proton 
dimensions. This caused several NOE violations as follows. Occasionally, overlap 
would result in a cross-peak being picked in the centre of what was in reality a group 
of two or more cross-peaks that were not completely resolved. Because of the 
tolerance level, such a cross-peak could be attributed by ARIA to an incorrect, non-
existent restraint. When the tolerances in chemical shifts were subsequently lowered 
in an attempt to circumvent the problem, some assignment possibilities were excluded 
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by ARIA that were in fact the correct restraints. If on the other hand the tolerances in 
chemical shifts were raised sufficiently for inclusion of the unresolved peak, the 
number of possibilities for ambiguous restraints increased, raising computational cost 
and providing a greater potential for computational error in the automated assignment 
procedure. For this reason, manual peak picking is probably more preferable to 
automated peak picking, as the human eye can often make better judgements that the 
algorithm. Moreover, by manually picking the cross-peaks, many peaks that were in 
fact actually attributable to noise were also eliminated. 
The problems of chemical shift tolerances also highlighted the necessity of 
having separate chemical shift tables for each spectrum - differences in cross-peak 
positions as little as 0.015 ppm from one spectrum to the next could potentially cause 
many violation problems. 
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Chapter 6 - The solution structure of VCP-2,3 
6.1 Secondary structure 
The secondary structure of a protein may be inferred from chemical shifts, 
slowly-exchanging amides, coupling constants and the pattern of backbone-backbone 
NOEs. This is a useful complement and precursor to a full determination of 3D 
structure based on all of the experimental data. 
A chemical shift index (CS!) (Wishart et al., 1992) was calculated for 
VCP---2,3 on the basis of Ha shifts (Figure 6 i). It is consistent with the prevalence of 
short n-strands, and a lack of helices, now recognised as being typical of CP modules 
(Barlow & Campbell, 1994) and many other small extracellular module-types (Bork 
et al., 1996). The incidence of residues with large (> 8 Hz) 3JWZN and strong 
HaIHN( +l) NOEs that are associated with extended regions of polypeptide (Wtithrich, 
1986), largely support this pattern of strands (Figure 6 ii). Smaller (< 5 Hz) 3 JITIaN 
and strong HNIHN(I+I) NOEs that are generally seen in turns (WUthrich, 1986), are 
observed for some residues that lie between the inferred strands, or at their 
extremities - again this is mostly consistent with the CS!. Amide protons that 
exchange with solvent relatively slowly and might participate in H-bonds are located 
mostly within the inferred 13-strands, as expected (Figure 6 iii). Taken together, the 
sequential NOEs, coupling constants and slowly exchanging amides imply that there 
are three strands in module 3 not suggested by the CS!. This is not altogether 
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Figure 6 I - a) Sequence of VCP2,3 (residues conserved in RCA proteins are boxed). b) CS! plot of 
VCP-2,3 showing areas of predicted n-strands (+]). The CS! plot also indicated that there were no 
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Figure 6 ii - NOE patterns and coupling constants in VCP-2,3 
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Figure 6 ii - a) Sequential and short range NOEs; weak medium and strong NOEs are represented by 
black boxes of increasing heights. 3J}{NHa  are indicated as: V> 5 Hz; 0 between 5 and 8 Hz; A> 8 Hz. 
Presence of a * indicates residues with Ha shift coinciding with residual water signal b) Position in 
sequence of inferred a-strands. 
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surprising since the CSI is not completely reliable when 13 C shifts are not included in 
the calculation. Moreover, CP modules have in general rather short strands and the 
Cs! is best suited to the identification of longer regions of regular secondary structure. 
From a consideration of all this data, together with the networks of long-range NOEs 
represented in Figure 6 iii, the locations of 13-strands may be inferred as: strand B2, 
19-21; strand D2, 30-34; strand E2, 40-42; strand F2, 45-50; strand G2, 58-60; strand 
112, 65-67; strand A3, 71-73; strand B3, 81-83; strand C3, 88-90; strand D3, 93-98; 
strand E3 , 104-106; strand F3, 111-114; strand G3, 117-119; and strand H 3 , 123-125. 
Module 2 differs from module 3 in that it lacks strands A and C, which form small 
anti-parallel 13-sheets in some but not all CP module structures solved previously 
(Barlow & Campbell, 1994; Wiles et al., 1997; Casasnovas et al., 1999). In both of 
the modules 13-strand H extends one residue beyond the fourth cysteine, thereby (in 
the case of module 2) effectively reducing the degrees of freedom available to 
residues of the linker (residues 67-70). This is a critical consideration when 
considering module-module flexibility and orientations (see below). Figure 6 iii 
shows the arrangement of strands inferred from manually assigned backbone-
backbone NOEs and amide-exchange data. 
In the case of VCP-2,3 it was surprising to find that very few amide hydrogens 
persisted for the long time-periods typical of other globular proteins - this is 
discussed further below. Module 2 contains only one HN that persists for > 30 
minutes after dissolving VCP2,3 in D20 (and this does not survive for 2 h). On the 
other hand module 3 has seven HNs that may be observed in the spectrum after 2 h in 
D20 and eight further examples that persist for> 30 minutes. An additional 18 I-INs, 
from both modules, are visible after 15 minutes. The difference in the behaviour of 
modules 2 and 3 in this respect has been noted previously (Kirkitadze et al., 1999b). 
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Figure 6 iii - NOEs observed in NMR spectra of VCP-2,3 
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Figure 6 iii - NOEs observed in NMR spectra of VCP-2,3. The residues are labelled by single letter 
code and sequence number at the Ca's. The persistence of backbone amide protons after dissolving in 
2H20 is indicated: present after (open grey circles) 13, (filled grey circles) 30, (white filled circles) 60, 
(black filled circles) 120 minutes. A double headed arrow indicates an NOE. Residues involved in 
inferred H-bonds are boxed. 
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Nonetheless, the available information was used to infer H-bonds with the help of the 
supporting networks of NOEs, as shown in Figure 2a. The Asn60-Pro6l bond was 
found to be in the cis configuration based on the presence of a characteristic 
Ha(Asn)60-Ha(Pro)61  NOE and absence of Ha(Asn) 60-H6(Pro) 61 NOEs. Other X-Pro 
bonds were in the trans conformation. 
6.2 Experimentally derived data used for the calculation 
A total of 1096 manually assigned NOEs, and the NOEs assigned 
automatically by ARIA on the basis of their chemical shift (see Chapter 5), served as 
input for structure calculation together with 54 4 dihedral restraints (based on 
coupling constants), 42 distance restraints representing the inferred H-bonds, and four 
restraints representing the disulphide bonds. Following ten cycles of simulated 
annealing performed within X-PLOR (BrUnger, 1992) using the ARIA scripts (Nilges 
et al., 1997) (Chapter 5), a total of 2187 unambiguous NOEs and 896 ambiguous 
NOEs were used in the final (eleventh) round of structure calculations. As expected 
for a compactly folded protein, amino acids contributing to inter-residue NOEs are 
distributed throughout the peptide sequence with an average of 20 inter-residue NOEs 
per residue (Figure 6 iv)). This is a healthy number of distance restraints and would 
be expected to lead to a high-resolution solution structure. Some residues, however, 
have only one non-sequential inter-residue NOE (Arg7, Asp16, Ser37, Thr54, G1y55, 
Asp87, Ser101, Gly102) while Ser76 has none. The residues with the most of this 
category of NOEs are Trp59 with 66 and Trpl18 with 53. Although there was a 
disparity in the number of slowly-exchanging amides, approximately equivalent 
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Figure 6 iv - NOEs at the interface of VCP-2,3 
5€8 









Figure 6 iv - Residues involved in the interface between VCP-2 and 3. The backbone of the protein is 
shown in orange, and the sidechains are green. Dotted lines and distances A are shown for observed 
NOEs between the linker and modules 2 and 3. The number of connectivities observed between the 
residues is also illustrated (diagram generated using the program INSIGHT) 
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numbers of inter-residue NOEs were identified in each of the two modules. Because 
of the interest in intermodular orientation it is worth noting that Va169 in the linker 
has 20 non-sequential inter-residue NOEs. In total, 27 NOEs were identified between 
the body of module 2 (i.e. up to and including Cys66) and the linker (residues 67-70), 
and 13 NOEs connected the linker and the body of module 3 (i.e. Cys7 1 and 
subsequent residues). Of these 40 NOEs (represented in Figure 6 iv), 20 had been 
unambiguously assigned and 20 were ambiguous but contributed > 50% to the 
intensity of the cross-peak (calculated within ARIA). Only two NOEs were 
potentially inter-modular, both of them ambiguous. One (Gly38Hct - Asp9lHf3) 
contributed less than 5% of the intensity of the ambiguous restraint, and the other 
(Tyr39H- Thr90H3) less than 25%. 
The structure calculation of VCP'2,3 was seeded with a total of 1096 manually 
assigned NOB's that were used as initial input for the ARIA protocol. A total of 54 
dihedral angle restraints and 42 distance restraints representing the inferred hydrogen 
bonds were also used along with four restraints representing the disulphide bonds. An 
ensemble of the final 50 structures calculated for VCP2,3 (following ten cycles of 
simulated annealing performed within X-PLOR using the ARIA scripts, see Chapter 
5), selected, on the bases of total potential energies, out of 100 structures calculated in 
iteration 11, are shown in figure 6 v. The final list of restraints used to calculate the 
structure consisted of 2187 unambiguous restraints and 887 ambiguous restraints 
(Table i). The distribution of the NOE's in the unambiguous restraints are shown in fig 
6 vi and resulted in an average of 20 inter-residue restraints per amino acid. Amino 
acids that had few unambiguous NOE's showed the highest deviation when compared 














Figure 6 v - Overlay of the 50 lowest energy structures 
calculated for VCP-2,3 
(a) 	 (b) 	 (c) 
Figure 6 v - Overlay of final 50 structures shown as backbone naces, superimposed on C(x's on a) both 
modules; b) module 2. C) Moiscript (Kraulis. 1991) representation of VCP-2.3 in the same orientation 














Figure 6 vi - Unambiguous NOE distribution and regions of 
highest deviation in the final 50 VCP-2,3 structures 
I 	Q 	pp 0 
All 110 o ' ll ~~i 	~ 1 1 p J! 




Residue sequence number 
Figure 6 vi - The hatched bars indicate numbers of sequential NOEs, black bars medium range (i-i + 
(2-4)) NOEs, and white bars long range NOEs. Only unambiguous NOEs are shown. The dotted line 
represents the rmsd (backbone) from the average structure for the ensemble of structures; continuous 
line shows the rnisd (backbone) when each module is considered separately. 
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only one non-sequential inter-residue NOE were Arg7, Asp16, Ser37, Thr54, G1y55, 
Asp87, Ser101, and G1y102. Ser76 had no non-sequential NOE's. The residues with 
the most inter-residue NOE's were Trp59, which had 66, and Trp 118, which had 53. 
Roughly equal numbers of inter-residue NOE's occur in both modules. A total of 27 
NOE's were identified between the body of module 2 (ie, up to and including Cys 66) 
and the linker (residues 67 to 70), while 13 NOEs connected the linker and the body 
of module 3 (i.e Cys 71 and subsequent residues). Of these 40 NOEs, 20 were 
unambiguous and 20 were ambiguous but contributed >50% to the intensity of the 
cross-peak (calculated within ARIA). Only two NOEs were potentially inter-modular, 
both of them ambiguous. One (Gly38H(x-Asp91H) contributed less than 5% of the 
intensity of the ambiguous restraint, and the other (Tyr39HE-Thr90H3) less than 25%. 
The favoured orientation of the modules (see Figure 6 v) is presumably defined by the 
40 NOE's between the bodies of the modules and the linker (figure 6 iv) and 
connectivities within the linker. There was no significant difference between the 
structures calculated with, or without, the Tyr 39-Thr9O ambiguous NOE (data not 
shown). 
6.3 The structures of the two CP modules in VCP2,3 
A set of 50 structures that were consistent with the experimentally derived 
distance and angle restraints (Table 1) were chosen from a total of 100 structures 
calculated in the eleventh and final iteration of the ARIA protocol. Selection was on 
the grounds of lowest total energy. Amongst the 50 selected structures, the structures 
of individual CP modules converged well. The mean root mean square deviation 







Table I - Structural statistics for the final 50 structures 
Total number of NOE restraints 3082 
Unambiguous 2195 
Ambiguous 887 
For Unambiguous NOE's: 
Intra-residue 879 
Sequential 548 
Short range (i-j<4) 346 
Long range (i-j>4) 422 
Root Mean Square deviations: 
Module 2 (backbone atoms C a,  N, CO) 0.552 
Module 3 0.468 
Modules 2,3 1.407 
Module 2 (C 	atoms only) 0.562 
Module 3 0.490 
Modules 2,3 1.422 
Angles (0) 0.422 t 	0.07 
Bonds (A) 0.0028 t 0.0006 
NOE's (A) 0.023 ± 0.0056 
Dihedrals (°) 0.238 ± 0.148 
Total Energy (kJmol -1 ) 240.6 ± 99.98 
Average intermodular orientations 
Table 1 - Structural statistics for 50 final structures. Also shown are the intermodular angles with 
respect to twist, tilt and skew. 
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3. The region of least convergence was the loop between strands F2 and G2 (the F2G2 
loop), - this is to be expected since these residues have few detectable long-range 
NOEs (Figure 6 vi) and this loop is the site of a five-residue insertion (G1y52 - Ser56). 
A second region that exhibits poor convergence is found between strands B3 and C3 
(G1y84 - Asp87). This corresponds to a region of CP-modules that in general is seen 
to be poorly conserved, is in many instances a site of insertions and deletions, is 
variable in terms of its structure, and has previously been termed the "hypervariable 
loop" (Barlow et al., 1993). 
Each of the two modules has a similar overall structure that is becoming 
recognised as typical of CP modules. Each module has an elongated shape with one 
long axis and two short ones. Both modules are composed of short n-strands 
surrounding a hydrophobic core, with the amino- and carboxy-termini lying at 
opposite ends of the long axis of the module. The n-strands are, in general, aligned 
approximately with the long axis and form short anti-parallel sheets. The G1y52 - 
Ser56 insertion extends the F 2G2 loop at the N-terminal end of the long axis of 
module 2 by 8 A. The hypervariable loop of module 2 is atypically short; in module 
3 its length is more typical and it projects an additional 3 A in a direction 
perpendicular to the long axis. Consequently module 2 appears more elongated than 
module 3. 
In addition to the four invariant cysteines, the core of each module contains 
the following buried (or only slightly surface exposed) hydrophobic side chains 
(conserved or partially conserved residues are underlined) - module 2; 11e15, Leu20, 
11e31, Tyr33, Leu41, Tr p59, Pro64; module 3; 11e77, Tyr89, Va195, Tyr97, Leu105, 
Vall 11, Trpl 18, Pro122. Tyr39 is partly exposed (Figure 6 vii(a)). Of the non-
conserved core residues, Leu20 lies towards the edge of module 2's core and is 
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obscured from solvent by Asp 14, while Vall 11 is buried in the core of module 3 and 
is replaced by Ser47 (with a potential H-bond between its y-hydroxyl and the C=O of 
Phe60) in module 2. In each module the Trp residues, that is an almost invariant 
component of the consensus sequence of CP-modules, occupies a buried position at 
one end-of the core directly adjacent to the Cysi-Ill disulphide. Other hydrophobic 
side chains are mainly exposed at the module surface, these include - module 2; 11e22, 
Va125, Phe27, 11e42, Tyr48, Leu5l, Met57, Va158; module 3; Tyr85, Phe88, Va194, 
TyrlO3, Ile 106, Leul12 (Figure 6 vii(b)). Va125 is a partially conserved residue of 
module 2 that is positioned such that it might form an interface with module 1 within 
the intact VCP. The equivalent residue in module 3 is Tyr89, which is buried within 
the lateral bulge of the hypervariable loop. Tyr103 is known to be buried in the 3-4 
interface in VCP-3,4 (Wiles et al., 1997). 
Of those residues that form the intermodular linker, the side-chain of Va169 is 
mainly buried within a small hydrophobic pocket that lies between the modules. There 
appear to be no other hydrophobic side-chains in van der Waals' contact but the CH2 
groups of G1y38, His40, Asp91, Glyl 15 and Glyl 16 are near-by. 
6.4 Intermodular orientation 
The orientation of module 3 relative to module 2 varies amongst the ensemble of 50 
calculated structures of VCP-2,3. One way to quantitate this is to calculate an overall 
mean rmsd for the whole structure instead of calculating values for the individual modules 
(see previous section). The mean rmsd is 1.42 A from the co-ordinate averaged structure 
for backbone atoms in the n-strands of both modules. This relatively low value confirms 
what is apparent from inspection of Figure 6 v - that there is a distinct, favoured set of 
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Figure 6 vii - a) Hydrophobic residues that are substantially surface exposed in VCP-2.3 (cyan) b) 
Hydrophobic residues that are buried (or only slightly surface exposed) in VCP-2.3 (orange). 
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intermodular orientation amongst the members of the ensemble. A convenient way to 
summarise the orientation of a module with respect to its neighbour, where the two 
modules are broadly similar in structure, is to calculate the values of tilt, twist and 
skew for an ensemble of structures as described previously (Barlow et al., 1993). The 
results of this procedure for VCP'-'2,3 are incorporated in Table 1. Each structure 
within the ensemble was calculated separately, starting from a random structure. 
There was no significant difference between the structures calculated with, or without, 
the Tyr39-Thr9O ambiguous NOE. Hence, the favoured orientation is presumably 
defined by the 40 NOEs between the bodies of the modules and the linker (Figure 6 
iii) and connectivities within the linker. 
The sample of VCP-2,3 prepared as part of the current study was also used in a 
set of biophysical experiments carried out by Dr Marina Kirkitadze in this laboratory. 
These were considered together with the NMR experiments that were carried out over 
a range of temperatures in order to gain insight into the nature of modular stability 
and intermodular contacts. In further NMR relaxation studies carried out on this 
sample of VCP'-2,3 by Krystyna Bromek in this laboratory, considerable insight was 
gained into the flexibility of the 2-3 intermodular junction of VCP. Finally, a sample 
of VCP-1-4 produced in Kotwal's laboratory from the clone provided by the Barlow 
laboratory was crystallised by Dr Krishna Murthy of the University of Alabama and 
the structure was solved (after completion of the NMR studies). All of this work, and 
its impact on the solution structure of VCP2,3 described in this Chapter, is discussed 
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Chapter 7 — Discussion 
7.1 Protein expression 
Pichia pastoris was successfully engineered to produce a KM7 1 cell line with 
a mutVhis phenotype that expressed recombinant VCP-2,3 in milligram quantities. 
Two plasmids, pPICZaA and pPIC9K, were incorporated into the yeast genome with 
the gene encoding VCP2,3 cloned into the pPICZaA plasmid. The plasmid pPIC9K 
allowed the yeast to metabolise histidine intracellularly, since the KM7 1 strain has a 
deficient histidinol dehydrogenase gene (his4), which prevents the cells from 
synthesising histidine. Expression of VCP-2,3 was induced by providing methanol as 
the sole carbon source. 
Initially, two different cell lines (KM71 and GS1 15) had been transformed 
with the pPICZaNCP-.2,3 construct. The GS 115 strain had previously been used in 
studies of VCP modules 3 and 4 (VCP-3,4) and successfully expressed the two CP 
modules at yields of 2 mg/l, using a pPIC9fVCP3,4 construct (Wiles et al., 1997). 
The KM71 mutS  strain expressed VCP-2,3 in higher yields throughout the test 
inductions and emerged as the clear favourite. 
One disadvantage of using the plasmid pPICZaA as the vector for 
transformation into P.pastoris was the need for further transformation of pPIC9K to 
confer the his phenotype. With this in mind, use of a plasmid that confers the his 
phenotype in the initial transformations would be a logical choice for producing 
protein with isotopic labels. Positively transformed cells could have been selected on 
their ability to grow in a histidine-deficient medium. 
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VCP-2,3 was expressed in yields of -25 mg/i thanks to isolation of a jackpot' 
clone of KM71. The increased level of expression for VCP-2,3 compared with those 
reported in the literature for VCP-3 ,4 is attributable to multiple integration events in 
VCP2,3 production. On the other hand, KM71 has been shown in previous studies 
to be better at producing foreign proteins than wild-type strains that lack the mutation 
in the AOXJ gene (Tschopp et al., 1987, Cregg et al., 1987, Chiruvolu et al., 1997). 
Use of the KM71 strain requires less growth media during the induction stages, which 
is more cost-effective if producing isotopically labelled protein for NMR studies. 
Indeed, levels of protein production of 400 mg/i for hepatitis surface antigen produced 
in P. pastoris, (Chiou et al., 1997) and 930 mg/i for bovine pancreatic trypsin 
inhibitor (Vedvick et al., 1991), are examples of the very high levels of expression in 
P. pastoris that have been reported in the literature. This expression system has now 
been used to produce recombinantly, proteins from bacteria, fungi, protists, plants, 
invertebrates and humans. 
Production of CP modules was originally accomplished using a 
Saccharomyces cerevisiae system. The published yields of protein using this yeast 
could be very low e.g. only around 0.1 mg/I growth in the case of factor H modules 15 
and 16 (Barlow et al., 1993). P. pastoris appears to represent a significant 
improvement although expression yields of the VCP2,3 CP module pair are 
relatively high compared with .other examples of CP modules expressed in this 
system. In this laboratory, MCP-.-1 was also expressed in P. pastoris using a 
KM71/pPIC9 expression system that yielded 5-7 mg/i of the recombinant protein 
(O'Leary, 2000). However attempts to produce useful levels of MCP1 ,2 failed. 
Similarly C4bBP-4 ,2 did not express well in P. pastoris, although yields were more 
respectable when a fermentor rather than shake-flasks was used. Expression of 
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VCP-1-4 gave modest yields - this protein was subsequently purified and crystallised 
(Murthy et a!, 2001). The CP module-pair from the GABAb receptor was expressed at 
levels of 12 mg/i using the same expression system as used for VCP-2,3. Module 2 
from the GABAb receptor pair was expressed individually in yields of 20 mg/I. In 
other laboratories,. P. pastoris has been used successfully to express CP modules 15-
17 of CR1 (glycosylation sites deleted), with yields of greater than 30 mg/l obtained 
using the pPIC9 plasmid (Kirkitadze et al., 1999a). On the other hand the same group 
has experienced difficulty with expression modules 1-3 of CR1 in the same system 
(Malgorzata Krych, personal communication). The four CP-modules of DAF and 
first two CP modules of CR2 have also been expressed at useful levels in P. pastoris 
(Lin et al., 2001, Szakonyi etal., 2001). The P. pastoris expression system, therefore, 
seems well suited to the recombinant production of CP module-containing protein 
fragments. 
E. coli has also been used for CP module over-expression. For example, the 
N-terminal CP module of membrane co-factor protein, MCP-1, with a GST fusion 
protein attached to aid purification was expressed in this laboratory at levels of only 
-1 mg/l. Much greater success was achieved with modules 1-3 of CR1 and (recently) 
modules 1-4 of DAF (now crystallised, Susan Lea, Oxford, personal communication). 
In these cases special re-folding protocols have been devised since in general E. coli 
is not nowadays the vector of first choice for the expression of proteins containing 
disulphides (VCP-2,3 has four). Finally CHO cells have proved effective for 
production of CP module-containing proteins that are intended for crystallography, 
examples being MCP-1,2 (Casasnovas et al., 1999) & P2GPI (Bouma et al., 1999). 
P. pastoris has a tendency to hyperg!ycosy!ate and sugars must be removed 
enzymatically, or N-g!ycosylation sites engineered out. Unlike the mammalian CCP- 
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containing proteins, however, VCP has no N-glycosylation sites and glycosylation 
was therefore not a problem in this particular case. Another potential problem of 
using the Pichia system for CP module expression is the tendency for non-covalently 
bound carbohydrate to co-elute with the protein during purification. These 
carbohydrates are secreted from P. pastoris and proved to be a problem for most of 
the recombinantly produced batches of CP modules produced in this laboratory. 
Subsequent purification protocols using a heparin column as the main purification 
step helped to solve the problem (Smith et al., 2000). 
In summary, a good choice for future production of CP module-containing 
proteins would be P. pastoris KM7 1 cells transformed with a pPIC9 plasmid 
containing the protein of interest and, if possible, purified using a heparin column or 
other affinity method. In general, experience has shown that N-glycosylation sites are 
best removed by mutaganesis provided they can be shown to be physiologically 
irrelevant. 
7.2 NMR data and assignment of VCP-2,3 
A sample of VCP-2,3 in a buffer of 10 mM sodium phosphate, pH 6.0 was 
used for all NMR experiments and resulted in good quality NMR spectra, with many 
dispersed resonances. The concentration of the protein was -P2.5 mM for all 2D and 
3D spectra and mixing times of 150 ms for NOESY spectra and 63 ms for TOCSY 
spectra proved to be more effective than shorter mixing times of 100 ms for NOESY 
and 39 ms for TOCSY. Longer mixing times were also used for acquisition of spectra 
in the VCP3,4 module pair (Wiles et al., 1997), although in that case a pH of 4.0 was 
used and some spectra were, acquired at 750 MHz rather than the 600 MHz used for 
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VCP-2,3. In the structure determination of Factor H modules 15 and 16 (ff11 5,16) 
somewhat longer mixing times of 75 ms for the TOCSY and 250 ms for the NOESY 
spectra were used - spin-diffusion is likely to occur under these circumstance. fl-Il 5-
16, which was not isotopically labelled due to the very low expression yields. 
Instead, due to overlap in the 2D spectra, structures of fl-115 and 11116 were solved 
individually before the module pair was fully assigned. Although this would have 
been a time consuming step, it might have proved a useful strategy in the case of 
VCP-2,3, if the individual modules had been available - there was significant overlap 
in most regions of the 2D NOESY spectra of VCP2,3, and even some overlap in the 
3D NOESY spectrum, which required painstaking analysis. Assignment of the 
proline residues in particular proved more difficult and would have been quicker had 
the spectra of individual modules been available. 
Despite the overlap mentioned in the previous paragraph, it proved not 
necessary to double-label VCP2,3 with ' 5N and 13 C as the NMR spectra contained 
many dispersed peaks that were sufficient for assignment and structure calculation. 
On the other hand, double labelling could have speeded up the whole process and 
improved the number and quality of experimental restraints. 
The 'H-' 5N 3D spectra of VCP-2,3 were particularly useful in the initial 
stages of assignment, as was the program ANSIG, which allowed connectivities 
between sequential residues to be assigned relatively quickly. The NMR spectra 
acquired with ' 5N labelled VCP-2,3 provided a means of assigning cross-peaks that 
were difficult to resolve using the 1 H-'H spectra alone. The 2  H2  spectra were 
particularly useful for aromatic assignment, as there was less overlap in the aromatic 
region due to the absence of signals originating from side chain NH protons. The 
2 H2 and Jhnhct  spectra proved useful for confirmation of Ha assignments that were 
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very close to the water signal and were not readily assignable in the 2D and 3D 
spectra. The Jhnha  data also highlighted a mistake in assignment of one of the serine 
residues, for which an HP proton had been mis-assigned as an Ha proton due to a low 
chemical shift for the H3. A series of scripts was used to convert the exported cross-
peak lists form ANSIG into chemical shift lists for each NOESY spectrum, followed 
by generation of restraint tables. Analysis of the output of these scripts, however, 
highlighted the necessity of editing the automatically picked cross-peaks in ANSIG, 
many of which had errors in the peak position - these were corrected manually. 
7.3 Brief review of relaxation studies of VCP-2,3 and 
intermodular flexibility 
A major series of relaxation studies were preformed on the 2.5 mM 15N-
labelled VCP 2,3 sample that had been used for the structure determination. These 
studies were performed by Krystyna Bromek and are described in detail in a recent 
paper (Henderson et al., 2001). It is instructive at this point to review the relaxation 
studies as a preamble to discussion of the solution structure in the next section. 
It has been established that multiple modules are required for functional 
activity in VCP and in other RCA proteins - thus the dynamical and orientational 
relationship between modules is of great interest. To properly characterise the 
solution structure of VCP-2,3 it is therefore important to determine whether the range 
of conformations represented amongst the ensemble of 50 calculated structures 
genuinely reflects the situation in solution. While poor convergence amongst the 
calculated structures might result from flexibility, it could instead be a consequence 
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of a lack of experimentally-derived restraints. On the other hand, the spectrum of 
intermodular orientations inferred from the structure calculation might comprise just a 
subset of a much more diverse collection of conformations that are exchanging 
rapidly compared to the build-up time (50-150 ms) of the 'H-'H NOE. 
The 15N T 1 relaxation rate and heteronuclear NOE of the backbone 'fl-' 5N 
pair are sensitive to motion on the rapid, 1012  s to 10 s, time-scale; in addition, 
chemical exchange can be sampled on the 10-6 s - 10-3 s time-scale as an Rex > 0 
addition to T2 [(T2 = (R2 + Rex)'I (Lipari & Szabo, 1982). The exchange of amide 
protons with solvent water is a slower process that reflects 101 - 10 s ' motion. Most 
importantly for the purposes of this study, it is possible to characterise the anisotropy 
of rotational diffusion from ' 5N relaxation studies. This is a function of the time-
averaged shape of the protein, which in turn reflects the mobility between modules on 
a time-scale slower than the overall correlation time. 
Based on the assignment of backbone ' 5N and 'H nuclei described in Chapter 
4, the 15N relaxation rates for a large number of residues in VCP-2,3 are given in 
Henderson et al., 2001. The relaxation properties of some individual residues are 
mentioned below in the discussion of the structure of VCP2,3. The most important 
result from the point of view of characterising intermodular motion was obtained by 
best-fitting a rotational diffusion tensor to the relaxation properties of each individual 
module treated as a rigid rotor (Dosset et al., 2000). Module 2 was best-fitted using 
an axially symmetric model (i.e. z > x, x = y ) for VCP2,3 with overall correlation 
time = 7.3 ns and D11/D 1 = 1.6 -this is the ratio of the long (z) axis of the molecule to 
its two shorter axes (x,y). This model was shown to be a significant improvement on 
an isotropic (x = y = z) fit (passed F-test at 5% probability) (Bevington & Robinson, 
147 
Chapter 7 
1992), while no further improvement was observed when fitting a fully anisotropic 
rotor (x < y < z). Data from module 3, on the other hand, were best fitted to an 
isotropic diffusion model with a correlation time = 6.6 ns; the best x2 fit of an axial 
rotor yielded D11/D 1 = 1.1 and the F-test for this axial ratio failed. It is important to 
appreciate that although this calculation is based on individual modules, in each case 
the values obtained relate to the whole molecule. The lower experimental values of 
D11/D i (between 1.1 and 1.6) would therefore suggest strongly that the modules are 
not arranged in an extended manner (with small tilt angle) as indicated by the 
structure calculations based on the NMR data. This inconsistency is discussed in the 
next section. 
7.4 The structure and dynamics of VCP-2,3; comparison 
with other structures 
The solution structure of VCP-2,3 reveals two elongated domains fused head-
to-tail at a small interface. The consensus cysteines, glycines, and prolines together 
with 12 out of the 14 consensus hydrophobic residues play important structural roles 
within the two domains, each of which has a typical CP module-like structure. It 
appears from an inspection of the exchangeability of backbone amide protons that 
both modules of VCP-2,3 undergo "breathing" motions on the 10 -3 - 101 s time-scale. 
Module 2 in particular is notably lacking in slowly exchanging amides and this is 
consistent with its melting temperature being lower than that of module 3 (Chapter 5, 
and Kirkitadze et al., 1999b). An analysis of relaxation data presented in Henderson 
etal., 2001 revealed more 1091012  s' motion in module 3 than in module 2. Despite 
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rather low levels of sequence identity, both modules superimpose well with each of 
the other 12 CP-module structures that had been published by the beginning of 2001. 
(see Table 1; <rmsd> for pair-wise superpositions = 0.9 A ± 0.4 A (s.d.) for the C(ts 
and Cps of the invariant Cys and Trp residues). VCP2, like fl+-1 6, MCP'-4 and the 
modules of 132GP1 has only 6 13-stands and lacks strands A2 and C2. These strands 
normally run anti parallel to each other and form the first 13-sheet near the N-
terminus. All other CP modules studied to date have 7 or 8 13-strands. Module 2 is 
most similar to MCP-1 in these comparisons (0.49 A) and least similar to fl-1---5 (2.02 
A). Module 3 deviates the least from B 2GPI-3 and is most dissimilar to MCP-2. 
The structure of module 3 in the context of VCP2,3 has small but 
significant differences in structure compared to its structure in the context of 
VCP--'3,4 (Figure 7 i). The pair-wise rmsd for all backbone atoms from Cys7l 
(Cys3 in VCP-3,4) to Cys 124 (Cys56 in VCP-2,3), inclusive, is 1.45 A (based on 
a comparison of lowest energy structures from the two ensembles). The D 3E3 turn 
(Asnl00-Tyrl03) appears to have experienced a hinge-like movement resulting in 
displacement by up to 3 A of the Gly 102 backbone. At the other end of strand E3 
there are differences in the position of the backbone of residues Ile 1 06-Asn 108 by 
up to 3.5 A. All of these residues are proximal to the interface with module 4. 
For example, 11e106 (Leu38 in VCP-'3,4) is a key interface residue, as is Tyr103 
(Tyr35). Several of them (Tyr103, Ilel06, G1y107 and Asn108) exhibit chemical 
shift differences between VCP-2,3 and VCP-3,4 (z3> 0.1 ppm) (figure 7 ii). 
Residues 101 and 107 also have significantly higher ' 5N Tjs when in VCP-2,3 
compared to VCP-3,4 - indeed G1y107 has the highest T1 amongst residues of 
module 3 in VCP-3,4. At the opposite end of the module, near the amino 
terminus, Asp9l in the mobile C3D3 turn and G1y115 in the F3G3 turn differ in 
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Table I - RMSD comparisons of CP modules 
Module 	VCP module 2 (rmsd) VCP module 3 (rmsdj 
fl-15 2.02 1.51 
ff115 1.57 1.18 
ff116 1.41 1.35 
VCP2 - 0.93 
VCP34 1.32 0.90 
VCP3 0.93 - 
VCP4 1.84 1.48 
MCP1 0.49 1.02 
MCP2 1.59 1.44 
B 2GPI1 0.96 1.18 
B2GPI2 1.61 1.30 
B2GPI 3 0.94 0.93 
B2 GPI4 1.33 1.16 
Cis 1.16 1.11 
*rmsd based on a pair wise comparison using Ca, CO and HN atoms of conserved Cys and Trp 
residues 
#Module 3 from VCP-.3,4 as described by Wiles et al. 
Table I - RMSD comparisons for VCP modules 2 and 3 with other CP modules. 
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Figure 7 i - Differences between VCP-3 from VCP-2,3 and 
VCP-3,4 
Figure 7 I - ribbon representation of VCP-3 from VCP-2.3 (red) and VCP-3.4 (purple) showing the 
different conformations of Tyr 85 in the hypervariable loop. Arrows indicate those residues that are 
involved in 2,3 or 3,4 interfaces and have different conformations. Cys residues, green;Trp. 




Figure 7 ii - Chemical shift differences between module 3 from 






Figure 7 ii - Chemical shift differences between module 3 assignments from VCP-2,3 and VCP-3,4. 
X-axis values were calculated as module 3 (VCP-3,4) Ha shift - module 3 (VCP--2,3) Ha shift. 
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position by 1.5-2.0 A. These residues are close to the small interface with module 2; 
the öHU  of G1y115 has changed (0.1 ppm) compared to its chemical shift in the 
context of VCP-3,4. These structural differences are not just an artefact of the 
structure calculation protocols - numerous NOEs found in the spectra of VCP-2,3 and 
assigned unambiguously to inter-residue cormectivities within module 3 were absent 
in the VCP-3,4 spectra; the relevant distance restraints were also violated by the 
structure of VCP3,4. The converse was also observed - i.e. module 3 NOEs 
occurred in the spectra of VCP3,4 that were absent in the spectra of VCP2,3. 
As might be expected the major differences in structure between module 3 
from VCP-2,3 and VCP-3,4 occur close to the intermodular interfaces. When the 
residues concerned (91-92,101-103,106-108,115) are excluded from the comparison, 
the pair-wise rmsd (backbone atoms) decreases to 1.16 A (i.e. based on a comparison 
of the lowest energy structures from each of the VCP-2,3 and VCP3,4 ensembles). 
In the case of Tyr 85 (figure 7 i) the difference is probably due to additional 
assignments in VCP-2,3 of Gly 84. Elsewhere, however, the differences are probably 
too great to be attributable to experimental uncertainty, meaning that changes of 
structure near the interface must somehow be propagated into the body of the module. 
That the presence or absence of neighbouring modules has a small but significant 
affect upon a module's 3D structure is in agreement with previously published 
biophysical studies of CP modules (Kirkitadze etal., 1999a,b,c,d) that demonstrated a 
context-dependency of melting temperatures, and enthalpies of unfolding, of 
individual modules. These studies also showed co-operativity of melting amongst 
linked modules. On the other hand, an earlier study of the 15-16 CP-module pair 
from factor H (Barlow et al., 1993) revealed no such structural changes - this study 
153 
Chapter 7 
however was based on a smaller data set since the protein was not 15N-labelled, and in 
any case these modules are not tightly interfaced as are modules 3 and 4 of VCP. 
Module 2 is more elongated than module 3 due to the five-residue insertion in 
the F2G2 loop. This lies close to the amino terminus of module 2 and it was 
speculated that it could conceivably interact with module 1 in VCP (subsequently 
confirmed by the crystal structure (Murthy et al. 2001)). These five residues have 
few long-range NOEs, and are very mobile on the 10-12_ 10-9 s time-scale. The loop 
has the sequence LGSTGSM, and its equivalents are GG in module 3 of VCP, PGN 
in VCP module 4 and GT in VCP module 1. Both Leu (51) and Met (57) side-chains 
are solvent-exposed in VCP2,3. This loop is conserved amongst the second CP 
modules of other poxvirus complement control proteins but insertions of similar 
length are found in few human CP-modules. Examples of note are the second (and 
the third) modules of C4bBP, chain a, and the second module of MCP. In the crystal 
structure of MCP modules 1 and 2 (MCP1 ,2) this loop (sequence LKGSVA) has a 
similar conformation to that of VCP module 2, but has swung in towards the body of 
the module. The Leu (109) and Val (114) of MCP are solvent-exposed and there is 
no contact with MCP module 1, which is tilted away from the loop. Module 2 of 
VCP also appears elongated due to a deletion, with respect to nearly all other CP-
modules, in the hypervariable region. As a result, unlike other CP-modules whose 
structures have been solved previously, module 2 has no lateral bulge here. 
Consequently, the semi-conserved Va125 is solvent exposed rather than buried in the 
bulge like, for example, Tyr85 of VCP module 3 and Tyr83 of MCP module 2. 
G1y24 (in the hypervariable region), Va125 and Asp27 each undergo motion on the 
fast time-scale and Va125 experiences additional 106103  s' motion. Residues 25 and 
27 of VCP module 2 correspond to residues that form n-strand C in module 3 but they 
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do not form a p3-strand in module 2. The equivalent region of module 3 (residues 85-
90) is also highly mobile on the 1012 - 10-9 s time-scale. 
The "top" of module 2 - i.e. the region that comes closest to module 3 - is 
similar in structure and sequence to the "top" of module 3. Residues 35-42, which 
have the sequence CNSGYHLI and correspond to the D 2E2 loop and strand E 2 , and 
residues 66-67 (the fourth Cys and the first residue of the linker, Glu) of VCP2,3 
overlay on the equivalent ten residues of VCP-'3,4 (CNSGYSLI + CQ) with an rmsd 
of 0.92 A (Ca and Cf3 atoms). The backbone at the "bottom" of module 3 follows a 
similar course to its equivalent in module 4 - thus the Cas of 70,71 (last residue of 
linker and first Cys), 89-92 (last residue of 13-strand C3 and the C3D3 loop), and 113-
118 (from strand F3 into strand G3) overlay on the equivalent residues of VCP3,4 
with an rmsd of 0.88 A. The sequences, however, are different; in particular the key 
interface residues of module 4 (Pro 106 and Tyr8l, VCP-3,4 numbering) are replaced 
by a Gly and an Asp in module 3. Another key interface hydrophobic side chain of 
the 3,4 junction that is lost in VCP-2,3 is that of the linker residue 11e58 (VCP-3,4 
numbering) that is replaced by Ser. The principal hydrophobic content of the small 
2,3 interface is provided by the buried side chain Va169 (equivalent to Va159 of 
VCP-3,4). It is therefore the replacement of three hydrophobic side chains (Pro, Tyr 
and Ile) by smaller or polar ones (Gly, Asp, Ser) that appears to be responsible for the 
dearth of intermodular contacts between modules 2 and 3 compared to the 3,4 
situation. A lack of well-defined structure in the 2,3 junction is also indicated by the 
high mobility of 13-strand C3 (88-90), and the C3133 loop (91-93) on both the fast (88, 
90, 91 and 93) and chemical exchange (91 and 93) time scales, and the high backbone 
15N T1 of linker residue Lys70. 
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A comparable dearth of contacts were detectable between the 15th and 16th 
modules of factor H (Barlow et al, 1993), and there are few contacts between the first 
and second modules of MCP according to the crystal structure (Casasnovas et al., 
1999). In the crystal structure of 3 2-glycoprotein I (3GPI) (Bouma et al., 1999) there 
are only limited hydrophobic contacts and a single hydrogen-bond within each of the 
three junctions between the four adjacent classical CP-modules - to take the most 
extreme example, only 242 A2 of surface area is buried between P2GPI modules 2 and 
3. Despite the scarcity of forces stabilising intermodular junctions, both MCP-1,2 
and P2GPI have been crystallised and display quite well defined intermodular 
orientations. Structures of VCP-2,3 calculated on the basis of NOEs also converge to 
a limited range of intermodular conformations despite the fact that only 195 A2 of 
surface area is buried in the lowest energy structure. In all of these cases it is possible 
that the actual situation, in solution, differs from the outcome of the structure 
determination - just a few out of many conformations of MCP-1,2 may have been 
selectively crystallised for example, or intermodular movement on a time-scale rapid 
with respect to the build up of the 'H-'H NOE might not be apparent in the NMR-
derived structures. 
It was therefore considered important to exploit the ability of NMR to provide 
insights into intermodular motion. This was done, according to the method recently 
reported by Copie et al. (1998), which involved comparing the anisotropy of 
rotational diffusion derived from an analysis of relaxation data for VCP-2,3 on the 
one hand, and from the calculated structure of VCP-2,3 on the other. Despite the fact 
that analysis of 15N relaxation times was made more complicated by the disparities 
between the internal fast motions of the two modules, it was obvious that the value of 
D11/D1 (-1.6) obtained (based on module 2) was too small to be consistent with the 
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extended head-to-tail conformation indicated by the structure calculation. To explain 
this, it is necessary to invoke mobility between the modules and therefore attention 
focuses on the intermodular linking sequences. Since linker residues show no 
evidence of mobility on the chemical exchange time-scale, and little evidence of 10 9- 
1012  s 1  motion (in Va169 and Lys70), any intermodular motion is likely to be on a 
time-scale that is faster than chemical exchange (106  s') but slower than the overall 
correlation time (408  s). According to this model, the NOEs that promote 
convergence of the structures during simulated annealing - and it is important to 
remember that all of these are between the bodies of the modules and the linker or 
within the linker, rather than between modules - represent, in fact, average distances 
between two mobile segments of the molecule that share only a small interface. It is 
impossible to distinguish, on the basis of an NOE, between the case of two protons 
that spend only a fraction of time relatively close together in space (e.g. 3.3 A apart), 
and a pair of protons that are at a fixed but longer distance (e.g. 5 A). Hence, to 
explain the D 11/D i ratio obtained from the relaxation studies it is necessary to invoke a 
large number of interconverting orientations, many of which are kinked (large tilt 
angles), whose time-averaged structure is more compact than the calculated structures 
(figure 7 iii). It is interesting to discuss how these findings fit with other biophysical 
studies of VCP. 
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VCP -3 	VCP 2,3(NMR) 
Figure 7 ii. - A flexible junction between modules 2 and 3 results in a more compact time averaged 
structure. The number below each illustration is the axial ratio (1)1fDj. 
158 
Chapter 7 
7.5 Biophysical studies of VCP-2,3 
Using the sample prepared for the NMR studies, a series of biophysical 
measurements were made on VCP2,3, and these are discussed in detail in a 
publication by Kirkitadze et al. (1999b). The calorimetric profile of VCP-2,3 showed 
a melting transition at 57 °C and a calorimetric enthalpy (86 kcal/mol) consistent 
with each of the two modules having a compact fold. The ratio of calorimetric and 
van't Hoff enthalpies was greater than one, together with a distinct shoulder on the 
main peak within the profile, indicated that melting of CCP modules 2 and 3 occur at 
similar, but not identical temperatures. In addition to the major 57 °C transition, a 
minor transition in the 30-40 °C range was visible in the calorimetric profile. In 
repeated scans, this appeared either as a discrete peak or as a shoulder on the edge of 
the main feature. As described in Chapter 4, heteronuclear NMR revealed the melting 
pathway of VCP-'2,3. Between 25 and 40 °C there was very little change in the 
chemical shifts of amide protons and 15N nuclei implying that negligible unfolding of 
the two modules occurs over this temperature range. Between 40 and 45 °C, 
resonances that had been assigned to module 2 lost intensity while new cross-peaks 
consistent with the presence of random-coil structure emerged. As the temperature 
increased above 45 °C, signals arising from module 2 faded rapidly, while module 3 
resonances remained largely unperturbed even at 52 °C. These data indicate that 
module 2 is less stable to temperature than module 3 within the context of the 2,3 
fragment and are in agreement with experiments using chemical denaturants, and with 
the greater abundance of slowly (> 1 hour) exchanging amide protons in module 3 
compared to module 2 described above. 
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Since neither module unfolds below'40 °C, the minor calorimetric feature in 
the 30-40 °C range could be assigned to the small interface between modules 2 and 3 
of VCP, as also seen from the NMR studies. This means that unless the presence of 
modules 1 and/or 4 stabilise the 2-3 junction within the context of the intact VCP 
molecule, then it will be partially melted at physiological temperature and will act as a 
flexible hinge at the centre of the molecule. Ultracentrifugation studies cond .  ucted at 
4 °C revealed the 2,3 module pair to be highly asymmetric with an axial ratio of 
approximately 5.3:1. Thus below the putative melting point of the junction, modules 
2 and 3 seem to adopt a very extended head-to-tail arrangement with a very limited 
intermodular junction. According to this interpretation, melting of the junction 
between modules 2 and 3 of VCP takes place at a lower temperature, and with an 
apparently smaller change in enthalpy, than the junction between the homologous 
modules 16 and 17 of CR1 for which a similar set of biophysical measurements have 
been made (Kirkitadze et al., 1999c). 
Hence the biophysical data strongly support the idea of a flexible hinge 
between modules 2 and 3 of VCP at 37 °C as suggested by the NMR studies. As the 
temperature is lowered, Krystyna Bromek showed that VCP-'2,3 becomes 
progressively more elongated (unpublished data) presumably due to the stabilisation 
of the 2-3 intermodular junction below its calorimetrically determined melting point 
(30-40 °C); and this agrees with the ultracentrifugation data at 4 °C. 
7.6 Comparison of NMR and crystal structures 
It proved possible (after the work described in this thesis was completed but 
before it was published) to produce crystals of intact VCP (recombinant, fully 
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functional material produced from a P. pastoris construct prepared in this laboratory 
by Dr. Nick Mullin) of sufficient quality to solve its structure at 2.2 A resolution 
(Murthy et al., 2001, Figure 7 iv). Crystallisation took place at 20 °C. This is the first 
3D structure of any intact RCA protein and it revealed for the first time the structures 
of module 1 of VCP and the 1-2 intermodular junction. Under the conditions used for 
crystallisation, all the intermodular junctions of VCP appear to be "frozen" since the 
four CCP modules are arranged in a nearly identical manner within the unit cells of 
two different crystal forms and in a total of five crystallographically independent 
examples of the molecule. The structure (Figure 7 iv) may be regarded as consisting 
of two pairs of closely interacting modules (1,2 and 3,4) with very few contacts 
between the bodies of modules 2 and 3 - in excellent agreement with previous results. 
The 2-3 junction of intact VCP, however, is different from the junction in VCP-2,3 
calculated from NOEs; on the other hand the 3-4 junction of intact VCP is very 
similar to that of VCP-3,4 but somewhat more tilted (Figure 7 iv). It is interesting to 
note that the structure of module 2 in the crystal has some significant differences from 
its structure in VCP2,3. Of special note, the Leul09-Ser1 14 insertion in module 2 
(see Figures 6 i and 7 iv) is a mobile and unstructured loop in VCP2,3 but has 
moved by some 15 A in the crystal structure to contact the G1n42, Lys43 insertion of 
module 1, and stabilise the 1-2 intermodular interface (Figure 7 iv). Figure 7 v shows 
a representation of the crystal structure of VCP with regard to twist, tilt and skew 
angles (see Chapter 1 for definitions). It is not known, but is a matter of interesting 
speculation, whether module 2 of VCP-2,3 is in fact destabilised by the lack of 
module 1. If so, then it is conceivable that the 2-3 junction is also destabilised by the 
lack of module 1 which in turn implies that the flexibility between these modules may 




Figure 7 iv - Crystal structure and NMR fragments of VCP 
X-ray crystal structure of VCP 
NMR structure of VCP-.3.4 
Figure 7 iv - Moiscript representations of VCP-3,4 (NMR). intact VCP (X-ray crystallography) and 
VCP-23 (NMR). The alignments represent the best fit orientations adopted for VCP-2.3 and VCP-3.4 
when compared with the crystal structure. 
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Figure 7 v - Intermodular angles in crystal structure of VCP defined by twist. tilt and skew. 
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On balance, however, the likelihood is that VCP does indeed have hinge- or pivot-like 
flexibility as a result of the dearth of contacts between its central modules. 
In all cases where examination of module-module interfaces is possible, 
recurring themes are present. The linker residues almost always have side chains that 
are entirely or partly hydrophobic, and two or more aromatic or histidine side chains 
lie in close proximity; one at the second turn towards the C-terminus of the preceding 
module and one near the first turn towards the N-terminus of the succeeding one. As 
mentioned previously, the relative orientations of one module with respect to the next 
is varied, even though the sequences close to the interfaces show a degree of 
similarity. This indicates that modelling other CP module pairs on the basis of 
homology could be difficult. 
7.7 Recreation of SPICE using VCP-2,3 and VCP-3,4 
The sequence of complement control proteins is highly conserved amongst the 
poxviruses. Comparison of VCP with SPICE (Rosengard & Ahearn, 1998), the 
complement control protein of Variola virus, indicates 11 substitutions (Figure 7 v) in 
modules 2-4, while module 1 is identical in the two proteins. SPICE has been reported to 
have four times the potency of VCP in complement inhibition, although these are 
preliminary findings and have not yet been published (Rosengard & Ahearn, 1998) and this 
might assist in the greater virulence of the Variola (small pox) virus. It is believed that loss 
of certain immunomodulatory components from Variola compared with other poxviruses, 
however, may be the dominant factor in increased virulence of smallpox. It is therefore of 
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Figure 7 v - Recreation of SPICE using NMR derived 
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Figure 7 vi - a) shows backbone trace of VCP-23 and VCP-3.4 solved by NMR. b) Recreation of 
possible structure of SPICE. Module 1 of SPICE is unchanged from VCP sequence - residues in SPICE 
that differ from VCP are annotated and shown in red. 
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interest to review the locations of the SPICE substitutions in the light of the 3D 
structures of VCP modules 2-4. Figure 7 vi indicates the positions of the substituted 
residues on a surface representation of the three modules. This reconstruction was 
created by overlaying structures of VCP-2,3 and 3,4 using module 3 for 
superposition. All 11 of the substituted residues are surface exposed - none appear to 
be of structural importance or (with the possible exception of His40) involved in the 
intermodular junctions. Nine of the residues concerned are visible in the view of the 
molecule presented - G1u86 of VCP-2,3 and Lys88 of VCP-3,4 are the exceptions. 
None of the substitutions are conservative but H40 -> Y, S45 -> Y, S73 -> L and S67 
(of VCP3,4) -> L would add significant hydrophobicity to a surface that already 
exposes a high proportion of non-polar side chains. Other replacements in SPICE 
would facilitate a difference in overall surface charge in module 2 due to the addition 
of two lysine and one histidine residues, replacing three acidic residues (fig 7v). 
Interestingly, replacing His->Tyr or Tyr->His at an analogous position in two separate 
CR1 binding regions has been shown to affect the C4b binding (Krych et al, 1998). 
7.8 - Other CP module studies and concluding remarks 
As discussed earlier, comparisons of VCP2,3 structures with the intact VCP 
structure (Murthy etal., 200 1) and VCP-3,4 (NMR) (Wiles etal., 1997) highlights 
some of the structural changes that may occur due to the presence of other modules. If 
change in one module can affect the structure of others, this has potential functional 
implications. The crystal structure of VCP has two regions that are likely candidates 
for specific interactions with C3b and C4b. These two sites are large positive charged 
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patches on modules 1 and 4 respectively that could be involved in binding to 
negatively charged regions on C3b/C4b and/or heparin. Regions of positive charge in 
CP modules have also been shown to be important in C3b and CO binding in other 
mutagenesis studies. In the case of active sites 1 and 2 of CR1 (CP modules 1-3 and 
8-10 respectively) for example, mutagenesis of residues with no charge, to basic 
residues, was shown to increase affinity for both C3b and CO (Krych et al., 1994, 
1998). As mentioned previously, it is tempting to speculate that intact VCP may show 
functional diversity by virtue of having some flexibility around the 2,3 interface. This 
would allow the putative ligand-binding areas of VCP to change position relative to 
each other. 
We have seen that VCP2,3 appears relatively mobile in solution with a 
possible hinge formed by the lack of a well defined 2,3 interface. Studies of the 
C4bBP a-chain showed that a region important for binding is a cluster of 
predominantly basic side-chains at the CP 1, 2 interface (Blom et al., 1999) with a 
number of R, K and H residues important for binding activity. VCP 2,3 has different, 
uncharged residues at some of the equivalent interface positions and retains only two 
of the five charged residues implied in C4bBP binding to its ligand. This indicates 
that the 2,3 interface is probably not directly involved in specific protein-protein 
interactions that have a strong dependency on the presence of basic residues. 
However, a cautious approach is necessary when considering 
structure/function relationships - results of recent studies with CP modules 1 and 2 
from CR2 bound to C3d have shown the module/ligand interaction is not dependant 
on clusters of basic residues. The two functional CP modules from CR2 were 
crystallised bound to the ligand, C3d (Szakonyi et al., 2001). This crystal structure 
revealed that the modules were arranged side by side, rather than in the head to tail 
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arrangement observed in all other structural studies of CP modules. This was possible 
due to a long (eight residue) linker, allowing module 2 to bend back towards module 1 
in a "V" shape - a non-consensus tryptophan residue was key to holding the two 
modules together. This was interesting in its own right, but perhaps even more 
interesting was the interface between CR2 and C3d. Residues in the B/C loop of CP 2 
were involved in formation of H-bonds with main chain carbonyl atoms of CM - only 
one amino acid from CM had any direct interaction with CR2. Several carbonyl 
groups formed an anion pocket, which housed R83 from CR2, a charged residue at the 
inter-protein interface. Only modules 2 had direct interaction with C3d, whilst module 
1 had an apparent scaffolding role stabilising module 2 and masking a non-binding 
surface. Perhaps this could help to explain why interfaces in module pairs from VCP 
show marked differences - VCP1,2 and VCP-3,4 orientations are well defined and 
can be thought of as the scaffold-type arrangement seen in CR2 binding, stabilising 
the modules and for orientating them appropriately to allow interactions to occur, 
whilst the centre of the protein is less well defined and has limited movement to 
provide functional diversity. 
In mutagenesis studies of CR1, mentioned briefly earlier, some of the residues 
mutated and shown to be key in binding were those that would be expected, by 
sequence homology, to form the intermodular interface (Krych et al., 1994, 1998). 
Loss of binding may be because alteration in these key residues disrupts the interface 
One could infer then that altering one amino acid at the interface may disrupt the 
orientation of the two modules, moving the charged areas out of alignment required 
for binding. The change in interface residues could also alter the structure of the 
modules themselves, which could affect the loops and turns. This could, in turn, 
change the position of individual residues that may be important. 
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Mutagenesis studies by Liszewski et a! (2000) on MCP have shown that 
mutation of residues 94-103 abolished co-factor activity, whilst CO activity is 
retained. Mutation of E102A affected C3b binding. These residues have very strong 
sequence homology when compared to VCP'-2,3, and lie at the VCP-2,3 interface. 
Changes in these residues are likely to disrupt the structure and intermodular 
orientation of MCP. Perhaps the interaction between VCP and CO is similar and is 
dependent on charge rather than orientation of modules, as mentioned earlier. Thus by 
changing residues near the interface, thereby altering the flexibility or interdomain 
movement at the proposed hinge in VCP-2,3, it might be possible to abolish co-factor 
activity either by decreasing the amount of intermodular flexibility, which could limit 
involvement of residues from the C-terminal half of VCP, or allowing too much 
freedom of movement of the modules that may twist key residues from normal site of 
interaction. This would therefore be a useful future mutagenesis experiment. 
Until more structural studies and rational structure-based mutagenesis have 
been carried out on VCP, the importance of intermodular interface residues, or 
intermodular flexibility remains unknown. The structure of CR2 bound to C3d added 
a surprising "twist" to the vast range of data available - it re-enforces the need for 
NMR and crystallography based structures. This work has highlighted the benefit of 
using different techniques in conjunction with one another to gain the best possible 
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* Makes assignment tables of shifts based on the individual spectra 
# which have crosspeaks - they don't need to have assignments 
* The outputs are 1) A table which summarizes unassigned atoms: 
$$_  shifts _unassigned. rdb 
# 2) A table containing all the shifts entires which is sorted on the 
basis of resid atnam 
* priority and shift: $$shifts_all_sorted.rdb and 3) A unique table 
sorted on resid 
# and atnam (sorted on the previous sort) which contains only one 
entry for the chemical shift: 
* $$shiftssorted.rdb. The all—sorted table will be used for 
subsequent operations. 
# 
# We have mades 2 versions of this to account for N15-based spectra 
requiring 
# a chemical shift database from H20 spectra and C13-NOESY's having 
come 
# from D20 spectra. The priorities for establishing this database 
will thus 
* be different. For N15-based spectra the order is 
(1)15N HSQC 	(2)13C TOCSY in H20 (3)4DHCCONH (4)4D 15N/13C 
NOESY (5)aromatics 
using nl5-hsqccn, hcchtoc, 	 4dhcconh, 	4dcnnoe, 
aromcthsqc, cbhd 
* 
* 	C-C NOESY 	 13C TOCSY/D20 	 2d long-range 
HMQC (For His etc.) 
* 	4dcl3noe, cl3cosy, M31Cs1Otoc 	cl3noesy, hmqcH 
# 
* 
# Priorities for selecting shift values: 
# Use NHSQC, CBCACON1JE and CBCANNH = 99 for c-noesy 
* Use HNSQC2 and CNOESY = 99 for rest 
* 
*set CBHDSP_P = 1 
set DCOSY P = 19 
set DNOESYP = 19 
set DTOCSY P = 19 
set NOESYP = 19 
set TOCSY P = 19 
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#set CNOESYP = 19 
#set CBCACONNH_M_P = 4 
#set CBCNH_M_P = 4 
#set HCCHCOSYP = 1 
#set HCCHMP = 1 
set NHSQC P = 19 
#set NHSQC2 P = 99 
set NTOCSYP = 19 
set NNOESYP = 19 
set NNOESYMEMP = 1 
# n-hsqc200499 
column -c resnamel resname -c residi resid -c atnamel atname \ 
-c atomTypel atomType -c shifti shift spectrum xpk -a priority 
N\ 
< n-hsqc.rdb I compute priority = $NHSQC_P \; > 
VCP23N220200shiftS rdb 
column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a 
priority N \ 
< n-hsqc.rdb I  compute priority = $NHSQC_P  
headchg -del >> VCP_23N220200shiftS.rdb 
# deucosy200499 
column -c resnamel resname -c residl resid -c atnamel atname \ 
-c atomTypel atomType -c shifti shift spectrum xpk -a priority 
< deucosy.rdb I compute priority = $DCOSY_P \; 	headchg -del >> 
VCP23N220200shifts rdb 
column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a 
priority N \ 
< deucosy.rdb I compute priority = $DCOSY_P  
headchg -del >> VCP23N220200shifts.rdb 
# deunoesy200499 
column resnamel residi atnamel atomTypel shifti spectrum xpk -a 
priority N \ 
< deunoesy.rdb I  compute priority = $DNOESYP  
headchg -del >> VCP23N220200shifts.rdb 
column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a 
priority N \ 
< deunoesy.rdb I compute priority = $DNOESY_P  
headchg -del >> VCP_23N220200shifts.rdb 
# deutocsy200499 
column -c resnamel resname -c residl resid -c atnamel atname \ 
-c atomTypel atomType -c shifti shift spectrum xpk -a priority 
< deutocsy.rdb I compute priority = $DTOCSYP  
44 
Appendix A 
headchg -del >> VCP_23N220200shiftS.rdb 
column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a 
priority N \ 
< deutocsy.rdb I compute priority = $DTOCSY_P  
headchg -del >> VCP_23N220200shifts.rdb 
# noesy200499 
column resnamel residi atnamel atomTypel shiftl spectrum xpk -a 
priority N \ 
< noesy.rdb I  compute priority = $NOESY_P  
headchg -del >> VCP_23N220200shifts.rdb 
column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a 
priority N \ 
< noesy.rdb I  compute priority = $NOESY_P  
headchg -del >> VCP_23N220200shifts.rdb 
# c-noesy 
#column resnamel residi atnamel atomTypel shifti spectrum xpk -a 
priority N \ 
# 	< c-noesy.rdb I compute priority = $CNOESY_P  
# headchg -del >> M31Cs_2shifts.rdb 
#column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a 
priority N \ 
# < c-noesy.rdb I compute priority = $CNOESY_P  
# headchg -del >> M3lCs2shifts.rdb 
#column resname3 resid3 atnatne3 atomType3 shift3 spectrum xpk -a 
priority N \ 
< c-noesy.rdb I compute priority = $CNOESY_P  
# headchg -del >> M31Cs_2shifts.rdb 
# cbcaconnhm 
#column resnamel residi atnamel atomTypel shiftl spectrum xpk -a 
priority N \ 
4* 	< cbcaconnh_m.rdb I compute priority = $CBCACONNH_M_P \; I 
# 	headchg -del >> M31Cs_2shifts.rdb 
#column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a 
priority N \ 
# 	< cbcaconnh_m.rdb I  compute priority = $CBCACONNH_M_P  
4* headchg -del >> M31Cs_2shifts.rdb 
#column resname3 resid3 atname3 atomType3 shift3 spectrum xpk -a 
priority N \ 
4* 	< cbcaconnh_m.rdb I compute priority = $CBCACONNH_M_P  
# 	headchg -del >> M3lCs2shifts.rdb 
4* cbcannh_m 
#column resnamel residi atnamel atomTypel shiftl spectrum xpk -a 
priority N \ 
4* 	< cbcannh_m.rdb I compute priority = $CBCANNH_M_P  
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# headchg -del >> M31Cs_2shifts.rdb 
#column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a 
priority N \ 
< cbcannh_m.rdb I compute priority = $CBCANNH_M_P  
# headchg -del >> M3lCs_2shifts.rdb 
#column resname3 resid3 atname3 atomType3 shift3 spectrum xpk -a 
priority N \ 
# < cbcannh_m.rdb I compute priority = $CBCANNH_M_P  
# headchg -del >> M3lCs_2shifts.rdb 
# hcch-cosy 
#column resnamel residi atnamel atomTypel shifti spectrum xpk -a 
priority N \ 
# < hcch-cosy.rdb I compute priority = $HCCHCOSY_P  
# headchg -del >> M31C5_2shifts.rdb 
#column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a 
priority N \ 
# < hcch-cosy.rdb I compute priority = $HCCHCOSY_P  
# headchg -del >> M31Cs_2shifts.rdb 
#column resname3 resid3 atname3 atomType3 shift3 spectrum xpk -a 
priority N \ 
# < hcch-cosy.rdb I compute priority = $HCCHCOSY_P  
# headchg -del >> M31C5_2shifts.rdb 
# n-tocsy200499 
column resnamel residi atnamel atomTypel shifti spectrum xpk -a 
priority N \ 
< n-tocsy.rdb I  compute priority = $NTOCSYP \; 	\ 
headchg -del >> VCP_23N220200shifts.rdb 
column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a 
priority N \ 
< n-tocsy.rdb I  compute priority = $NTOCSYP  
headchg -del >> VCP23N220200shifts.rdb 
column resname3 resid3 atname3 atomType3 shift3 spectrum xpk -a 
priority N \ 
< n-tocsy.rdb I  compute priority = $NTOCSY_P  
headchg -del >> VCP23N220200shifts.rdb 
* tocsy160499 
column resnamel residi atnamel atomTypel shiftl spectrum xpk -a 
priority N \ 
< tocsy.rdb I compute priority = $TOCSY_P  
headchg -del >> VCP_23N220200shifts.rdb 
column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a 
priority N \ 
< tocsy.rdb I  compute priority = $TOCSYP  




#column resnamel residl atnamel atomTypel shifti spectrum xpk -a 
priority N \ 
< n-hsqc2.rdb I compute priority = $NHSQC2_P  
# headchg -del >> M31Cs_2shifts.rdb 
#column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a 
priority N \ 
< n-hsqc2.rdb 	I compute priority = $NHSQC2_P  
# 	headchg -del >> r43lCs_2shifts.rdb 
# n-noesy200499 
column resnamel residi atnamel atomTypel shifti spectrum xpk -a 
priority N \ 
< n-noesy.rdb 	I compute priority = $NNOESY_P  
headchg -del >> VCP_23N220200shifts.rdlD 
column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a 
priority N \ 
< n-noesy.rdb I compute priority = $NNOESY_P  
headchg -del >> VCP23N220200shifts.rdb 
column resname3 resid3 atnarne3 atomType3 shift3 spectrum xpk -a 
priority N \ 
< n-noesy.rdb 	I compute priority = $NNOESY_P  
headchg -del >> VCP_23N220200shifts.rdb 
# n-noesymem200499 
column resnamel residl atnamel atomTypel shiftl spectrum xpk -a 
priority N \ 
< n-noesymem.rdb I compute priority = $NNOESYMEM_P  
headchg -del >> VCP_23N220200shifts.rdb 
column resname2 resid2 atname2 atomType2 shift2 spectrum xpk -a 
priority N \ 
< n-noesymem.rdb I compute priority = $NNOESYMEM_P  
headchg -del >> VCP23N220200shifts.rdb 
column resname3 resid3 atname3 atomType3 shift3 spectrum xpk -a 
priority N \ 
< n-noesymem.rdb I compute priority = $NNOESYNEM_P  
headchg -del >> VCP_23N220200shifts.rdb 
# Save the unassigned shifts 
# Either residues with no assignements or crosspeaks with no 
# assignments 
row resid eq null or atname eq null < VCP_23N220200shifts.rdiD \ 
> vCP23N220200shifts_unassigned.rdb 
# now sort the table 
# Note the tee means that the uniqtable will be based on the sort 




#(# M31Cs_shiftS_SOrted.rdb) will be the higest priority entry for a 
given 
# resid and atnam. 
row resid ne null and atname ne null < VCP23N22O200shiftS.rdb \ 
sorttbl resname I jointbl resname=resname translate.rdb I\ 
row atname eq new.atname \ 
column resname resid -c old.atname atname atomType shift spectrum 
\ 
xpk priority I sorttbl resid atname priority shift \ 
tee VCP23N220200shifts_all_sorted.rdb I\ 
uniqtbl resid atname > VCP_23N220200shifts_sorted.rdb 
# That's it! 
make—shift—summary 
This macro takes the output of make _shift_list and sorts the chemical shifts by atom, 
grouping together all chemical shifts assigned to an atom. 
#L/bin/tcsh -f 
# uses tsch rather than csh in cases where the buffer size is too 
large 
# 
# Takes output from makeShiftList which contains all assigned 
crosspeaks 
# Gives a summary table which has the mean chemical shift 
# and the spread of the chemical shifts. This table is then split 
into 
* two tables, one containing H shifts and their spreads, and one 
containing 
# N and C chemical shifts and their spreads: this two tables 
# are the input to the next script umakeConnectedShifts. 
# Also puts out a list of "offender" or 
* assignments with an unacceptable spread, in order of how bad they 
are. 
* This is extremely useful for checking assignments. Note that the 
priority 
# of the experiment is carried along. Priorities can also be given to 
dimensions 
* and used to weight various parameters such as the tolerance given 
to a chemical 
# shift in the ambiguous treatment. 
#####**# RDB and CSH 
operations*####*################*########*#######*####** 
# 
# 	 RDB operator: sorttbl 
# 
#Usage: sorttbl [options] [-ri column {[-r] column] 
* 
#Opt ions: 
* 	-c 	Check that the rdbtable is sorted on the selected 
columns. 
-d 	Dictionary order. Only letters, digits, and SPACE are 
significant 
* 	 in comparisons. 
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# 	-f 	Fold in lower case. Treat upper- and lower-case letters 
equally. 
# 	-help 	Print this help info. 
# -i 	Ignore characters outside the ASCII range 040-0176 in 
non-numeric 
comparisons. 
# 	-r 	Reverse order. Applys to the following column only. 
# -T dir 	Place temporary files in directory 'dir'. 
# 	-u 	Make rows unique on selected columns. 
# 
#Sorts an rdbtable on one or more columns. Each column may be sorted 
in normal 
#(ascending) or reverse (descending) order. Note that the '-r' on the 
command 
#line applies only to the next column; the absense of a '-r' means 
the next 
#column will sort in normal order. 
#Also a column of monthnames (Jan, Apr, ...) in any case letters, may 
be sorted. 
#This operator reads an rdbtable via STDIN and writes an rdbtable via 
STDOUT. 
#Options may be abbreviated. 
# 	 RDB operator: searchtbl 
#Usage: searchtbl [options] rdbtbl < keytbl 
searchtbl [options] -md index—file [rdbtbl] < keytbl 
#Options: 
# 	-help 	Print this help info. 
# -md Index file search. 
-part 	Partial (initial) match. Applies to string type data 
only. 
# 	-sgl 	Only a single row match is needed. 
# -rev Reverse sort option. File 'rdbtbl' is sorted in reverse 
order. 
# 	-vom 	Verify only mode. If an item of info from keytbl is 
valid prints 
"ok", else an error message, on STDERR. NO new rdbtable 
is 
produced. Used by another process for verification. 
# 
#This operator does a fast search of 'rdbtbl' (or index —file) using a 
binary 
#search on a key of of one or more columns. The 'rdbtbl' (or 
index file) must 
#be sorted on the key columns. Each column in the key may be of type 
string 
#or type numeric (but be carefull with numeric data and exact 
matches) . In the 
#second form of usage for this operator if 'rdbtbl' is not given its 
name will 
#be inferred from the name of index —file. For example if index—file 
is 




#The column(s) in the file 'keytbl' specify both the key column 
name(s) and the 
#argument values to search for. File 'Keytbi' is in rdbtable format. 
# 
#Normally an argument value and a data field must compare exactally 
for a match 
#to occur (exact match) . If the paritial match otpion (-part) is 
selected, and 
#if the argument value compares with the initial part of the data 
field it is 
#considered a match. This applies to string type data only. Note that 
for 
#numeric type data an exact match is always necessary. 
# 
#Normally all rows that match will be written to the new rdbtable, in 
the 
#same order as in the old rdbtable. If only a single row key match is 
#appropriate some execution time can be saved by specifing the '-sgl' 
option. 
#This operator writes an rdbtable via STDOUT. Options may be 
abbreviated. 
#Returns the number of non-finds at exit. 
###### 
# 	 RDB operator: summ 
#Usage: summ [options] [column . 
# 
#Opt iOnS: 
# 	-cu 	A Count of the unique values for each column given. 
# -cun Like option '-cu' but also shows counts of null (empty) 
and 
# 	 blank values (have only space chars), if either exist. 
-cuu 	A Count of each unique value for each column given. 
# 	-cu2 Like option '-cuu' but shows only counts greater than 
one. 
# 	-help 	Print this help info. 
# -m 	The mm, average, max, total for each column given. 
# 	-v Inverse option. Selects all columns except those named. 
U 
#Produces "summary" information about the rdbtable. If no columns are 
given 
Uthen information about all columns is produced. A Count of the data 
rows 
#is always shown. 
# 
#This operator reads an rdbtable via STDIN and writes a summary 
report via 
#STDOUT. Options may be abbreviated. 
U 
## CSH Commands 
U 
# 	foreach var (wordlist) 
# 




wordlist. The sequence of commands between this 
command and 
the matching end is executed for each new value of 
var. (Both 
# 	 foreach and end must appear alone on separate lines.) 
The built-in command continue may be used to continue 
the loop 
prematurely and the built-in command break to 
terminate it 
# 	 prematurely. When this command is read from the 
terminal, the 
# 	 loop is read up once prompting with ? before any 
statements in 
# 	 the loop are executed. 
# 
set [var [ = value I 
set var[n] = word 
# 	 With no arguments, set displays the values of all 
shell 
# 	 variables. Multiword values are displayed as a 
parenthesized 
# 	 list. With the var argument alone, set assigns an 
empty (null) 
# 	 value to the variable var. With arguments of the 
form var = 
value set assigns value to var, where value is one 
of: 
# 	 word 	A single word (or quoted string). 
(wordlist) A space-separated list of words 
enclosed in 
# 	 parentheses. 
# 
# 	 Values are command and filename expanded before being 
assigned. 
# 	 The form set var[n] = word replaces the n'th word in 
a 
# 	 multiword value with word. 
# 








# Do All shifts 
# 
set SHIFT _TABLE = VCP23N220200shifts_all_sorted.rdb 	#Generated 
from makeShiftList 
set SHIFT—SUMMARY—TABLE = VCP 23N220200_summary. rdb 
set SHIFT _ SUMMARY _TABLE_H = VCP23N220200_summary_h.rdb 	#H atoms 
set SHIFT SUMMARY_TABLE_NC = VCP23N220200summarync.rdb #N and C 
atoms 
set OFFENDERS H = offenders lN.rdb 
set OFFENDERS NC = offenders 1N2.rdb 
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set MAX PRIORITY = 20 # Exclude shifts from indirect proton 




# Get header. Adds a column "delta" for the spread of chemical 
shifts. 
# Takes the top 2 lines from $SHIFT TABLE to make header for 
$SHIFTSTJNMARY_TABLE 
# 
column resid resname atname shift -a delta N < $SHIFT TABLE \ 
head -2 > $SHIFT SUMMARY TABLE 
# 
# Resids 
# "row resid lt 200" --> lt the number of residues in the protein. 
sorttbl -u resid < $SHIFT_TABLE I row resid ge 1 and resid le 127 
column resid resname > resids2.rdb 
# 
# For each Resid: 
# For each Resid, find a unique list of the atnames. Then search the 
$SHIFT_TABLE 
# for each atname and sum the shifts (getting Min Avg Max and Total). 
Dump the Avg 




foreach R (column resid < resids_2.rdb I headchg -del) 
set RN = row resid eq $R < resids_2.rdb I column resname 
headchg -del'  
row resid eq $R < resids_2.rdb I /home2/brian/IRIX/bin/searchtbi 
$SHIFT TABLE I\ 
sorttbi -u atname I  column resid atname > atnames2.rdb 
# For each atomname 
# 
foreach A (column atname < atnames_2.rdb I headchg -del) 
printf "%s\ts\t%s\t" $R $RN $A >> $SHIFT_SUIVIMARY_TABLE 
row atname eq $A < atnames_2.rdb I 
/home2/brian/IRIX/bin/searchtbl $SHIFT TABLE \ 
row priority it $MAX PRIORITY > temp table.rdb 
set PRIO = uniqtbi atname < temp tabie.rdb I column 
priority I headchg -del - 
row priority eq $PRIO < temp_tabie.rdbl\ 
summ -m shift I \ 
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nawk -F'[ ,] [ ,]* '/Min, Avg, Max, Total! {printf 
119..4f\t 9..4f\n 11 , $ 8, $9 - $ 7 }' \ 
>> $ SHIFT_SUMMARY_TABLE 
end 
end 
# Er, that's it! 
# Split out a summary table for H 
# and a separate one for N and C 
row atname mat '"H"' < $SHIFT 
—
SUMMARY—TABLE \ 
sorttbl -r delta > $SHIFT SUMMARY TABLE H 
row atname nmat '"H" < $SHIFT 
—
SUMMARY—TABLE \ 
sorttbl -r delta > $SHIFT SUMMARY TABLE NC 
# 
# Now find out what is causing the worst offenders 
# 
row delta gt 0.030 < $SHIFT_SUIVIMARY_ TABLE _H I  sorttbl resid I\ 
column -c resid s.resid -c atname s.atname \ 
-c shift s.shift -c delta s.delta \ 
jointbl s.resid=resid $SHIFT_TABLE I row s.atname eq atname 
column resname s.resid s.atname s.shift s.delta shift spectrum 
xpk I\ 
sorttbl -r s.delta shift > $OFFENDERSH 
row delta gt 0.30 < $SHIFT_ SUMMARY _ TABLE _NC sorttbl resid I\ 
column -c resid s.resid -c atname s.atname \ 
-c shift s.shift -c delta s.delta \ 
jointbl s.resid=resid $SHIFT_TABLE I  row s.atname eq atname I\ 
column resname s.resid s.atname s.shift s.delta shift spectrum 
xpk I\ 
sorttbl -r s.delta shift > $OFFENDERSNC 
make—connected—shifts 
This script uses the output from make _shift_summary to give an average chemical 





# This script makes a master table of proton shifts and the 
# shifts of their attached heavy atoms, using the individual 
# _h and _nc tables output from the makeShiftSummary script. 
# Requires the table connected.rdb which is a list of what 
# H's are attached to what C's and N's. Also requires a 
# pdb file with no coordinates ( M3105 dummy.pdb which was 
# generated in xplor with the inp_file generate.inp) 
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# Also requires the fortran program pdb2rdb. 
U 
# make dummy shift table with ALL nuclei. 
U 
# U############################################################## 
U NOTE we should use the BMRB database values, with large delta's in 
the 
U dummy shift table. 
# See /zeus/arcrl/nmrprogs/assign4d/newShiftS.rdb as a first pass 
# at a list of these values. 
U 
# 
U pdb2rdb takes an input pdb file with no coodinates and converts to 
rdb 
# format. The point is to get all the atnames/renames/resids for the 
protein 
U of interest. Entries with C(CO), 0 and S are removed since they 
are not used 
# for the NNR constraints. A column shift is added and set to -99.0. 
A column 
# delta is also added --this can be made large where there are no 
assignments!!! 
# The statement "\;resname = ucfirst \( lc \( resname \) \) \;" is a 
perl 
# operation which takes the first letter of resname and makes it 
uppercase (ucfirst) 
U and the rest lower case (lc) 
pdb2rdb < VCP23200499_dummy.pdb row atname ne C and atname nmat 
'"O"' and atname nmat itl'5?II 	\ 
column resname resid atname -a shift -N -a delta -N I\ 
compute shift = -99.0 \; resname = ucfirst \( lc \( resname \) \) 
\ 	> VCP 2300499 dummy_shifts.rdb 
U Now make H shift table starting with the summary table made from 
# the rdb script makeShiftSummary and with the dummy table 
U The summary table containing experimental shifts and deltas 
# set minimum delta 
sorttbl resname atname < VCP23N22O200summary.rdb \ 
column resname resid atname shift delta I\ 
compute if \( delta lt 0.030 \) { delta = 0.030  
row atname mat '"H"' > t.rdb 
# Append the dummy table with shift=-99.0 
sorttbl resname atname < VCP 23200499 dummy_shifts.rdb I\ 
column resname resid atname shift delta I\ 
row atname mat IIIHIU! I headchg -del >> t.rdb 
# Sort the combined table recursively based on resid and atname 
# and then recursively based on shift. Those with no assignments 
# will be given Shift=-99.0 
U Note this table is sorted on the basis of resname which is 
U necessary to the last step where the H's and C's are connected. 
sorttbl resid atname -r shift < t.rdb I  uniqtbl resid atname I\ 
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sorttbl resname > VCP23N220200_shiftS_h.rdb 
# Now make NC shift table 
#Get all thr rows whose atname doesn't have H as the first letter 
# set minimum heavy.delta 
sorttbl resnarne atname < VCP23N220200_summary.rdb \ 
column resname resid -c atname heavy.atname -c shift heavy.shift 
-c delta heavy.delta \ 
compute if \( heavy.delta it 0.30 \) { heavy.delta = 0.30  
row heavy.atname nmat '"H"' > t2.rdb 
#Append heavy atnam rows to the t2.rdb file. 
sorttbl resname atname < VCP23200499_dummy_shifts.rdb I\ 
column resname resid -c atname heavy.atname -c shift heavy.shift 
-c delta heavy.delta I\ 
row heavy.atname nmat '"H"' 	headchg -del >> t2.rdb 
# Sort the combined table recursively based on resid and atname 
# and then recursively based on shift. Those with no assignments 
# will be given Shift=-99.0. Note this table is sorted on the basis 
of 
# resid which is necessary to the last step where the H's and C's are 
connected. 
sorttbl resid heavy.atname -r heavy.shift < t2.rdb I uniqtbl resid 
heavy.atname I \ 
sorttbl resid > VCP23N220200_shifts_nc.rdb 
# Join appropriate Hs to Ns or Cs 
# This is where the file connected.rdb is required which shows what 
C/N atoms are 
# connected to what H's. Note the connected and M31Cs shiftsh have 
already been 
# sorted based on resname, and M31Cs_shiftsnc.rdb has already been 
sorted 
# based on resid. 
column resname -c atname c.atname -c heavy.atname c.heavy.atname < 
connected.rdb I\ 
jointbl resname=resname VCP_23N220200_shifts_h.rdb I row c.atname 
eq atname \ 
column resname resid c.heavy.atname c.atname shift delta \ 
sorttbl resid I jointbi resid=resid VCP23N220200_shifts_nc.rdb 
row heavy.atname eq c.heavy.atname I\ 
column resname resid -c c.atname atname shift heavy.atname 
heavy.shift \ 
delta heavy.delta > VCP23N220200_HX_Shifts2.rdb 
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Appendix B - Chemical shift table 
Res Type 	Res No. Atom type Shift (ppm) Atom Type Shift (ppm) 
Arg 7 HA 4.33 
Arg 7 HB1 1.8412 
Arg 7 HB2 1.6938 
Arg 7 HD1 3.0553 
Arg 7 HD2 3.0553 
Arg 7 HG1 1.636 
Arg 7 HG2 1.537 
Arg 7 HN 8.1172 N 122.2407 
Arg 7 HE 7.0775 NE 119.1195 
Arg 7 HH1# 6.509 NH1 
Arg 7 HH11 NH1 
Arg 7 HH12 NH1 
Arg 7 HH2# 6.509 NH2 
Arg 7 HH21 NH2 
Arg 7 HH22 NH2 
Arg 8 HA 4.773 
Arg 8 HB1 1.856 
Arg 8 HB2 1.592 
Arg 8 HD1 3.036 
Arg 8 HD2 3.036 
Arg 8 HG1 1.451 
Arg 8 HG2 1.451 
Arg 8 HN 8.0026 N 119.2322 
Arg 8 HE 7.155 NE 119.889 
Arg 8 HH11 NH1 
Arg 8 HH12 NH1 
Arg 8 HH21 NH2 
Arg 8 HH22 NH2 
Cys 9 HA 4.2027 
Cys 9 HB1 2.42 
Cys 9 HB2 2.131 
Cys 9 HN 8.7546 N 119.8453 
Pro 10 HA 4.49 
Pro 10 HB1 2.36 
Pro 10 HB2 1.9835 
Pro 10 HD1 3.5707 
Pro 10 HD2 3.079 
Pro 10 HG1 2.099 
Pro 10 HG2 2.099 
Ser 11 HA 4.4137 
Ser 11 HB1 3.838 
Ser 11 HB2 3.7203 
Ser 11 HN 8.5175 N 117.4073 
Pro 12 HA 4.1117 
Pro 12 HB1 1.415 
Pro 12 HB2 1.1085 
Pro 12 HD1 3.732 
Pro 12 HD2 3.623 
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Pro 12 HG1 
Pro 12 HG2 
Arg 13 HA 
Arg 13 HB1 
Arg 13 HB2 
Arg 13 HD1 
Arg 13 HD2 
Arg 13 HG1 
Arg 13 HG2 
Arg 13 HN 
Arg 13 HE 
Arg 13 HI-il# 
Arg 13 HH11 
Arg 13 HH12 
Arg 13 HH2# 
Arg 13 HH2I 
Arg 13 HH22 
Asp 14 HA 
Asp 14 HB1 
Asp 14 HB2 
Asp 14 HN 
lie 15 HA 
Ile 15 HB 
Ile 15 HD11 
Ile 15 HD12 
lie 15 HD13 
Ile 15 HG11 
lie 15 HG12 
lie 15 HG21 
lie 15 HG22 
Ile 15 HG23 
lie 15 HN 
Asp 16 HA 
Asp 16 HB1 
Asp 16 HB2 
Asp 16 HN 
Asn 17 HA 
Asn 17 HB1 
Asn 17 HB2 
Asn 17 HN 
Asn 17 HD21 
Asn 17 HD22 
Giy 18 HAl 
Giy 18 HA2 
Giy 18 HN 
Gin 19 HA 
Gin 19 HBI 
Gin 19 HB2 
Gin 19 HG1 
Gin 19 HG2 
Gin 19 HN 
Gin 19 HE21 









































































Leu 20 HA 4.5429 
Leu 20 1-1131 1.1417 
Leu 20 1-1132 1.1417 
Leu 20 HD11 0.466 
Leu 20 HD12 0.466 
Leu 20 HD13 0.466 
Leu 20 HD21 0.374 
Leu 20 HD22 0.374 
Leu 20 HD23 0.374 
Leu 20 HG 1.143 
Leu 20 HN 8.1625 N 120.8599 
Asp 21 HA 4.7135 
Asp 21 1-1131 2.592 
Asp 21 1-1132 2.304 
Asp 21 HN 8.3350 N 123.5129 
Ile 22 HA 3.894 
Ile 22 HB 1.674 
Ile 22 HD11 0.4665 
Ile 22 HD12 0.4665 
Ile 22 HD13 0.4665 
Ile 22 HG11 1.36 
Ile 22 HG12 0.676 
Ile 22 HG21 0.64 
Ile 22 HG22 0.64 
Ile 22 I-1G23 0.64 
Ile 22 HN 8.5924 N 126.3286 
Gly 23 HAl 4.0582 
Gly 23 HA2 4.0565 
Gly 23 HN 8.7473 N 119.1449 
Gly 24 HAl 4.334 
Gly 24 HA2 3.916 
Giy 24 HN 7.4530 N 107.3457 
Val 25 HA 4.868 
Val 25 HB 2.6737 
Val 25 HG11 0.923 
Val 25 HG12 0.923 
Val 25 HG13 0.923 
Val 25 HG21 0.72 
Val 25 HG22 0.72 
Val 25 HG23 0.72 
Val 25 HN 8.1514 N 105.7912 
Asp 26 HA 4.8535 
Asp 26 1-1131 2.687 
Asp 26 HB2 2.508 
Asp 26 HN 7.4457 N 	118.6895 
Phe 27 HA 3.786 
Phe 27 1-1131 2.975 
Phe 27 1-1132 2.918 
Phe 27 HD1 7.0818 
Phe 27 HD2 7.0818 
Phe 27 HE1 7.3531 
Phe 27 HE2 7.3531 




Phe 27 HN 8.3767 N 119.9556 
Gly 28 HAl 4.083 
Gly 28 HA2 3.474 
Gly 28 HN 8.749 N 117.4296 
Ser 29 HA 4.4612 
Ser 29 HB1 3.716 
Ser 29 HB2 3.716 
Ser 29 HN 8.331 N 117.3816 
Ser 30 HA 5.6892 
Ser 30 1-1131 3.3777 
Ser 30 1-1132 3.291 
Ser 30 HN 8.3277 N 113.0245 
Ile 31 HA 4.509 
Ile 31 HB 1.016 
Ile 31 HD11 -0.5192 
Ile 31 HD12 -0.5192 
Ile 31 HD13 -0.5192 
Ile 31 HG11 0.803 
Ile 31 HG12 0.3717 
Ile 31 HG21 0.0728 
Ile 31 HG22 0.0728 
Ile 31 HG23 0.0728 
Ile 31 FIN 8.566 N 117.6027 
Thr 32 HA 5.0385 
Thr 32 HB 3.863 
Thr 32 HG21 1.072 
Thr 32 HG22 1.072 
Thr 32 HG23 1.072 
Thr 32 HN 8.038 N 116.8395 
Tyr 33 HA 4.955 
Tyr 33 1-1131 2.5272 
Tyr 33 HB2 2.5272 
Tyr 33 HD1 6.7409 
Tyr 33 HD2 6.7409 
Tyr 33 HE1 6.4789 
Tyr 33 HE2 6.4789 
Tyr 33 HN 9.4244 N 127.7223 
Ser 34 HA 4.49 
Ser 34 1-1131 3.844 
Ser 34 HB2 3.721 
Ser 34 HN 8.5192 N 112.3459 
Cys 35 HA 5.241 
Cys 35 1-1131 2.941 
Cys 35 HB2 2.394 
Cys 35 HN 8.6727 N 116.5423 
Asn 36 HA 4.5287 
Asn 36 HB1 2.9415 
Asn 36 1-1132 2.397 
Asn 36 FIN 8.6741 N 121.9529 
Asn 36 H021 7.504 ND2 108.717 
Asn 36 HD22 6.713 ND2 108.717 
Ser 37 HA 4.232 
Ser 37 1-1131 3.808 
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Ser 37 H132 3.808 
Ser 37 HN 8.3705 N 
Gly 38 HAl 4.15 
Gly 38 HA2 3.421 
Gly 38 HN 8.8254 N 
Tyr 39 HA 4.9315 
Tyr 39 HB1 3.221 
Tyr 39 H132 2.424 
Tyr 39 HD1 6.5846 
Tyr 39 HD2 6.5846 
Tyr 39 HE1 6.6407 
Tyr 39 HE2 6.6407 
Tyr 39 HN 8.2265 N 118.7353 
His 40 F-lA 4.937 
His 40 HB1 3.104 
His 40 HB2 3.014 
His 40 HD2 7.089 
His 40 HE1 
His 40 HN 9.4255 N 117.8479 
His 40 HD1 ND1 
His 40 HE2 NE2 
Leu 41 HA 4.4712 
Leu 41 HB1 1.4897 
Leu 41 HB2 1.4033 
Leu 41 HD11 0.5777 
Leu 41 HD12 0.5777 
Leu 41 HD13 0.5777 
Leu 41 HD21 0.3835 
Leu 41 HD22 0.3835 
Leu 41 HD23 0.3835 
Leu 41 HG 1.17 
Leu 41 HN 8.3520 N 127.3552 
Ile 42 HA 4.176 
Ile 42 HB 1.837 
Ile 42 HD11 0.602 
Ile 42 HD12 0.602 
Ile 42 HDI3 0.602 
Ile 42 HG11 1.234 
Ile 42 HG12 1.1 
Ile 42 HG21 0.752 
Ile 42 HG22 0.752 
Ile 42 HG23 0.752 
Ile 42 HN 9.1839 N 128.9366 
Gly 43 HAl 4.514 
Gly 43 HA2 3.61 
Gly 43 HN 8.2490 N 116.2869 
Glu 44 HA 4.404 
Glu 44 HB1 2.18 
Glu 44 H132 1.8205 
Glu 44 HG1 2.391 
Glu 44 HG2 2.297 
Glu 44 HN 8.3668 N 119.923 





Ser 45 HB1 4.252 
Ser 45 HB2 3.795 
Ser 45 HN 8.2730 N 113.3324 
Lys 46 HA 5.5085 
Lys 46 HB1 1.6325 
Lys 46 HB2 1.4585 
Lys 46 HD1 1.555 
Lys 46 HD2 1.555 
Lys 46 MEl 2.835 
Lys 46 HE2 2.835 
Lys 46 HG1 1.335 
Lys 46 HG2 1.2223 
Lys 46 HN 7.3919 N 119.2821 
Lys 46 HZ1 NZ 
Lys 46 HZ2 NZ 
Lys 46 HZ3 NZ 
Ser 47 HA 4.8267 
Ser 47 HB1 3.7416 
Ser 47 HB2 3.5995 
Ser 47 HN 8.1780 N 116.2535 
Tyr 48 HA 5.4387 
Tyr 48 HB1 2.95 
Tyr 48 HB2 2.793 
Tyr 48 HD1 7.0926 
Tyr 48 HD2 7.0926 
Tyr 48 HE1 6.7543 
Tyr 48 HE2 6.7543 
Tyr 48 HN 8.5544 N 122.0209 
Cys 49 HA 4.084 
Cys 49 HBI 2.495 
Cys 49 HB2 1.4195 
Cys 49 HN 8.3290 N 121.5754 
Glu 50 HA 4.5595 
Glu 50 HB1 2.131 
Glu 50 HB2 1.73 
Glu 50 HG1 1.976 
Glu 50 HG2 1.587 
Glu 50 HN 9.103 N 
Leu 51 MA 4.601 
Leu 51 HB1 1.644 
Leu 51 HB2 1.531 
Leu 51 HD11 0.687 
Leu 51 HDI2 0.687 
Leu 51 HD13 0.687 
Leu 51 MD21 0.658 
Leu 51 HD22 0.658 
Leu 51 HD23 0.658 
Leu 51 HG 1.246 
Leu 51 MN 7.9214 N 
Gly 52 HAl 4.3272 
Gly 52 HA2 3.833 
Gly 52 HN 8.8175 N 






Ser 53 HB1 3.95 
Ser 53 HB2 3.921 
Ser 53 HN 8.6921 N 115.9721 
Thr 54 HA 4.408 
Thr 54 HB 4.499 
Thr 54 HG21 1.154 
Thr 54 HG22 1.154 
Thr 54 HG23 1.154 
Thr 54 HN 7.867 N 109.5237 
Gly 55 HAl 4.257 
Gly 55 HA2 3.4895 
Gly 55 HN 7.8613 N 108.72 
Ser 56 HA 4.519 
Ser 56 HB1 3.725 
Ser 56 HB2 3.648 
Ser 56 HN 7.4777 N 114.7306 
Met 57 HA 5.046 
Met 57 HB1 1.672 
Met 57 HB2 1.586 
Met 57 HE1 
Met 57 HE2 
Met 57 HE3 
Met 57 HG1 2.294 
Met 57 HG2 2.0315 
Met 57 HN 8.173 N 121.9561 
Val 58 HA 4.393 
Val 58 HB 1.979 
Val 58 HG11 0.747 
Val 58 HG12 0.747 
Val 58 HG13 0.747 
Val 58 HG21 0.6775 
Val 58 HG22 0.6775 
Val 58 HG23 0.6775 
Val 58 HN 9.0955 N 119.0844 
Trp 59 HA 5.007 
Trp 59 HB1 3.292 
Trp 59 HB2 2.798 
Trp 59 HOl 7.141 
Trp 59 HE3 7.1377 
Trp 59 HH2 7.5182 
Trp 59 HZ2 7.1746 
Trp 59 HZ3 6.7868 
Trp 59 HN 7.7207 N 121.9619 
Trp 59 HE1 10.3884 NE1 127.0873 
Asn 60 HA 4.97 
Asn 60 HB1 2.7414 
Asn 60 HB2 2.371 
Asn 60 HN 9.5845 N 123.7945 
Asn 60 HD21 7.882 ND2 112.8656 
Asn 60 HD22 6.71 ND2 112.8656 
Pro 61 HA 5.033 
Pro 61 HB1 2.4977 
Pro 61 HB2 2.2895 
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Pro 61 HD1 4.2423 
Pro 61 HD2 3.7383 
Pro 61 HG1 1.892 
Pro 61 I-$G2 1.892 
Glu 62 HA 4.136 
Glu 62 1-1131 2.069 
Glu 62 1-1132 1.958 
Glu 62 HG1 2.378 
Glu 62 HG2 2.378 
Glu 62 HN 8.2665 N 117.5942 
Ala 63 HA 3.69 
Ala 63 1-1131 0.993 
Ala 63 1-1132 0.993 
Ala 63 HB3 0.993 
Ala 63 HN 7.8315 N 122.9688 
Pro 64 HA 4.5732 
Pro 64 HB1 1.852 
Pro 64 1-1132 1.54 
Pro 64 HD1 2.977 
Pro 64 H02 2.977 
Pro 64 HG1 1.487 
Pro 64 HG2 0.3845 
lie 65 HA 4.3665 
lie 65 HB 1.646 
Ile 65 HD11 0.488 
lie 65 HD12 0.488 
Ile 65 HD13 0.488 
lie 65 HG11 1.267 
He 65 HG12 0.987 
lie 65 HG21 0.769 
He 65 HG22 0.769 
Ile 65 HG23 0.769 
lie 65 HN 7.5682 N 109.4444 
Cys 66 HA 5.1736 
Cys 66 HB1 2.737 
Cys 66 HB2 2.475 
Cys 66 HN 8.8600 N 120.6586 
Glu 67 HA 4.8387 
Glu 67 HB1 1.827 
Glu 67 1-1132 1.771 
Glu 67 HG1 2.264 
Glu 67 HG2 2.219 
Glu 67 HN 8.9290 N 124.4372 
Ser 68 HA 3.816 
Ser 68 HB1 3.527 
Ser 68 1-1132 3.527 
Ser 68 HN 8.9520 N 121.6756 
Val 69 HA 3.829 
Val 69 HB 1.649 
Val 69 HG11 0.5625 
Val 69 HG12 0.5625 
Val 69 HG13 0.5625 
Val 69 HG21 0.5485 
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Val 69 HG22 0.5485 
Val 69 HG23 0.5485 
Val 69 HN 7.7907 N 122.9853 
Lys 70 HA 4.6513 
Lys 70 1-1131 1.821 
Lys 70 HB2 1.49 
Lys 70 HD1 1.277 
Lys 70 HD2 1.203 
Lys 70 HE1 2.5823 
Lys 70 HE2 2.5823 
Lys 70 HG1 1.11 
Lys 70 HG2 1.11 
Lys 70 HN 8.1170 N 124.5894 
Lys 70 HZ1 NZ 
Lys 70 HZ2 NZ 
Lys 70 HZ3 NZ 
Cys 71 HA 4.277 
Cys 71 HB1 3.0855 
Cys 71 H132 2.15 
Cys 71 HN 8.7970 N 116.7848 
Gin 72 HA 4.7812 
Gin 72 H131 2.054 
Gin 72 HB2 2.054 
Gin 72 HG1 2.51 
Gin 72 HG2 2.4125 
Gin 72 HN 8.4213 N 119.8458 
Gin 72 HE21 7.49 NE2 111.959 
Gin 72 HE22 6.798 NE2 111.959 
Ser 73 HA 4.4355 
Ser 73 HB1 3.904 
Ser 73 1-1132 3.859 
Ser 73 HN 7.9505 N 114.3212 
Pro 74 HA 3.1667 
Pro 74 HB1 0.87 
Pro 74 HB2 -0.206 
Pro 74 HD1 3.199 
Pro 74 HD2 3.158 
Pro 74 HG1 0.618 
Pro 74 HG2 0.3017 
Pro 75 HA 4.2535 
Pro 75 HB1 2.2425 
Pro 75 1-1132 1.65 
Pro 75 HDI 3.0743 
Pro 75 HD2 2.886 
Pro 75 HG1 1.9335 
Pro 75 HG2 1.76 
Ser 76 HA 4.5874 
Ser 76 H131 3.822 
Ser 76 HB2 3.775 
Ser 76 HN 8.411 N 117.8555 
Ile 77 HA 4.616 
Ile 77 HB 1.7466 
Ile 77 HD11 0.452 
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Ile 77 HD12 0.452 
Ile 77 HD13 0.452 
Ile 77 HGI1 1.011 
Ile 77 HG12 0.7925 
Ile 77 HG21 0.618 
Ile 77 HG22 0.618 
Ile 77 HG23 0.618 
Ile 77 HN 8.5985 N 116.9143 
Ser 78 HA 4.142 
Ser 78 HB1 3.7317 
Ser 78 HB2 3.666 
Ser 78 HN 8.283 N 118.7716 
Asn 79 HA 3.738 
Asn 79 HB1 2.122 
Asn 79 HB2 1.243 
Asn 79 HN 8.8833 N 115.5845 
Asn 79 HD21 7.415 ND2 116.5215 
Asn 79 HD22 6.721 ND2 116.5215 
Giy 80 HAl 4.328 
Giy 80 HA2 4.0315 
Gly 80 HN 7.0543 N 101.719 
Arg 81 HA 4.689 
Arg 81 HB1 1.7397 
Arg 81 HB2 1.5925 
Arg 81 HD1 2.9915 
Arg 81 HD2 2.9915 
Arg 81 HG1 1.3953 
Arg 81 HG2 1.2147 
Arg 81 HN 8.788 N 116.5706 
Arg 81 HE 6.8805 NE 119.581 
Arg 81 HH11 NH1 
Arg 81 HH12 NH1 
Arg 81 HH21 NI-12 
Arg 81 HH22 NI-12 
His 82 HA 4.988 
His 82 HB1 1.9153 
His 82 HB2 1.3434 
His 82 HD2 7.59 
His 82 HE1 6.5388 
His 82 HN 7.4984 N 114.484 
His 82 HD1 ND1 
His 82 HE2 NE2 
Asn 83 HA 4.5875 
Asn 83 HB1 3.103 
Asn 83 HB2 2.572 
Asn 83 HN 7.8376 N 119.0528 
Asn 83 HD21 7.3400 ND2 110.0915 
Asn 83 HD22 6.9595 ND2 110.0915 
Giy 84 HAl 4.188 
Giy 84 HA2 3.428 
Giy 84 HN 10.5547 N 
Tyr 85 HA 4.7287 
Tyr 85 HB1 3.145 
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Tyr 85 1-1132 2.852 
Tyr 85 HD1 7.06 
Tyr 85 HD2 7.06 
Tyr 85 HE1 6.77 
Tyr 85 HE2 6.77 
Tyr 85 HN 8.0632 N 121.1487 
Glu 86 HA 4.393 
Glu 86 1-1131 1.777 
Glu 86 1-1132 0.909 
Glu 86 HG1 2.033 
Glu 86 HG2 1.996 
Glu 86 HN 7.6000 N 119.5635 
Asp 87 HA 4.37 
Asp 87 1-1131 2.346 
Asp 87 1-1132 2.346 
Asp 87 HN 8.3120 N 118.4497 
Phe 88 HA 5.1385 
Phe 88 1-1131 2.879 
Phe 88 1-1132 2.651 
Phe 88 HD1 7.034 
Phe 88 HD2 7.034 
Phe 88 HE1 7.257 
Phe 88 HE2 7.257 
Phe 88 HZ 7.23 
Phe 88 HN 7.1480 N 113.2987 
Tyr 89 HA 4.6143 
Tyr 89 1-1131 2.9025 
Tyr 89 1-1132 2.512 
Tyr 89 HD1 7.0342 
Tyr 89 HD2 7.0342 
Tyr 89 HE1 6.5989 
Tyr 89 HE2 6.5989 
Tyr 89 HN 8.8432 N 119.0051 
Thr 90 HA 4.318 
Thr 90 HB 4.209 
Thr 90 HG21 1.1987 
Thr 90 HG22 1.1987 
Thr 90 HG23 1.1987 0.020 
1.0240 
Thr 90 HN 8.1710 N 112.2744 
Asp 91 HA 4.075 
Asp 91 1-1131 2.528 
Asp 91 1-1132 2.528 
Asp 91 HN 8.5430 N 123.8181 
Gly 92 HAl 4.378 
G)y 92 HA2 3.545 
Gly 92 HN 9.0763 N 114.6371 
Ser 93 HA 4.414 
Ser 93 1-1131 4.081 
Ser 93 1-1132 3.8798 
Ser 93 HN 7.9480 N 116.8436 
Val 94 HA 5.3107 
Val 94 HB 1.818 
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Val 94 HG11 0.8813 
Val 94 HG12 0.8813 
Vat 94 HG13 0.8813 
Vat 94 HG21 0.7203 
Val 94 HG22 0.7203 
Vat 94 HG23 0.7203 
Vat 94 FIN 8.2377 N 121.7191 
Vat 95 HA 4.218 
Vat 95 HB 1.1547 
Vat 95 UGh 1 0.2646 
Vat 95 HG12 0.2646 
Vat 95 HG13 0.2646 
Vat 95 HG21 0.1985 
Vat 95 HG22 0.1985 
Vat 95 HG23 0.1985 
Vat 95 FIN 8.6941 N 128.0055 
Thr 96 HA 5.0457 
Thr 96 FIB 3.794 
Thr 96 HG21 1.0777 
Thr 96 HG22 1.0777 
Thr 96 HG23 1.0777 
Thr 96 FIN 8.411 N 120.0093 
Tyr 97 HA 4.973 
Tyr 97 H131 2.6808 
Tyr 97 HB2 2.462 
Tyr 97 HD1 6.7991 
Tyr 97 HD2 6.7991 
Tyr 97 HE1 6.4914 
Tyr 97 HE2 6.4914 
Tyr 97 HN 9.0102 N 125.8777 
Ser 98 HA 4.514 
Ser 98 HB1 3.7195 
Ser 98 H132 3.617 
Ser 98 HN 8.7987 N 111.7201 
Cys 99 HA 5.232 
Cys 99 HB1 3.014 
Cys 99 H132 2.496 
Cys 99 FIN 8.761 N 118.1932 
Asn 100 HA 4.491 
Asn 100 H131 2.9377 
Asn 100 HB2 2.3575 
Asn 100 FIN 8.6242 N 121.8873 
Asn 100 HD21 7.5313 ND2 108.613 
Asn 100 H022 6.624 ND2 108.613 
Ser 101 HA 4.197 
Ser 101 HB1 3.819 
Ser 101 HB2 3.819 
Ser 101 HN 8.341 N 113.6614 
Gly 102 HAl 4.205 
Gty 102 HA2 3.478 
Gly 102 HN 8.7645 N 113.7785 
Tyr 103 HA 4.6 
Tyr 103 H131 3.255 
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Tyr 103 HB2 2.457 
Tyr 103 HOl 6.6262 
Tyr 103 HD2 6.6262 
Tyr 103 HE1 6.629 
Tyr 103 HE2 6.629 
Tyr 103 HN 8.0898 
Ser 104 HA 4.643 
Ser 104 1-1131 3.652 
Ser 104 1-1132 3.652 
Ser 104 HN 9.4416 
Leu 105 HA 4.6115 
Leu 105 HB1 1.624 
Lau 105 1-1132 1.505 
Leu 105 HD11 0.672 
Leu 105 HD12 0.672 
Leu 105 HD13 0.672 
Leu 105 HD21 0.515 
Leu 105 HD22 0.515 
Leu 105 F1D23 0.515 
Leu 105 HG 1.261 
Leu 105 HN 8.248 
Ile 106 HA 4.227 
Ile 106 HB 1.9267 
Ile 106 HD1I 0.5857 
Ile 106 HD12 0.5857 
Ile 106 HD13 0.5857 
Ile 106 HG11 1.271 
Ile 106 HG12 1.179 
Ile 106 HG21 0.736 
Ile 106 HG22 0.736 
Ile 106 HG23 0.736 
Ile 106 HN 9.3240 N 
Giy 107 HAl 4.4177 
Giy 107 HA2 3.544 
Giy 107 HN 8.3030 N 
Asn 108 HA 4.576 
Asn 108 HB1 2.892 
Asn 108 1-1132 2.674 
Asn 108 HN 8.2127 N 
Asn 108 HD21 7.6460 ND2 
Asn 108 HD22 6.8750 ND2 
Ser 109 HA 4.0045 
Ser 109 HB1 4.2 
Ser 109 HB2 3.863 
Ser 109 HN 8.3275 N 
Giy 110 HAl 5.025 
Giy 110 HA2 3.333 
Giy 110 HN 7.8182 N 
Val 111 HA 4.193 
Vat 111 HB 2.0947 
Val 111 HG11 0.7873 
Val 111 HG12 0.7873 















Vat 111 HG21 0.618 
Vat 111 HG22 0.618 
Vat 111 HG23 0.618 
Val 111 HN 8.9959 N 119.8112 
Leu 112 HA 5.1773 
Leu 112 HB1 1.5755 
Leu 112 H132 1.3725 
Leu 112 H131  0.769 
Leu 112 HD12 0.769 
Leu 112 HD13 0.769 
Leu 112 HD21 0.7155 
Leu 112 HD22 0.7155 
Leu 112 HD23 0.7155 
Leu 112 HG 1.183 
Leu 112 HN 8.3530 N 125.4265 
Cys 113 HA 3.9842 
Cys 113 HB1 2.332 
Cys 113 HB2 1.0547 
Cys 113 HN 8.5714 N 127.2747 
Ser 114 HA 4.7835 
Ser 114 H131 3.648 
Ser 114 H132 3.504 
Ser 114 HN 8.7860 N 124.4573 
Gly 115 HAl 3.682 
Gly 115 HA2 3.638 
Gly 115 HN 9.3558 N 118.4684 
Gly 116 HAl 3.871 
Gly 116 HA2 3.119 
Gly 116 HN 7.9982 N 104.3903 
Glu 117 HA 4.54 
Glu 117 HB1 2.006 
Glu 117 HB2 1.731 
Glu 117 HG1 2.221 
Glu 117 HG2 2.133 
Glu 117 HN 7.2672 N 119.7915 
Trp 118 HA 5.2927 
Trp 118 HB1 3.251 
Trp 118 H132 2.881 
Trp 118 HD1 7.1155 
Trp 118 HE3 7.058 
Trp 118 HH2 5.9959 
Trp 118 HZ2 6.798 
Tip 118 HZ3 6.752 
Trp 118 HN 8.4093 N 122.7505 
TIp 118 HE1 9.5048 NE1 128.6522 
Ser 119 HA 4.438 
Ser 119 H131 4.376 
Ser 119 H132 4.11 
Ser 119 HN 8.067 N 116.2191 
Asp 120 HA 4.629 
Asp 120 HB1 2.534 
Asp 120 HB2 2.474 
Asp 120. HN 7.9055 N 115.8752 
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Pro 121 HA 4.147 
Pro 121 1-1131 1.4877 
Pro 121 1-1132 1.4877 
Pro 121 HD1 3.893 
Pro 121 HD2 3.6865 
Pro 121 HG1 1.825 
Pro 121 HG2 1.679 
Pro 122 HA 4.6247 
Pro 122 1-1131 1.933 
Pro 122 1-1132 1.596 
Pro 122 HD1 3.08 
Pro 122 HD2 2.2297 
Pro 122 HG1 0.997 
Pro 122 HG2 0.672 
Thr 123 HA 4.448 
Thr 123 HB 3.898 
Thr 123 HG21 1.077 
Thr 123 HG22 1.077 
Thr 123 HG23 1.077 
Thr 123 HN 7.9347 N 106.5773 
Cys 124 HA 5.4316 
Cys 124 1-1131 2.7345 
Cys 124 1-1132 2.4733 
Cys 124 HN 8.9275 N 121.2655 
Gin 125 HA 4.915 
Gin 125 1-1131 2.04 
Gin 125 1-1132 1.746 
Gin 125 HG1 2.306 
Gin 125 HG2 2.238 
Gin 125 HN 9.3012 N 123.8339 
Gin 125 HE21 7.466 NE2 111.39 
Gin 125 HE22 6.709 NE2 111.39 
Ile 126 HA 3.8295 
Ile 126 HB 1.5403 
Ile 126 HD11 0.4855 
Ile 126 HD12 0.4855 
Ile 126 HD13 0.4855 
Ile 126 HG11 1.06 
Ile 126 HG12 0.707 
Ile 126 HG21 0.7085 
Ile 126 HG22 0.7085 
Ile 126 HG23 0.7085 
Ile 126 HN 8.6608 N 126.4859 
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